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Salmonella remains one of the two most common causes of bacterial food poisoning and is 
primarily associated with the consumption of poultry meat. These organisms colonize the 
alimentary tract and are excreted in the faeces by healthy infected birds thereby entering the human 
food chain. S. Typhimurium and S. Enteritidis are numerically the predominant serotypes affecting 
poultry causing human infections through consumption of meat. Infection via the egg is also an 
important factor in the epidemiology of infection in poultry and man through consumption of 
contaminated eggs and vertical transmission through the egg from broiler breeders to broiler 
progeny (BARROW and LOVELL 1991). Over the past 5 years Salmonella Enteritidis infections in 
humans have increased on both sides of the Atlantic ocean. S. Enteritidis appears to be increasing 
on at least the continents of North America, South America, and Europe, and may include Africa. 
Although the reason for the global increase is not yet clear, investigations in individual countries 
suggest it is related to consumption of eggs and poultry which harbour the organism (RODRIGUE 
et al. 1990) 
 
Incidence of Salmonella food poisoning has increased remarkably world wide in the last few years, 
especially those caused by S. Enteritidis. Poultry products (meat and eggs) have been implicated 
repeatedly in human outbreaks of Salmonella food poisoning (HAFEZ. 1993).  During 1997, S. 
Enteritidis accounted for 85% of all cases of human salmonellosis in Europe, but incidence has 
declined from this peak (FISHER. 2001). Further investigations established that phage type (PT) 4 
S. Enteritidis predominated during this pandemia, but other phage types were often detected. During 
this same period, salmonellosis from S. Typhimurium and other serotypes remained relatively stable 
throughout Europe and the US. In contrast to the experience of Europe, the US and Canada have 
experienced only a four- to sixfold increase in human illness (currently at four cases per 100000 
people). There is concern about the potential for S. Enteritidis in the US to increase to European 
levels, because of the recent emergence of PT4 S. Enteritidis in California and other western states 
(WARD et al. 1987, ANONYMOUS. 1999). The spread of S. Enteritidis infections in the United 
States was tracked to identify potential risk factors and preventive measures. From 1985 through 
1991, 380 outbreaks were reported involving 13,056 ill persons and 50 deaths. The proportion of 
Northeast outbreaks fell from 81% in 1985 to 55% in 1991 as the number of outbreaks in other 
areas increased. Grade A shell eggs were implicated in 82% of outbreaks. Eggborne S. Enteritidis 
infections are a major public health problem (MISHU et al. 1994) 
 
In countries with intensive poultry production such as Germany it has been determined that under 
current condition it would be very difficult to eliminate Salmonella contamination in poultry 
production. However, the possibility to reduce invasive serovariants is realistic (HAFEZ. 1993). A 
probiotic is often referred to as a live microbial food supplement that beneficially affects the host by 
improving its intestinal microbial balance. It is still a mystery how probiotics actually exert their 
effect on the host. It may be that probiotics directly aggravate the pathogens by producing 
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antimicrobial and antibacterial compounds like bacteriocins or volatile fatty acids. Probiotics may 
also decrease the gut pH by stimulating lactic acid-creating microflora. Other postulated 
mechanisms include the idea that probiotics compete with the pathogens for receptor sites and that 
they also may compete for nutrients and growth factors. Some researchers propose that probiotics 
improve immune function and stimulate immune modulating cells. Lastly, probiotics may produce 
lactase that may aid in lactose digestion (KOPP-HOOLIHAN. 2001)  
 
The use of probiotics to improve microbial balance is not new.  The concept first evolved around 
1900 when the Nobel Prize winning, Russian scientist – Metchnikoff suggested the long, healthy 
lives of Bulgarian peasants was the result of their fermented milk consumption (SANDERS. 2000) 
Since then the study of probiotics has increased and is now being considered for its many probable 
health advantages that include increase in resistance to infectious diseases of the intestinal tract, 
cancer suppression, decrease in serum cholesterol levels, alleviation of lactose intolerance 
symptoms, improved digestion and stimulation of gastrointestinal immunity among others 
(COLLINS and GIBSON 1999). Prophylactic and therapeutic treatments with probiotics either 
before or after the pathogens were significantly reduced chick mortality  and shedding of the 
pathogens. Prophylactic treatments were also effective qualitatively in reducing the isolation of S. 
Typhimurium (WATKINS and MILLER 1983, WEINACK et al. 1986). Probiotics inhibit growth 
of serovar Enteritidis under caecal growth conditions. The undissociated forms of acetate and 
propionate produced in the mixed culture inhibited the growth of serovar Enteritidis (VAN DER 
WIELEN et al. 2002) 
Probiotic bacteria have several immunomodulatory effects: adjuvant-like properties and 
antiinflammatory properties. Moreover, both quantitative and qualitative differences in immune 
exclusion, immune elimination, and immune regulation. Distinct regulatory effects associated with 
probiotic consumption have been detected in healthy subjects and patients with inflammatory 
diseases (ISOLAURI et al. 2001). Probiotics were potentiate the gut defence barrier by 
nonimmunologic and immunologic means. It normalize increased intestinal permeability and 
altered gut microecology, and potentiate the immunologic defence barrier of the host, at least by 
enhancing the IgA response and by alleviating the intestinal inflammatory response 
(KIRJAVAINEN et al. 1999) 
 
This study aims to examine biological methods to fight or to repell salmonellosis in chickens. 
 
1- Main agent herein is the E. coli strain Nissle 1917 that is known since the year of 1917 and has 
frequently been used as a probiotic in human medicine. It’s antagonistic effect on Salmonella 
Enteritidis has been tested in-vitro as well as in two in-vivo-tests in SPF-chickens. Both, E. coli and 
S. Enteritidis have been marked with Rifampicin or Nalidixin-acid and Novobiocin. The in-vitro-
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tests were supposed to give information about the possible antagonism of the E. coli strain Nissle 
1917 against S. Enteritidis and about the role of the two cryptic plasmids in the probiotic action. 
 
2- The first experiment with SPF chickens is aiming further to examine wether a single application 
of the probiotic on the first respectively the second day of life, before or after an infection with S. 
Enteritidis, has been able to grant a stable colonization for the probiotic and to eliminate or to 
restrain the Salmonella infection. We examined the probiotic effects of marked and unmarked E. 
coli strain Nissle 1917 on colonization of S. Enteritidis PT4, on the dynamism of the intestinal flora 
and it’s influence on immunologic and on growth parameters and to examine the influence of the 
resistance-marker on the means of colonization, E. coli strain Nissle 1917 was also used unmarked. 
To support the effect a Bdellovibrio bacteriovorus originally isolated from chickens, which is 
known as a degradient of gram-negative bacteria has been co-cultured. 
 
3- In the second experiment the probiotic was applied daily. The main issue was the sole influence 
of the probiotic on the parameters mentioned before and the significance of the two cryptic 
plasmids concerning their role in probiotic action of E. coli strain Nissle 1917.  
 
4- Depending on the means of detectability of E. coli strain Nissle 1917 and 14 days after 
colonization the probiotic is supposed to be applied daily from day 14 onwards. The probiotic’s 
antagonistic effect is being evaluated based on quantitative bacteriological examination of the 
















2                   Review of Literature 
 
2.1 Salmonella 
Salmonellas are gram negative bacteria, non sporing rods that do not have capsules. Salmonellas 
include more than 2.200 closely related serovariants. Each strain can be subclassified as a phage 
type. Most strains of Salmonella are found in the gut, and some invasive serovariants are able to 
spread from cause systematic illness. Paratyphoid organisms contain endotoxin which is responsible 
for their pathogenic effect (HAFEZ. 1993) Salmonellae can be differentiated on the basis of their 
epidemiology and clinical significance to both man and animals. a) Typhus-paratyphus group (S. 
Typhi, S. Paratyphi) as the cause of specific typhoid (diseases of man). In animals S. Typhi occurs 
as a result of environmental contamination mainly in birds., b) Salmonellae which occur in all 
useful animals and are transmissible to man. This includes the majority of Salmonellae, the 
prototype being S. Typhimurium. These salmonellae cause food poisoning in man (enteric 
salmonellae). c) Salmonellae which occur mainly in animals and rarely lead to human disease, these 
organisms have often become adapted to one particular animal species. The following are all part of 
this group, S. Dublin, S. Gallinarum-pullorum, S. Abortusovis, S. Abortusequi, S. Abortusbovis, S. 
Choleraesuis, S. Typhisuis and S. Typhimurium var. copenhagen. The salmonellae most frequently 
identified in specimens of animal origin, including food material are S. Typhimurium, S. Dublin, S. 
Gallinarum-pullorum, S. Derby, S. Infantis, S. Agona, S. Panama, S. Enteritidis, S. Heidelberg 
(BISPING and AMTSBERG 1988) 
 
The number of reported isolates of S. Enteritidis has increased dramatically in the last 10 years. For 
many years phage typing has been a useful epidemiologic tool for studying outbreaks of S. Typhi 
and S. Enteritidis. In 1987, Ward et al. described a phage typing scheme for S. Enteritidis. This 
system differentiated 27 phage types by use of 10 typing phages. With these phages, they typed 573 
strains of S. Enteritidis from humans (42 outbreaks), animals, food, and the environment. Ninety-six 
percent of the strains were typeable. The most common phage types were 8 (48.2%), 13a (20.1%), 
13 (7.8%), and 14b (7.8%). Most of the strains were specifically collected from egg-related 
outbreaks in the northeastern United States in 1988 and 1989, probably accounting for the 
distribution of the four most common types in this sample. This system was particularly useful for 
differentiating a group of animal strains that had a number of diverse phage types. For 49 animal 
strains typed, 16 different patterns were obtained. Phage type 8 represented 32% of these strains, 
but no other phage type represented more than 8% of these strains. One-half of the 16 animal strains 
that were phage type 8 were from poultry. This phage typing system will be useful for comparing 
phage types found in the United States with those types encountered world wide and for 
determining whether virulent strains of phage type 4 are entering the United States (HICKMAN-
BRENNER et al. 1991). The recent isolation of phage type 4 S. Enteritidis strains from poultry and 
humans in the United States has generated considerable concern because this phage type is 
predominant in both animals and humans in many other nations. Understanding whether the 
presence of these strains in poultry flocks poses an elevated threat to public health is a critical issue 
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for developing effective disease control programs. The present study evaluated whether S. 
Enteritidis strains of various phage types found in poultry in the United States (phage types 4, 8, 
and 13a) differed in their potential for horizontal transmission from experimentally infected chicks 
to uninoculated chicks housed in the same isolator units. Five days after two seeder chicks in each 
group of 12 were inoculated with oral doses of approximately 103 S. Enteritidis cells at 8 days of 
age, caeca and livers were sampled from seeder chicks and from their contact-exposed penmates. 
On the basis of the detection of S. Enteritidis in caecal samples, phage type 4 strains were 
transmitted horizontally at a significantly lower frequency than were strains of other phage types. 
Nevertheless, two of three phage type 4 strains evaluated were very highly invasive (GAST and 
HOLT 1998) 
 
The paratyphoid Salmonella bacteria, comprising more than 2,000 serovars or serotypes, are a 
major problem to the poultry industry. This is largely the result of entry of the bacteria into the 
human food chain. Human infection takes the form of a gastroenteritis, which in highly susceptible 
individuals can result in death. Some strains of certain serotypes have the capacity to produce 
morbidity and mortality in very young chickens. In adult birds, some serovars become localised in 
the reproductive tract with concomitant vertical transmission. The association between S. Enteritidis 
and table eggs has produced a great deal of publicity and concern with resulting national and 
international attempts at controlling the major serotypes, S. Typhimurium and S. Enteritidis, at the 
breeder and layer level. Control is possible through rigorous hygiene and management procedures, 
but is not always economically viable. As a result, control by serological and bacteriological testing 
and slaughter may also not be feasible. Antibiotics have been used to reduce carriage but can cause 
problems of resistance and increased susceptibility. The use of growth promoting antibiotics can 
also increase susceptibility to infection. Other means of increasing the resistance of poultry to 
infection are therefore being sought. These include the use of intestinal flora preparations for 
competitive exclusion of Salmonella from newly hatched chicks. Killed and live vaccines are used, 
both with some success. However, the safety of some live vaccines is still uncertain (BARROW. 
2000). It has therefore not been obvious how S. Enteritidis is especially able to follow the human 
infection route described and, above all, at a critical step, how it so successfully contaminates and 
grows in egg contents. S. Enteritidis has been shown by a number of investigators to generate a 
striking degree of strain heterogeneity (PARKER et al. 2001) 
 
2.1.1 Incidence of Salmonella 
The German National Reference Laboratory for Salmonella (NRL-Salm) types about 5000 to 7000 
Salmonella isolations per year. They originate from animals, food, feed and the environment. In 
West Germany, the number of human S. Enteritidis cases was monitored by a national surveillance 
program from 1973 to 1982. In 1975, the number of human infections began to increase, indicating 
the beginning of the S. Enteritidis epidemic in West Germany. S. Enteritidis was responsible for 62 
outbreaks, most of which were traced to raw eggs. By 1988, the number of disease outbreaks caused 
by S. Enteritidis had increased to 1,365. In order to monitor the epidemiological situation of S. 
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Enteritidis in Germany, in 1990-1991. 1138 isolates from more than 180 locations in West 
Germany were phage typed. 1124 strains (98.8%) from all sources were typeable, belonging to 21 
different phage types (PT). PT4 strains were isolated most frequently (70.8%). In addition, PT7, 25, 
34 and 8 were of epidemiological relevance with incidences of 7.2 to 4.5%. The comparison of data 
shows that in Germany, like in other parts of Europe, PT4 predominates. This phage type is, 
however, infrequent in North America, where PT8 has the highest incidence (SCHROETER et al. 
1994)  
 
The incidence of S. Typhimurium infections among fowl increased in the region of Potsdam in 
general, and on various big farms in particular, 1976 and over the first half of 1977. The outbreaks 
included subclinical infections and clinically manifest diseases which caused remarkable loss of 
broilers from the affected stocks (up to 15.92%). Parent stocks contaminated with S. Typhimurium 
were to be the sources of infection in all cases. A total of 1,220 Salmonella strains were isolated 
from fowl and its environment, with 1,151 of them being S. Typhimurium (2.98%of all samples 
tested). The following amounts of S. Typhimurium strains were isolated from different types of 
samples which had been collected from infected broiler stocks: 8.10% from dead broilers, 5.86% 
from dead broiler parents, 2.11% from pulp linings of transport cages for day-old chicks, 1.23% 
from litter, 1.0% from hatching material (eggs or dead and jammed embryo, and 0.12% from swabs 
used in hygiene supervision). No Salmonellae were isolated from feedstuff (KOHLER et al. 1979)  
 
Salmonellosis bear the character of a model of zoonotic diarrhoeal diseases. Whereas those serovars 
predominantly adapted to human beings or animal species are without any importance in this 
connection, such serovars with own epizootic processes in different animal species with or without 
causing illness are able to be transferred to human beings via foods of animal origin and to act as 
etiological agents of gastroenteritis. Some strains of them equipped by special properties often 
encoded by plasmids can be transferred from man to man, too. In GDR in 1987 S. Enteritidis 
(34.0%), S. Typhimurium (17.9%), S. Manhattan (7.7%) and S. Agona (7.4%) amounted to two 
thirds of all the Salmonella isolates in connection with human enteritis (BOHME et al. 1989)  
 
Over the past 5 years S. Enteritidis infections in humans have increased on both sides of the Atlantic 
ocean. The WHO salmonella surveillance data for 1979-87 were reviewed and show that S. 
Enteritidis appears to be increasing on at least the continents of North America, South America, and 
Europe, and may include Africa. S. Enteritidis isolates increased in 24 (69%) of 35 countries 
between 1979 and 1987. In 1979, only 2 (10%) of 21 countries with reported data reported S. 
Enteritidis as their most common salmonella serotype; in 1987, 9 (43%) of 21 countries reported S. 
Enteritidis as their most common serotype; 8 (89%) of 9 were European countries. Although the 
reason for the global increase is not yet clear, investigations in individual countries suggest it is 
related to consumption of eggs and poultry which harbour the organism (RODRIGUE et al. 1990). 
S. Enteritidis accounted for 5.45% of the 118.685 Salmonella isolates from man and for 2.65% of 
the 3.315 Salmonella isolates from food in Italy in the eleven year period 1978 to 1988. In the years 
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1978-1982 no S. Enteritidis strain was isolated from eggs and poultry; in the years 1983-1988 the 
53% of S. Enteritidis isolates from food were from eggs and poultry. In 1989 S. Enteritidis 
accounted for 744 isolates from man and 22 from food of which 80% were from eggs and poultry 
(FANTASIA et al. 1991). A significant increase in the number of isolations of S. Enteritidis has 
been observed in Argentina since 1986. Outbreaks of foodborne diseases in humans were associated 
with the consumption of raw or undercooked hens' eggs. Between 1986 and the first 6 months of 
1993 there were 150 outbreaks reported, affecting more than 6000 persons (CAFFER and EIGUER 
1994)  
 
Epidemiology of infection by salmonellae in humans has changed in that, a part from the 
spectacular outbreaks amongst the users of industrial catering, the majority of cases occurs as 
sporadic cases. Further dramatic decline in the number of cases of human infection by salmonellae 
is currently unlikely. However, a reduction in cases will occur as a result of the improved handling 
of eggs. In the human population the number of reported cases of S. Enteritidis typically reaches a 
peak in the summer, but there were also peaks outside this period. A great number of Salmonella 
outbreaks in humans caused by chickens did not originate from the large scale livestock farms but 
from smaller animal stocks. The increased number of findings in the dissected material of dead or 
diseased animals (11.9%), in faecal samples (3.21%) and in blood tests on animals slaughtered 
because of injury or disease (3,1%) point to an increased sprea of Salmonella infections in the 
domestic livestock of Brandenburg in 1995. The S. Enteritidis strains differentiated for typing from 
the federal state of Brandenburg also make clear in 1992, with 88.51%, the significance of the 
phage type 4/6, followed by 6/6 (3.41%) and 1/1 (2.48%) in human population. All other isolates 
attained for lysotyping are present with a proportion of less than 1.55% (RUST. 2000)  
 
In Hungary, 14 819 human S. Enteritidis strains were isolated between 1976 and 1983. Phage type 
was determined of 10 132 human strains originating from 6852 foci, and of 711 strains isolated 
from animals and water in this period. The human strains were typable in 99.4% and they belonged 
into 21 phage types. Five phage types (1, 4, 7, 16 and 17) were more frequent than 1%. Phage type 
7 predominated among the strains isolated between 1976 and 1980, including 65.6%-89.3% of the 
strains. There was a change in the prevalence of phage types from 1980-1981, as phage type 7 was 
ousted by phage type 1. The date of the change in the predominance of phage types coincided with 
the considerable increase of S. Enteritidis isolates; the number of isolates was nearly fivefold in 
1980 of that in 1976. Phage type 7 frequent in the first period proved to be homogeneous; the 
strains could not be subdivided either by the temperate phages carried by them or by other phages. 
The incidence of phage types 1 and 7 was nearly the same among the strains derived from animals, 
food, water and hygienic control examinations, and there was no temporal difference in the 
frequency of the two phage types as it was observed among the human strains. The human strains 
originated in 49.5% from outbreaks and in 50.5% from sporadic cases in the country. Of the strains 
examined for phage type during the eight-year period, 41.9% were isolated from 23 field epidemics, 
84 community outbreaks and 757 family infections (LASZLO et al. 1985)  
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During the last few years the prevalence of S. Enteritidis in people in Canada has increased slightly 
from 9 to 12% of all Salmonella isolates. Nation-wide surveys showed a low prevalence of S. 
Enteritidis in poultry flocks S. Enteritidis was isolated from environmental samples of 2.7% of layer 
flocks and of 3% of broiler flocks. The overall prevalence of S. Enteritidis-contaminated eggs from 
two flocks with infected hens was less than 0.06%. With the exception of S. Enteritidis phage type 
(PT)4, which has not been isolated from poultry in Canada, the phage types that occur most 
commonly in poultry (PT 8, 13 and 13a) are also the most prevalent in people. Phage typing was the 
most effective method for subdividing S. Enteritidis strains. Eighty-three percent of the S. 
Enteritidis isolates from poultry and its environment were sensitive to antimicrobial agents. The 
reasons why strains of the same phage type differ in virulence need to be elucidated (POPPE. 1994). 
The first S. Enteritidis phage type (PT) 1 infection in a commercial layer flock of 2700 birds in 
Finland occurred in 1995. All the birds were ordered to be killed, the eggs to be destroyed and 
access to the layer house was denied in order to prevent spread of the infection. Ninety one 
commercial layers, 61 replacement pullets and 1062 eggs were collected for the analyses 
(JOHANSSON et al. 1996) 
 
2.1.2 Monitoring and detection of Salmonella 
All successful infection control and monitoring programmes must have suitable detection systems 
that can identify simply and cheaply flock or herd breakdowns as possible after initial infection. For 
enteric salmonellas like S. Enteritidis, a number of sensitive culture methods based on enrichment 
and selective media are common place (WHO. 1994). Methods are now available that incorporate 
various compounds into the isolation media so as to rapidly differentiate salmonellas from other 
enteric bacteria. Also elegant systems that combine enrichment, selection and preliminary 
identification of the Salmonella are becoming available as the so called (one-step) isolation 
procedures (DAVIES and WRAY 1994)  
 
The application of these techniques to the monitoring for Salmonella in flocks using faecal and 
environmental samlpes has worked well in many countries. Bacteriological monitoring alone does 
have some disadvantages. Firstly, it is a costly and time consuming process which is not really 
suited to mass screening programes. Generally a screening sample size of about 60 is used which 
should detect prevalence values above five percent in flocks containing ten to one hundred thousand 
birds (DAVIES and WRAY 1994). Sensitivity can be improved by the collection of environmental 
samples, but it appears that some low level infections in flocks still remain undetected using current 
methods. An alternative approach is to include a serological test as a mass screening test. Indeed the 
basis of the control and eradication of S. Pullorum and S. Gallinarum for the last 50 years has been 
the application of the farm-side rapid slide agglutination test using whole blood. This is a very 
simple test, but because both these salmonellas are highly invasive high levels of serum antibodies 
are produced which can easily be detected by the rapid slide agglutination test. 
Nowaday techniques such as ELISAs are used widely for mass screening of large populations for a 
whole variety of diseases and not suprisingly many ELISA tests have been developed for the 
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detection of Salmonella antibodies in chickens and other domestic livestock (BARROW. 1992). 
The most significant salmonellas from a public health point of view including S. Enteritidis and S. 
Typhimurium, are in varying degrees all invasive in chickens. Thus about 10 days after infection 
detectable antibodies are produced in birds which persist and thereafter decline slowly following 
clearance of the bacterium. This response during infection is reproduceble from bird to bird which 
contrasts with the excretion of the organism. Detection of circulating Salmonella antibodies is likely 
to be at least as sensitive a marker as bacteriology in detecting infected flocks (VAN ZIJDERVELD 
et al. 1992) 
 
2.1.3 Pathogenicity of Salmonella 
S. Enteritidis phage type 4 was recovered significantly more frequently from the crops of birds 
which had been received food for 24 hours than from birds allowed food ad libitum. There was, 
however, no difference in its isolation rate from tissues. Within one hour of infection, S. Enteritidis 
could be recovered from a variety of tissues, including the oviduct, of a small proportion of the 
infected birds (HUMPHREY et al. 1993). One-day-old and 7-day-old specific-pathogen-free 
chickens were orally infected with a field isolate of S. Enteritidis phage type 13A. Chickens were 
sequentially euthanatized at various intervals until 42 days of age, and selected tissues were 
collected for microscopic evaluation. Eleven of 53 chickens (21%) infected at 1 day of age and 2 of 
28 chickens (7%) infected at 7 days of age died. Gross and microscopic lesions were more frequent 
and severe in chickens infected at 1 day of age and in chickens that died (almost all of these were 1-
day-infected as well). Lesions were characterized by mild to severe fibrinous pericarditis, 
airsacculitis, perihepatitis, peritonitis, caecal cores, and enlarged, firm yolk sacs. Gross the 
microscopic lesions were present from postinoculation day 2 until termination of this study 
(GORHAM et al. 1994) 
 
Four different strains of White Leghorn hens were orally infected with 1 x 108 cfu of S. Enteritidis 
phage Type 8 per bird. The birds were monitored for 10 wk postinfection for colonization of 
internal organs, fecal shedding of S. Enteritidis, and the production of S. Enteritidis-contaminated 
eggs. There was no difference among the four hen strains in regards to the probability of S. 
Enteritidis isolation from liver and spleen, ovary, and caecal tissue within the first 30 d 
postinfection. However, during the first 14 d postinfection, S. Enteritidis organisms were isolated in 
significantly higher rates from eggs and fecal samples of strain A than from samples obtained from 
the other three hen strains. Results suggest that there may be inherent differences between strains of 
laying hens with regard to their response to infection with S. Enteritidis (LINDELL et al. 1994)   
 
A total of 105 specific pathogen-free (SPF) laying hens and eight cocks were orally infected with 
strains of S. Enteritidis. The organs of these animals were examined bacteriologically for up to 6 
weeks post infectionem (p.i.). One-half of the eggs laid on a single day were examined 1 day after 
laying, and the other half 28 days after laying. The siderophore, ferrioxamine E, was added to the 
pre-enrichment medium. A high correlation was found to exist between colonization of the caecum 
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by salmonellas and the level of contamination of the egg shell. No correlation was found between 
the contamination of the egg shell and that of the egg content. The strains used for infection were 
not recovered from any yolk out of a total of 938 eggs. S. Enteritidis was isolated from the albumen 
in four cases (0.4%). Storage of the eggs for 28 days after laying resulted in a decrease in the 
frequency of Salmonella detection on the egg shell and in the egg content. The strains used for 
infection could be isolated from various sections of the sexual organs for up to 2 weeks p.i. S. 
Enteritidis was most frequently found in the ovary and rarely in the oviduct, but never in the pre-
ovulatory mature follicles. In the groups that included Salmonella-infected cocks, the Salmonella 
detection frequency did not increase either for the egg content or for the organs of the laying hens. 
It seems that primary vertical transmission of salmonellas occurs, in rare cases, as a result of an 
infection of the albumen but not of the yolk (METHNER et al. 1995)  
 
The colonization of two S. Enteritidis strains (phage types 4 and 8) originating from meat turkey 
flocks, were carried out. Three-day old poults were inoculated orally with approximately 106 
cfu/bird (one group with PT8 and the other with PT4). Clinical signs were not observed in any of 
the groups. The total reisolation rates from cloacal swabs in birds inoculated with PT4 was higher 
than from birds inoculated with PT8. The inoculated strains could also be detected in contact birds. 
Examination of internal organs 21 days p.i. revealed higher isolation rates in the group infected with 
PT4 than with PT8. The results indicate that both phage types of S. Enteritidis were able to colonize 
the intestinal tract and the internal organs of turkey poults. However, the colonization and duration 
of shedding differed between the two phage types. This may be due to the fact that PT8 strain used 
was free from the S. Enteritidis virulence plasmid 37 Mda (HAFEZ and STADLER 1997) Two 
small free range flocks with 32 hens, whose S. Enteritidis contaminated eggs caused salmonellosis 
in man, were investigated for localisation of the agent. S. Enteritidis phage type 4 was isolated from 
12 of 32 hens (37.5%). Eight hens (25%) harbored the bacterium in the ovary and/or the oviduct. 
The rapid slide agglutination test with S. Pullorum-antigen revealed 21 positive hens (66%). All 
eight hens with S. Enteritidis phage type 4 in the reproductive tract were seropositive (HOOP and 
KELLER 1991) 
 
White leghorn SPF chickens were inoculated orally with S. Enteritidis phage type 4 at the age of 
one day (group 1) and four weeks (group 2). From 3 h until 4 weeks postinoculation (pi). Clinical 
disease and mortality were only observed in group 1. Mortality was 8%. The birds were depressed, 
had diarrhoea and an indurated yolk sac. Infection of the liver and the heart was present within 12 h 
pi in both groups. The percentage of infected organs was very high and similar in both groups 
during the first week pi. Thereafter the isolation rate of Salmonella was declining faster in group 2. 
The crop, the proventriculus, the lower intestinal tract and the bursa of Fabricius were the 
predilective sites of isolation in both groups. Most prevalent lesions were serous typhlitis, 
omphalitis and polyserositis. Histopathology revealed inflammation in the intestines and visceral 
organs. In some birds granulomatous nodules were present in the caeca. Antibodies were detected 
from 18 and 5 days pi in group 1 and 2, respectively. Granulomatous nodules were typical of 
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infection with this strain of S. Enteritidis phage type 4. These granulomatous nodules together with 
the retained yolk sac possibly are a source of Salmonella organisms that may account for 
intermittent faecal shedding by carrier birds (DESMIDT et al. 1997). In each of two replicate trials, 
1-d-old chicks were inoculated orally with a phage type 13 S. Enteritidis isolate (resistant to 
nalidixic acid). Although S. Enteritidis was found in the livers, spleens, and caeca of all sampled 
chicks at 1 wk postinoculation, colonization generally persisted beyond 4 wk postinoculation only 
in the caeca. Nearly half of the remaining hens were still shedding S. Enteritidis in their feces at 24 
wk of age, but only 1 of 62 hens laid eggs that were internally contaminated with S. Enteritidis 
during the initial 4 to 6 wk of egg production. Chickens exposed to S. Enteritidis shortly after 
hatching can apparently remain infected until maturity, at which time they might produce 
contaminated eggs or spread the infection to other susceptible, previously unexposed hens (GAST 
and HOLT 1998) 
 
2.2 Probiotics  
2.2.1 History of probiotics 
METCHNIKOFF. (1907) first developed the concept of what we now know as probiotics at the 
beginning of this century. His hypothesis was that the complex microbiota of the colon was having 
an adverse effect on the host through what he termed the "autointoxication effect." As such, he 
believed that modification of the activity of the colonic microflora could occur through the ingestion 
of soured milks. The theory was developed after he observed that Bulgarian peasants consumed 
large quantities of such milks and exhibited longevity. Metchnikoff isolated the bacteria responsible 
and used them in human feeding trials. Probiotics, living cultures of micro-organisms, are currently 
of great interest as counter parts to antibiotics. The idea behind the use of probiotics is that the 
development and stability of intestinal microflora can be enhanced. The protection against 
infections is increased, resulting in fewer health problems and increased productivity. The 
mechanism of action of probiotics is not yet known, although there are several hypotheses. There is 
increasing evidence to suggest that probiotics act by stimulating the host's immune systems. The 
only accepted example of effective protection against infections provided by living micro-organism 
is the 'Nurmi concept', whereby one-day-old chicks acquire an enhanced protection against 
Salmonella infections when they are administered the complex healthy intestinal flora of older 
chicks. The effects of probiotics on the growth, feed conversion or production of farm animals are, 
even in specific situations, not consistent enough to consider their use out of economic 
considerations. Probiotics are used to (re)establish the intestinal flora of patients or persons with 
lactose intolerance. The claims that probiotics have cholesterol-lowering and anti-tumour actions 
are based on animal experiments and require further investigations (VELDMAN. 1992)  
 
Probiotic is a live microbial food supplement that beneficially affects the host animal by improving 
its intestinal microbial balance. For human adult use, this includes fermented milk products as well 
as over-the-counter preparations that contain lyophilized bacteria. The microorganisms involved are 
usually lactic acid producers such as lactobacilli and bifidobacteria. An effective probiotic should 
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exert a beneficial effect on the host, be nonpathogenic and nontoxic, contain a large number of 
viable cells, be capable of surviving and metabolizing in the gut, remain viable during storage and 
use, have good sensory properties, and be isolated from the same species as its intended host. 
Postulated health advantages associated with probiotic intake are the alleviation of symptoms of 
lactose malabsorption, increase in natural resistance to infectious diseases of the intestinal tract, 
suppression of cancer, reduction in serum cholesterol concentrations, improved digestion, and 
stimulation of gastrointestinal immunity (FULLER. 1989, GIBSON and ROBERFROID 1995) 
Probiotics modulate the composition of the human gut microbiota. The beneficial effects may result 
from suppression of harmful microorganisms or stimulation of organisms which contribute in a 
positive way to the nutrition and health of the host. Both types of supplement represent an attempt 
to reconstitute the gut flora to its normal composition which has been adversely affected by dietary 
and environmental stresses (FULLER and GIBSON 1997). Commercial probiotic preparations are 
usually mixtures of lactobacilli and bifidobacteria and enterococci although yeasts such as 
saccharomyces have also been used (table 1) (MACFARLANE and CUMMINGS 1999) 
 
Table 1: Some bacteria and yeasts used as probiotics 
Bifidobacterium longum    L. acidophilus 
B. breve      L. casei 
B. infantis      L. bulgaricus 
B. bifidum      L. gasseri 
B. adolescentis     Bacillus toyoi 
Lactococcus cremoris    B. subtilis 
L. lactis      B. licheniformis 
Streptococcus thermophilus    Saccharomyces boulardii 
Enterococcus faecium    S. cerevisiae 
Lactobacillus rhamnosus 
 
2.2.2. Healthy importance of probiotics 
Health effects of probiotics were increased nutritional value (better digestibility, increased 
absorption of  minerals and vitamins), promotion of intestinal lactose digestion, positive influence 
on intestinal flora (antibiotics or radiation induced colitis), prevention of intestinal tract infections 
(bacteria or virus induced) regulation of gut motility (constipation, irritable bowel syndrome), 
improvement of immune system, prevention of cancer, reduction of catabolic products eliminated 
by kidney and liver, prevention of atherosclerosis (reduction of serum cholesterol), prevention of 
osteoporosis, better development (growth), improved well-being (DUGAS et al. 1999). The 
therapeutic potential of these bacteria in fermented dairy products is dependent on their survival 
during manufacture and storage. Probiotic bacteria are increasingly used in food and pharmaceutical 
applications to balance disturbed intestinal microflora and related dysfunction of the human 
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gastrointestinal tract. L. acidophilus and Bifidobacterium spp. have been reported to be beneficial 
probiotic organisms that provide excellent therapeutic benefits. The biological activity of probiotic 
bacteria is due in part to their ability to attach to enterocytes. This inhibits the binding of enteric 
pathogens by a process of competitive exclusion. Attachment of probiotic bacteria to cell surface 
receptors of enterocytes also initiates signalling events that result in the synthesis of cytokines. 
Probiotic bacteria also exert an influence on commensal micro-organisms by the production of 
lactic acid and bacteriocins. These substances inhibit growth of pathogens and also alter the 
ecological balance of enteric commensals. Production of butyric acid by some probiotic bacteria 
affects the turnover of enterocytes and neutralizes the activity of dietary carcinogens, that are 
generated by the metabolic activity of commensal bacteria in subjects consuming a high-protein diet 
(KAILASAPATHY and CHIN 2000)  
 
Probiotics are traditionally defined as viable microorganisms that have a beneficial effect in the 
prevention and treatment of specific pathologic conditions when they are ingested. Currently, the 
best-studied probiotics are the lactic acid bacteria, particularly Lactobacillus spp. and 
Bifidobacterium spp. However, other organisms used as probiotics in humans include E. coli, 
Streptococcus spp., Enterococcus spp., Bacteroides spp., Bacillus spp., Propionibacterium spp. and 
various fungi. Some probiotic preparations contain mixtures of more than one bacterial strain. 
Probiotics have been examined for their effectiveness in the prevention and treatment of a diverse 
spectrum of gastrointestinal disorders such as antibiotic-associated diarrhea (including C. difficile-
associated intestinal disease), infectious bacterial and viral diarrhea (including diarrhea caused by 
rotavirus, Shigella, Salmonella, enterotoxigenic E. coli, Vibrio cholerae and human 
immunodeficiency virus/acquired immunodeficiency disorder, enteral feeding diarrhea. Probiotics 
have been found to inhibit intestinal bacterial enzymes involved in the synthesis of colonic 
carcinogens. There are many mechanisms by which probiotics enhance intestinal health, including 
stimulation of immunity, competition for limited nutrients, inhibition of epithelial and mucosal 
adherence, inhibition of epithelial invasion and production of antimicrobial substances. Probiotics 
represent an exciting prophylactic and therapeutic advance, although additional investigations must 
be undertaken before their role in intestinal health can be delineated clearly (ROLFE. 2000)  
 
Bifidobacteria and lactobacilli are purportedly beneficial to human health and are called probiotics. 
Their survival during passage through the human gut, when administered in fermented milk 
products, has been investigated intensely in recent years. Well-controlled, small-scale studies on 
diarrhea in both adults and infants have shown that probiotics are beneficial and that they survive in 
sufficient numbers to affect gut microbial metabolism. An ideal probiotic would be one that can 
survive passage through the gastrointestinal tract, establish itself permanently in the small intestine 
and colon, and provide a specific health benefit for the host by eliciting an immune response; 
secretion, production, and synthesis of compounds such as short-chain fatty acids, lactic acid, and 
bacteriocins (BEZKOROVAINY. 2001). Human studies have demonstrated that selected probiotic 
strains can influence the composition of the intestinal microflora and modulate the host immune 
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system. Functional foods, containing selected probiotic strains, have been shown to contribute to 
human health. Probiotics are becoming more and more accepted in clinical practice, where they are 
successfully employed in the management of diarrhoea, food allergy (SCHIFFRIN and BLUM 
2001). Probiotics are defined as the microbial food supplements, which beneficially affect the host 
by improving its intestinal microbial balance. Probiotics are the health enhancing functional food 
ingredients used therapeutically to prevent diarrhea and modulate immunity. Lactobacillus, 
Bifidobacterium and several other microbial species are perceived to exert such effects by changing 
the composition of the gut microbiota. However, it is important that exogenously administered 
bacteria reach and establish themselves in the large intestine in an intact form (KAUR et al. 2002). 
Probiotics have been defined as viable microorganisms that have a beneficial effect in the 
prevention and treatment of specific pathologic conditions. These microorganisms are believed to 
exert biological effects through a phenomenon known as colonization resistance, whereby the 
indigenous anaerobic flora limits the concentration of potentially pathogenic (mostly aerobic) flora 
in the digestive tract (CHOW. 2002)  
 
2.2.3 Effects of Probiotics on Salmonella and other bacterial pathogens 
The bacterium, E. coli occurs in untold millions on the mucous membranes of the intestines. In 
normal circumstances, it is not pathogenic (not capable of causing disease) and, as we shall see 
later, it is an extremely useful microorganism of the human body's intestinal flora which consists of 
all kinds of bacteria, yeasts, parasites and fungi. One of the principal functions of a normal, healthy 
intestinal flora is to set up a microbial defence system against foreign invaders. Diseases and the 
reckless use of excessive quantities of antibiotics have seriously disrupted the intestinal flora and 
hampered its recolonization. The contribution of normal E. coli flora to the microbial barrier of the 
gastrointestinal tract is based on their antagonism to pathogenic germs. E. coli is able to do that 
because these bacteria are capable of producing biological antibiotics such as colicin, microcin and 
short-chain fatty acids. This bacterium has been known for more than a century. In 1917, during the 
first World War, Prof. A. Nissle noticed that among a group of soldiers who were seriously ill and 
dying as a result of pathogenic E. coli infection, one of them had remained completely (gut-
healthy). In this man's stools, Prof. Nissle found a special E. coli strain which he examined and 
cultured. This is how the first non-pathogenic strain was discovered, which was naturally called E. 
coli strain Nissle 1917. Alfred Nissle used an extract of his bacterial culture to treat many chronic 
intestinal diseases. A German laboratory subsequently took up this strain culture and cultured it 
further, first on an agar culture medium, later in lyophilized form consistently derived from the 
primitive bacterium, it is still cultured today, only now with the aid of biotechnology in a large 
fermentation yeast vessel under modern pharmaceutical conditions. It is sold under the trade name 
Mutaflor as a registered pharmaceutical product in Germany. In 1936, a team of researchers in 
laboratories discovered a different, slightly more active E. coli strain with the right properties. This 
was called E. coli strain R. 1936 (EWIJK. 1991). The establishment of  the clinically important non-
pathogenic E.coli strain Nissle 1917 in the gastrointestinal tract (GI-tract) of germfree and 
monoassociated rats was investigated. The development of microbial counts and the possible 
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adherence were checked in different parts of the GI-tract and at different times after oral inoculation 
of the microbes. Following the monoassociation with E. coli, a yeast strain C. albicans was 
inoculated in the animals. E. coli strain Nissle 1917 colonizes the GI-tract of rats with a high 
proliferation rate. An adherence of this microorganism to epithelial surface was not detected. The 
counts of  Candida cannot  be influenced by the E. coli under the conditions used in these 
experiments, although the healthy state of the animals was stabilised immediately (LORENZ and 
SCHULZE 1996)  
 
E. coli strain Nissle 1917 (Mutaflor) had the ability to colonize within the intestine and inhibit 
growth of enteropathogenic and uropathogenic E. coli and other enteric bacteria (MALCHOW. 
1997). E. coli strain Nissle 1917 (E. coli DSM 6601, Mutaflor) was significantly reduced 
colonization with true and potential bacterial pathogens (LODINOVA-ZADNIKOVA and 
SONNENBORN 1997). Mutaflor may be having an effect, first it may be blocking receptors in the 
intestinal mucosa and thus preventing adhesive pathogenic bacteria from becoming established, 
second it has antagonistic activity against a variety of pathogenic and non-pathogenic 
enterobacteria, probably due to the production of bacteriocins or microcins, third the growth and 
metabolic activity of E. coli may have caused changes in the pH or chemical composition of the 
colonic lumen that are unfavourable to bacteria involved in the pathogensis of ulcerative or that 
promote repair and nourishment of  the mucosa (REMBACKEN et al. 1999)  
 
An avirulent, wild-type avian E. coli (E. coli Av) was electrotrans-formed with a plasmid coding for 
the production of microcin 24  (pGOB 18) and was designated E. coli AvGOB18. The transformant 
inhibited the growth of seven serotypes of Salmonella commonly associated with colonization and 
contamination of poultry products and seven strains of E. coli O157:H7 in the in vitro 
colicin/microcinassay. The transformant did not inhibit the replication of multiple isolates of L. 
monocytogenes or C. jejuni, but S. Typhimurium was reduced significantly in the intestinal tracts of 
broiler chickens when E. coli AvGOB18 was administered continually in the water supply 
(WOOLEY et al. 1999)  
 
E. coli is part of the normal gastrointestinal microflora which exerts a barrier effect against 
enteropathogens. Several E. coli strains develop a protective effect against other 
Enterobacteriaceae.  Two E. coli strains, EMO, a human faecal strain, and JM105 K-12 were tested 
for their ability to prevent in vivo and in vitro infection by S. Typhimurium C5.  Inhibition of C5 
cell invasion by E. coli was investigated in vitro . The protective effect of E coli was examined in 
vivo in germfree or conventional  mice orally infected by the lethal strain C5. In vitro, the two 
strains did not prevent the growth of C5 by secreted microcins or modified cell invasion of C5. In 
vivo, colonization level and translocation rate of C5 were significantly reduced during the three 
days after infection with (2x106 cfu/mouse). In contrast, no reduction in faecal C5 excretion was 
observed in C5 infected conventional mice (1x108 cfu/mouse) receiving the EM0 or JM105 cultures 
daily. Establishment of E coli strains, which do not display antimicrobial activity, protects germfree 
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mice against infection and delays the establishment of C5 in the gut (HUDAULT  et al. 2001). E. 
coli serotype DSM 6601 had antagonistic effect against different enterobacteria (enterotoxic E. coli 
(ETEC), enterohaemorrhagic E. coli (EHEC), S. Enteritidis, S. Typhimurium) and yeast (candida 
groups) in vitro (HEESEMANN and SCHUBERT 2000), also E. coli serotype DSM 6601 had a 
competitive character against many microorganisms in vitro and in vivo. E. coli serotype DSM 
6601 was inhibited the growth of different bacterial species, Proteus vulgaris, S. Enteritidis, 
Shigella dysenteriae, Yersinia enterocolitica und Vibrio cholerae. E. coli serotype DSM 6601 was 
inhibited the growth of Candida albicans (HACKER et al. 2000). E. coli serotype Nissle 1917 was 
decreased invasion of pathogenic E. coli and S. Typhimurium C 17 or LT2 to intestinal tract in vitro 
(Olschlager et al. 2001, Boudeau et al. 2001) 
 
Lactobacillus implantation resulted in a similar effect of antibiotics manifested by increasing weight 
gain and better feed efficiency, fat digestibility and nitrogen retention, lower weight of caeca and 
faeces and remarkable change in the bacterial flora of the caeca and small intestine. Marked 
increase in colonies of Lactobacillus at nine days of age was accompanied by an almost total 
disappearance of the enterococci organisms (TORTUERO. 1973). Lactobacilli reduced the number 
of salmonellae adhering to the crop mucosa by 1 to 2 logs. Treatment with lactobacilli did not lower 
the number of chickens shedding salmonellae or reduce the number of salmonellae adhering to the 
mucosa of the caecum. Lactobacilli as a single bacterial treatment played a minor role in protecting 
the crop, but no protection of the caecum was demonstrated (SOERJADI et al. 1981). The L. 
acidophilus prophylactic treatments were also effective qualitatively in reducing the isolation of S. 
Typhimurium and S. aureus from crop contents but not, to a great extent, from caecal or rectal 
contents of gnotobiotic chicks at postmortem (WATKINS and  MILLER 1983). L. reuteri 
administration in ovo increases its rate of intestinal colonization and decreases the colonization of 
Salmonella and E. coli in both chicks and poults, additionally mortality due to in-hatcher exposure 
to E. coli or Salmonella is reduced (EDENS et al. 1997)  
 
There was a significant difference in the isolation of S. Enteritidis from the internal organs liver and 
spleen when probiotic-treated and nonprobiotic-treated groups were compared. There was no 
significant difference in the mean body weight between the two experimental groups at each 
collection period. These results indicated that a combination of L. acidophilus, E. faecium, and S. 
Enteritidis, S. Typhimurium, and S. Heidelberg-Specific antibodies have a beneficial effect in 
reducing the colonization of S. Enteritidis in market-aged broilers (TELLEZ et al 2001). A mixed 
culture of L. crispatus and C. lactatifermentans inhibits growth of serovar Enteritidis under caecal 
growth conditions. The undissociated forms of acetate and propionate produced in the mixed culture 
inhibited the growth of serovar Enteritidis (VAN DER WIELEN et al. 2002). L. acidophilus was 
capable of competing with E. coli in the gut of gnotobiotic chicks, also L. acidophilus  prevented 
excessive mortality when chicks were challenged with E. coli (WATKINS et al. 1982). Chickens 
given probiotics from day one to day three had 70% reduction in the frequency of C. jejuni 
shedding  in colonized chicks and 27% reduction in jejunal colonization in colonized chicks at 
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slaughter when compared with the control group in broiler chickens (MORISHITA et al. 1997). L. 
gasseri SBT2055 (LG2055SR) has the ability to establish in the human gastrointestinal tract. No 
significant changes in faecal anaerobes were observed. On the other hand, some changes were seen 
in the number of faecal aerobes and facultative anaerobes. The number of the genus Staphylococcus 
significantly decreased during LG2055SR ingestion (FUJIWARA et al. 2001). Lactobacillus 
inoculated into the crop a few hours after hatching did not induce a reduction of S. Infantis in the 
caecal contents (ADLER and DAMASSA 1980). Neither single nor multiple treatment with six 
morphologically distinct isolates of L. acidophilus resulted in major protection against infection by 
S. Typhimurium (WEINACK et al. 1986) 
 
2.2.5 Effect of Probiotics on immunity and immune response 
Regarding the influence of probiotics on cell-mediated immunity. Probiotics intake increases the 
production of IgA antibodies. The activity of macrophages and NK-cells also increase. which leads 
to an increased killing of bacteria. It has also been shown that probiotic bacteria modulate the 
cytokine activity. Cytokines are signal substances in the immune system, which regulate the activity 
of the immune cells. Cytokines also work as a link between the immune system and the nervous 
system (KAILA et al. 1992, PERDIGON et al. 1990, MOREAU et al. 1990) 
 
The influence of formaldehyde-killed E. coli strain Nissle 1917 on macrophages of C57BL/6 mice 
was investigated in vitro. It has been shown that E. coli strain Nissle 1917 activated macrophages 
derived from bone marrow produced Interleukin-6 with high efficiency. In addition, E. coli strain 
Nissle 1917 stimulated macrophages to secrete tumor necrosis factor, as measured by a bioassay. 
Furthermore, macrophages were activated by E. coli strain Nissle 1917 to produce a 3 fold amount 
of oxygen radicals compared to the spontaneous oxygen radical production. In contrast to this 
finding, the phagocytic capacity of these macrophages was only slightly increased. The results of 
the in vitro experiments presented clearly show that the E. coli strain Nissle 1917 is an efficient 
immunomodulator of the unspecific immune system (Hockertz. 1991). Oral colonization with 
another non-pathogenic strain of E. coli 083:K24:H31 stimulated in a significant way the local 
antibody formation in the gut, saliva and milk. Early induction of sIgA formation is important 
where it replaces partially the lacking immunoglobulin. E. coli 083:K24:H31 had a favourable 
effect on reduction of the number of infections, a reduced presence of pathogenic microflora in the 
alimentary tract and elsewhere. In carriers the strain replaced successfully pathogenic strains and 
assisted the restitution of the impaired intestinal microflora (LODINOVA-ZADNIKOVA et al. 
1992)  
 
Effect of oral administration of E.coli (non-pathogenic) strain Nissle 1917 serotype (O6:K5:H1) 
Mutaflor in maintaining remission of ulcerative colitis. The Mutaflor in this trial has been 
demonstrated to colonize the intestines within a few days, oral ingestion of E. coli Nissle 1917 leads 
to a serologic antibody response, immunological competence was demonstrated further by 
immunomodulating effects on macrophages such as an increase in phagocytic capacity (KRUIS et 
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al. 1997). Oral administration of live vaccines COLINFANT (E. coli O83:K24:H31) and Mutaflor 
(E. coli O6:K5:H1) prepared from non-enteropathogenic E. coli strains, both strains colonized 
effectively the intestine for many weeks. The presence of E. coli in the intestine stimulated 
significantly the antibody production in the gut, saliva and serum, in addition to early presence of 
non-enteropathogenic E. coli strains in the intestine decreased significantly colonization of the 
intestine and also other mucosal surfaces of the body with pathogenic bacterial strains, moreover 
presence of  COLINFANT strain in the intestine decreased also significantly the infections, the 
mortality rate in connection with infection, and the need for antibiotics, both strains replaced 
pathogenic strains in carriers after treatment with antibiotics (LODINOVA-ZADNIKOVA et al. 
1998)  
 
Protected germ free piglets against the lethal effects of the S. Typhimurium LT2 strain by a living 
nonenteropathogenic E. coli bacteria strain Nissle 1917, serotype O6:K5:H1 (Mutaflor). This E. coli 
strain does not produce enterotoxins, it is not enteroinvasive, exhibits no pathogenic P, M or S 
fimbriae and has common type 1 fimbriae, found in many intestinal E. coli strains. The Nissle strain 
induces pro-inflammatory cytokines interleukin-1 and interleukin-6 and it protects mice against 
experimental infection by Listeria monocytogenes or Candida albicans. Macrophages represent the 
major immune cell stimulated by this microorganism. The Nissle strain was increased serum IgG 
more than ten times, serum IgM more than twenty times and the amounts of IgM, IgG and IgA 
increased also in the intestinal content (TREBICHAVSKY et al., 1998)    
 
Non-pathogenic E. coli was increase number of IgM, IgG and IgA-secreting lymphocytes which 
found in spleen, mesenteric lymph nodes and Peyer's patches in colonized animals as compared to 
germ free piglets. B cells from thymus were not affected by E. coli stimulation. The onset of 
intestinal colonization, non-pathogenic E. coli specifically and polyclonally stimulates the mucosal 
and systemic humoral immunity (CUKROWSKA et al. 2001). E. coli colonization induced a 
significant increase in the proliferation of blood cells cultivated with bacterial components of E. coli 
Nissle 1917 and another E. coli strain. Significantly higher amounts of specific anti- E. coli Nissle 
1917 antibodies (Ab) of immunoglobulin (Ig)A isotype and nonspecific polyclonal IgM were found. 
The oral application of E. coli Nissle 1917 significantly stimulates specific humoral and cellular 
responses and simultaneously induces nonspecific natural immunity (CUKROWSKA et al. 2002). 
The gastrointestinal tract functions as a barrier against antigens from microorganisms and food. The 
generation of immunophysiologic regulation in the gut depends on the establishment of indigenous 
microflora. Among the possible mechanisms of probiotic therapy is promotion of a 
nonimmunologic gut defense barrier, which includes the normalization of increased intestinal 
permeability and altered gut microecology. Another possible mechanism of probiotic therapy is 
improvement of the intestine's immunologic barrier, particularly through intestinal immunoglobulin 
A responses and alleviation of intestinal inflammatory responses, which produce a gut-stabilizing 
effect. Many probiotic effects are mediated through immune regulation, particularly through 
balance control of proinflammatory and anti-inflammatory cytokines. These data show that 
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probiotics can be used as innovative tools to alleviate intestinal inflammation, normalize gut 
mucosal dysfunction, and down-regulate hypersensitivity reactions. More recent data show that 
differences exist in the immunomodulatory effects of candidate probiotic bacteria. Moreover, 
distinct regulatory effects have been detected in healthy subjects and in patients with inflammatory 
diseases (ISOLAURI et al. 2001)  
 
The majority of evidence from in vitro systems, animal models and humans suggests that probiotics 
can enhance both specific and nonspecific immune responses (PESTKA. 1993). These effects are 
believed to be mediated through activating macrophages, increasing levels of cytokines, increasing 
natural killer cell activity and/or increasing levels of immunoglobulins (SANDERS. 1999). The 
effects of dietary supplementation of a commercial probiotic (Protexin) on daily feed consumption, 
egg yield, egg weight, food conversion ratio and humoral immune response in layer hens were 
investigated. In 7 replicates, a total of 280 40-week-old layers were given diets containing either 0, 
250, 500 or 750 parts per million (ppm) for 90 d. When compared with the controls, the food 
consumption, food conversion ratio and the proportions of damaged eggs were lower in the group 
consuming 500 ppm probiotic. There was no significant difference between the controls and the 
groups receiving 250 and 750 ppm probiotic in food consumption, food conversion ratio and 
proportion of damaged eggs. Similarly, the egg yield, egg weight, specific gravity, and peripheral 
immune response showed no statistically significant differences between the groups (BALEVI et al. 
2001)  
 
Most importantly, probiotics can exert these positive effects on the immune system without eliciting 
a harmful inflammatory response. The immune response may be further enhanced when one or 
more probiotics are consumed together and work synergistically, as seems to be the case when 
Lactobacillus is administered in conjunction with Bifidobacteria (DE SIMONE. 1992). The 
immune system consists of organs and several cell types. Antigen interaction with these cells 
induces a cellular immune response mediated by activated cells and a humoral immune response 
mediated by antibodies. The cellular interactions are enhanced by adhesion molecules, and the 
activated cells release different cytokines. These complex cellular interactions induce a systemic 
immune response. If the antigen penetrates by the oral route, a secretory immune response is 
obtained, which is mediated by secretory IgA. Potential health benefits of lactic acid bacteria 
include protection against enteric infections, use as an oral adjuvant, the immunopotentiator in 
malnutrition, and the prevention of chemically induced tumors. L. casei could prevent enteric 
infections and stimulate secretory IgA in malnourished animals (PERDIGON et al. 1995)  
 
Consuming a fermented milk product with either L. acidophilus LA1 or B. bifidum Bb12, there was 
no change in lymphocyte population, although macrophage phagocytosis of E. coli increased 
(SCHIFFRIN et al. 1995). In both experimental animals and humans, probiotic cultures have been 
observed to influence local and systemic immune responses. Various Lactobacillus and 
Bifidobacteria strains have been demonstrated to enhance nonspecific immunity by increasing 
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macrophage activation and natural killer cell activity (TANNOCK. 1999). Lactic acid bacteria in 
food can transiently colonize the intestine and exert health beneficial (probiotic) effects. Lactose 
digestion, improvement of diarrheal disorders, prophylaxis of intestinal and urogenital infections as 
a result of formation or reconstruction of a balanced indigenous microflora. Immunomodulatory 
effects resulting in the improved host resistance. E. faecium M-74 may have an significant 
immunostimulatory effect on both phagocytosis performed by neutrophils and antibody production 
(FERENCIK et al. 1999). For many years, probiotic bacteria have been known to confer health 
benefits to the consumer. One possible mechanism for this may be the ability of probiotic bacteria 
to modulate immune responses. Oral administration of L. casei strain Shirota (LcS) has been found 
to enhance innate immunity by stimulating the activity of splenic NK cells. Oral administration of 
other probiotic bacteria, such as S. thermophilus, L. fermentum and yeast, elicited different immune 
responses (MATSUZAKI and CHIN 2000) 
 
Lactic acid bacteria are present in the intestine of most animals. The beneficial role played by these 
microorganisms in the humans and other animals, including the effect on the immune system, has 
been extensively reported. They are present in many foods and are frequently used as probiotics to 
improve some biological functions in the host. The activation of the systemic and secretory immune 
response by LAB requires many complex interactions among the different constituents of the 
intestinal ecosystem (microflora, epithelial cells and immune cells). Through different mechanisms 
they send signals to activate immune cells. Thus the knowledge of the normal intestinal microflora, 
the contribution of LAB and their role in the numerous functions in the digestive tract as well as the 
functioning of the mucosal immune system form the basis for the study and selection of a probiotic 
strain with immunostimulatory properties (PERDIGON. 2001) 
 
2.3 Host and intestinal microflora  
In most mammals and birds, particularly those whose diet was mainly cereal, lactobacilli 
constituted the major component of the flora of the stomach, small intestine and, in some cases, 
large intestine. They occupied a much less dominating position in the herbivora and carnivora. 
Rogosa ,s medium was satisfactory for enumerating the lactobacilli that were present in most 
species of animals. Streptococci had a somewhat similar distribution to lactobacilli in the 
homothermic animals. They were, however, present in much smaller numbers in species other than 
the carnivora and herbivora. Yeasts were present in comparatively large numbers in the monkey, 
pig, rat, mouse, hamster and guinea-pig, and either in small numbers or not at all in the birds, 
herbivora and carnivora. No yeasts were found in the rabbit. C. perfringens was either absent, or 
present in only small numbers, in animals other than the carnivora. E. coli was found infrequently in 
rabbit and guinea pig, E. coli was usually present in all regions of the alimentary tract in 
homothermic animals (SMITH. 1965). Differential bacterial counts were made on the intestinal 
contents of three groups of six healthy chickens aged 18 days, 7 weeks and 5 months respectively. 
The flora was found to be qualitatively similar in all age groups, consisting of lactobacilli, 
streptococci, E. coli and C. perfringens in descending order, the concentration of bacteria in all 
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groups being highest in the caeca and progressively lower in the posterior and anterior small 
intestine. Bacteroides were confined to the caeca of each age group examined where they were 
present in a similar concentration to that of the lactobacilli. The slight variation that occurred with 
age was most noticeable in the 18-day-old chicks which gave higher counts of lactobacilli, 
streptococci and E. coli in the caecal contents. The 7-week and 5-month-old birds gave very similar 
quantitative and qualitative results at all three sites of the intestine (TIMMS. 1968). The caeca of 
newly hatched chicks obtained either from commercial hatcheries or from a carefully controlled 
experimental hatchery have been shown to contain high numbers of a variety of microorganisms. 
Fecal streptococci, clostridia, enterobacteria, pediococci, and occasionally P. aeruginosa have all 
been isolated, but never lactobacilli. After the chick has been on feed for 1 day, the numbers of 
lactobacilli in the crops and caeca are quite variable; by the 3rd day, however, large numbers are 
present throughout the alimentary tract (BARNES et al. 1980b)  
 
Many factors affect the composition of the large-intestinal microbiota in humans. These include the 
age, susceptibility to infections, nutritional requirements, and immunologic status of the host and the 
pH, transit time, interactions between flora components, and presence and availability of 
fermentable material in the gut. The main fermentable dietary substrates in the adult gut are 
carbohydrate-based materials such as dietary fibers, resistant starches, oligosaccharides, food 
sweeteners, and other nonabsorbed sugars. There is a lesser contribution from nitrogen-based 
materials like proteins and amino acids (COLLINS and GIBSON 1999)  
 
The normal human microflora is a complex ecosystem that is in part dependent on enteric nutrients 
for establishing colonization. The gut microbiota are important to the host with regard to metabolic 
functions and resistance to bacterial infections. At birth, bacterial colonization of a previously 
germ-free human gut begins. Diet and environmental conditions can influence this ecosystem. A 
breast-fed, full-term infant has a preferred intestine microbiota in which bifidobacteria predominate 
over potentially harmful bacteria, whereas in formula-fed infants, coliforms, enterococci, and 
bacteroides were predominat (DAI and WALKER 1999)  
 
The colonic microflora is important to health. The growth and metabolism of the many individual 
bacterial species inhabiting the large bowel depend primarily on the substrates available to them, 
most of which come from the diet. This has led to attempts to modify the structure and metabolic 
activities of the microbial community through diet using probiotics and prebiotics. Probiotics are 
live microbial food supplements. The best known are the lactic acid bacteria and bifidobacteria, 
which are widely used in yoghurts and other dairy products. These organisms are non-pathogenic 
and non-toxigenic, retain viability during storage, and survive passage through the stomach and 
small bowel. Prebiotics are non-digestible food ingredients which selectively stimulate the growth 
or activities, or both, of lactobacilli or bifidobacteria in the colon, thereby improving health 
(MACFARLANE and CUMMINGS 1999) 
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Diet, among other environmental and genetic factors, is currently recognised to have an important 
role in health and disease. There is increasing evidence that the human colonic microbiota can 
contribute positively towards host nutrition and health. As such, dietary modulation has been 
proposed as important for improved gut health, especially during the highly sensitive stage of 
infancy. However, various functional food ingredients such as oligosaccharides, prebiotics, proteins 
and probiotics could effect a beneficial modification in the composition and activities of gut 
microflora of infants (GIBSON et al. 2002). The microflora of the digestive tract is a complex 
microbial ecosystem, well balanced, which in an aboral direction undergoes specific changes as to 
the ratio of aerobic and anaerobic microorganisms the functions of which supplement each other the 
aerobes ensure for the whole ecosystem. The microbial profile of the digestive tract is typical by the 
absence of anaerobic microorganisms in the stomach and conversely their absolute predominance in 
the distal colon. The basic physiological functions of the microflora of the digestive tract can be 
characterized as follows, microbial barrier against pathogens and potential pathogens,  formation of 
products of the microflora and their influence on the blood supply of the intestinal mucosa and 
peristaltics, stimulation of the immune system in the gut,  reduction of bacterial translocation,  
production of vitamins (ZBORIL 2002) 
 
2.4 Bdellovibrios. Bacterial parasites of Bacteria 
The bdellovibrios are vibriod to rod-shaped Gram-negative bacteria of relatively small size. Outside 
the host, they usually measure 1-2 µm in length and 0.25-0.40 µm in width. Slight differences in 
size and shape have been reported (ABRAM and DAVIS 1970, BURNHAM et al. 1970, SHILO 
1966, STOLP and STARR 1963). During growth inside the host, bedllovibrio elongates into a 
rather large spiral-shaped cell. Segmentation of the spiral entity produces daughter cells that are 
identical in morphology with free-living Bdellovibrios outside the host cell. All parasitic strains so 
far studied are extremely motile. High-frequency cinematography (200 pictures7sec) has revealed a 
relative speed of locomotion of upto 100 cell-lengths per sec. The unusually thick flagellum has a 
diameter of 28 nm. It consists of an inner core (13 nm) and a surrounding sheath (7.5 nm) 
originating from the cell wall and being continuous with it. In the presence of 6M urea the sheath 
separates from the core of the flagellum; the cell wall, however, is not affected (SEIDLER and 
STARR 1968). All the marine isolates were vibroid Gram negative cells, 0.8 to 1.39 µm long and 
0.22 to 0.45 µm wide, having a single sheathed polar flagellum 2-3 µm long. In phase-contrast 
microscope, the cells exhibited the jerky motion typical for bdellovibrios (MARBACH et al. 1976). 
The genus Bdellovibrio has four known species, presently: B. bacteriovorus, B. stolpii, B. starrii, 
and one other that is presently unnamed. Each of these bacteria are obligate parasites, utilizing 
Gram-negative bacteria in order to reproduce, in a process that eventually kills its host.  Due to the 
nature of its propagation, it has a unique biphasic life cycle, as well as environmental requirements.  
It has been found to be quite abundant in nature, and in addition to the aquatic environment, it is 
also found in sewage and in soils. Just like its own prey, it is also a Gram-negative bacterium.  The 
dimensions of the cell are approximately 0.20 µm by 0.80 µm, but this varies from species to 
species as well as over the duration of its life cycle (GRAY and RUBY 1991). Bdellovibrios are 
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abundantly spread in the natural environment and carry out their lytic impact against suitable Gram-
negative bacteria. Bdellovibrios play at least under in vitro conditions a role in elimination of Gram-
negative bacteria, including pathogenic ones. Bdellovibrios had lytic properties, it play an important 
role in maintenance of homeostasis in the ecological system (EDAO. 2001) 
 
2.4.1 Isolation, propagation, and maintenance of parasitic Bdellovibrios  
The first representative of the bdellovibrios was in Berlin in 1962 by STOLP and PETZOLD 
(1962). Acomprehensive study on the tiny parasite and its interactions with the bacterial host was 
made in 1963 by STOLP and STARR (1963), using 11 additional strains isolated from California 
soils. The results clearly showed that the parasite of bacteria is itself a bacterium; it  was given the 
name Bdellovibrio bacteriovorus. The individual strains of the parasite were shown to be restricted 
in their lytic activity to Gram-negative bacteria; some were able to attack a broad spectrum of host 
bacteria, others had a limited host. The saprophtic bdellovibrios had rather unusual morphological 
and physiological properties, and did not show a close relationship to any of the already known 
kinds of bacteria. The Bdellovibrios were divided into two groups parastic strains and saprophytic 
strains. A bdellovibrio cell that possesses the capability of attacking a living bacterium, attaching to 
its surface, penetrating the cell wall, muliplying inside the host. A bdellovibrio cell that is capable 
of multiplying on a laboratory nutrient medium is called saprophytic. This enrichment method is 
based on the selective growth conditions provided for the bdellovibrios in a concentrated 
suspension of prospective host bacteria (1010 cells/ml) in highly diluted yeast extract 0.03% or 
mineral salt solution. The techniques successfully applied for isolation of bdellovibrios do not allow 
quantitative estimations in a natural environment, mainly for: centrifugation and filtration, only part 
of the bdellovibrios will be recoverd, use of the particular prospective host bacterium does not allow 
the development of bdellovibrios that do not attack the given host but might attack others, 
enrichment of bdellovibrios does not permit an estimation of the original concentration (STARR 
and SEIDLER 1971) 
 
In experiments that require quantitative estimation of choice, the maintenance of cultures of 
bdellovibrio, as with other bacteria is possible by, keeping the culture after incubation at low 
temperature (2-4 °C), preserving the organism by storage under deep frozen conditions (-30°C) or 
lyophilization, because of rather rapid loss in viability. A lysate from a liquid culture containing 
actively motile bdellovibrios in great numbers (109 cells/ml or more) is supplied with fresh host 
bacteria (24-hr old); and incubated on the shaker for 30 min., at the end of 30 min. incubation 
period, many host cells are infected and contain intracellular (intramural) parasites. After addition 
of glycerol final concentration 10%, the culture is stored at -30 °C for more than two years. Attack 
and attachment occur with the nonflagellated end of the parasite (BURNHAM et al. 1968, 
SCHERFF et al. 1966, STARR and BAIGENT 1966, STOLP and PETZOLD 1962, STOLP and 
STARR 1963). A strain of Bdellovibrio bacteriovorus (designated strain Uki2) was isolated which 
was capable of growing either saprophytically in host-free medium or endoparasitically in E. coli. It 
was quantitatively determined that each bdellovibrio could develop in solid medium to produce a 
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colony, and 65% of the cells in a late exponential-phase culture were capable of inducing E. coli 
spheroplasts. A photomicrographic sequence of single E. coli spheroplasts containing Bdellovibrio 
demonstrated that parasitically derived B. bacteriovorus Uki2 could develop saprophytically after 
release from the host cells (DIEDRICH et al. 1970)  
 
Incubation of B. bacteriovorus 109J, B. stolpii Uki2, or B. starri A3.12 with washed eucaryotic 
animal cells (mouse liver, hamster kideny, or bovine mammary gland) resulted in neither 
attachment nor growth of the bdellovibrios. When cells of these bdellovibrio strains were incubated 
with erythrocyte suspensions (bovine or rabbit) a very low level of bdellovibrio attachment and 
penteration occurred, but no growth could be detected (LENZ and HESPELL 1978) Bdellovibrio 
have a dramatic effect on the population of their prey bacteria.  Though some projections have been 
as small as 40%, it has been estimated that up to 80% of the bacteria in a given marine environment 
are susceptable to infection by this predatory bacteria (RICE et al. 1998). Bdellovibrios had a broad 
prey spectra includes the common genera of Aeromonas, Escherichia, Pseudomonas, Salmonella 
and Vibrio (PAN et al. 1997)   
 
2.4.2 Parasite-host interactions 
The Bdellovibrio bacteriovorus developmental cycle (figure 1). Bdellovibrios exist in one  
of two phases: attack phase and growth phase.  In the attack phase bdellovibrios swim around in 
search of susceptible prey bacteria. During this phase there is no growth or DNA replication.  Once 
they encounter a prey cell, they attach to the outer surface and through a combination of mechanical 
and enzymatic means they penetrate the wall layers and reside in the periplasmic space.  Following 
penetration the prey cells becomes rounded forming an osmotically stable bdelloplast.  While in 
bdelloplast the bdellovibrio grows into a long spiral, replicates and segregates its DNA, and 
fragments into individual flagellated progeny.  The remnants of the bdelloplast lyse releasing 
progeny attack phase bdellovibrios in search of more prey cells (TUDOR et al. 1990) 
 
Penetration was blocked by inhibitors of protein synthesis (streptomycin, chloramphenicol), 
although attachment occurred. Multiplication inside the host cell and release of progeny, during the 
process of invasion of the parasite,the cytoplasmic membrane of the host bacterium is separated 
from the cell wall and is pushed a side by the entering bdellovibrio cell, thus locating the parasite 
between the cell wall and the CM (BURGER et al. 1968, BURNHAM et al. 1968, SCHERFF et al. 







Figure 1. The Bdellovibrio bacteriovorus developmental cycle (after TUDOR et al. 1990)  
 
 
After disintegration of cell contents, the spherical body becomes sensitive to osmotic shock. The 
spheroplast-like bodies enlarge in size and explode in distilled water, the intramural growth phase 
of bdellovibrio generally requires one hour or more, depending on the system. The parasite then 
develops into a spiral-shaped cell which is several times (5-10 X) the length of the infecting cell, 
and by segmental fragmentation and genesis of flagella develops into motile daughter cells 
morphologically identical with the parental parasite, the bdellovibrio progeny are finally released 
leaving an empty envelope (BURGER et al. 1968, STARR and BAIGENT 1966). A proteolytic 
exoenzyme formed by certain bdellovibrio strain digested heat-killed, acid-treated or EDTA-treated 
host organisms, but did not affect intact host organisms. High phosphate concentrations inhibited 
exoenzyme activity. The morphological sequence of lysis induced by exoenzyme-forming parasitic 
bdellovibrio strains sugested that this lysis was a two-stage process: the first stage was specific 
attachment of bdellovibrios with damage to the cell wall of the host organisms; the second stage 
was non-specific digestion of cellular components by exoenzyme produced by the bdellovibrios 
(SHILO and BRUFF 1965). B. bacteriovorus 109J attached to both capsulated and non-capsulated 
E. coli K29 cells. Electron microscopy revealed penetration of the thick polysaccharide capsule 
without any major disintegration of the neighbouring capsular matrix. The capsule remained intact 
during bdelloplast formation and lysis was unaffected by capsulation of the prey cell (KOVAL and 





2.4.3 Characterization of bdellocysts of Bdellovibrios 
Bdellovibrio sp. strain W will infected and produce resting cells, termed bdellocysts, in a variety of 
gram-negative bacteria. Bdellocysts appeared to be produced only within susceptible prey and never 
in their absence. Optimum conditions for encystment included infection of stationary-phase prey 
cells in 0.05 M potassium phosphate buffer (pH 7.5) at concentrations of prey and bdellovibrios of 2 
x 109 cells per ml with a multiplicity of infection of unity. Bdellocysts contained more 
deoxyribonucleic acid, ribonucleic acid, protein, and carbohydrate per cell than did vegetative cells. 
Poly-ß-hydroxybutyrate and dipicolinic acid were not detected. Bdellocysts were more resistant 
than vegetative cells to effects of elevated temperatures, sonic treatment, and desiccation. 
Bdellocysts remained viable for extended periods when incubated in the absence of prey, whereas 
vegetative cells lost viability rapidly under the same conditions. Their survival under starvation 
conditions may be due to the low rate of endogenous respiration by the bdellocysts. Bdellocysts are 
capable of germination in the presence or absence of prey cells in rich medium such as peptone-
yeast extract. Under proper conditions, Bdellovibrio sp. strain W cells develop into bdellocysts in 
appropriate prey bacteria. After attachment and penetration of the prey cell, the encysting 
bdellovibrio began to accumulate inclusion material and increase in size, and was surrounded by an 
outer layer of amorphous electron dense material. The cytoplasm of the encysting cell appeared 
more electron dense, and the nuclear areas appeared more compact. During germination of 
bdellocysts, the outer wall was uniformly broken down, the inclusion material changed shape and 
affinity for the heavy metal stain, and the nuclear areas expanded. As the outer wall was dissolved, 
outgrowth began with the elongation of the germinant as it emerged from the prey ghost as an 
actively motile cell (TUDOR and CONTI 1977a,b) 
 
2.4.4. Food Preservation using Bdellovibrios 
Just as it has been used as a biological control agent to selectively eliminate bacterial blooms, 
bdellovibrio are now coming into the light as a useful preventative agent against pathogenic 
microbes and bacteria that cause food spoilage. The issue of food safety is of importance to the food 
industry, governement regulatory agencies and to all consumers, so this aspect of bdellovibrio could 
be quite important. Already, it has been shown to be an effective eliminator of pseudomonas on 
crops, such as soybean, and in safe maintenance of food storages. By application of a buffered spray 
or dip, bdellovibrio may be applied to manufactered food as an alternative to other, less favorable 
additives (JACKSON and WHITING 1992). Bdellovibrio can effectively reduce the numbers of 
Aeromonas spp., E. coli, Pseudomonas spp., S. Poona and Shigella spp. Within a time span of 7 
hours, and at a temperature of 30ºC, reductions of these populations ranged from 0.1 to 7.7 log 
values.  E. coli was most effectively reduced of these, and was optimally eliminated at temperatures 
of 30-37ºC, whereas lowering the temperature to 12-19ºC took over 24 hours to achieve the same 
effect.  As bdellovibrio cannot function well outside neutral pH environments, a pH of 5.6-8.6 was 
found to be a limiting factor in these tests (JACKSON and WHITING 1992, FRATAMICO and 
WHITING 1994)   
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3. Materials and Methods  
 
3.1 Experimental birds  
100 one-day old specific pathogen free (SPF) chicks placed in electrically heated starter batteries 
located within abiological hazard isolation units on the research House of Institute of Poultry 
Diseases, Faculty of Veterinary Medicine, Free University Berlin.  
 
3.2 Diets 
Chickens were given antibiotic-free, layer ration. This experiment 1 was Tük-Tük-Alleinfutter I for 
layer chickens Type 072, Hobbersdorf- Germany. Composition of the basal diet used in was 
crudprotein 16.50%, methionine 0.35%, crudfat 5.0%, crudfiber 4.5%, crudach 12,0%, calcium 
3,5%, phosphorus 0,50%, sodium 0,16%, vitamin A 12.000 I.U., vitamin D3 2.500 I. U., vitamin E 
10 mg, cupper, BHA, canthaxanthin 10 mg. 
The ration in experiment 2 was Tük-Tük-Alleinfutter for broiler chicken Type 004 - Hobbersdorf- 
Germany. Composition of the basal diet used in was crudprotein 15.0%, crudfat 3.5%, crudfiber 
6.20%, crudach 6.80%, calcium 1.20%, phosphorus 0,50%, sodium 0.13%, vitamin A 9.000 I.U., 
vitamin D3 2.000 I. U., vitamin E 10 mg, cupper, BHA 10 mg. 
 
3.3 Bacteria 
S. Enteritidis (PT4) was obtained from Institute of Poultry Diseases, Faculty of Veterinary 
Medicine, Free University Berlin. This strain was made resistant to novobiocin and nalidixic acid 
by subculturing in 8 successive broth cultures containing increasing concentrations of antibiotics 
starting with 10 µg/ml novobiocin and 10 µg /ml nalidixic acid in the first day, after that using broth 
containing 20, 50, 100, 125, 250, 500 and ending with 1000 µg /ml. Selective agar supplemented 
with 25 µg /ml novobiocin and 20 µg /ml nalidixic acid was used as the plating medium to select 
the resistant mutants (CORRIER et al. 1991; TELLEZ et al. 1993; HAFEZ and STADLER 1997, 
BARNHART et al. 1999). Inocula for challenge were prepared from peptone broth cultures 
incubated at 37 °C for 24 hr  serially diluted in sterile HM-buffer. The viable cell concentration of 
the inoculum was determined by colony counts on Gassner agar plates supplemented with 25 µg /ml 
novobiocin and 20 µg /ml nalidixic acid to obtain challenge inocula containing 2.50 x 106 viable 
cells /ml  S. Enteritidis. 
 
3.4. E. coli Nissle 1917 
It was obtained from Ardeypharm GmbH, Herdecke, Germany. This strain was made resistant to 
novobiocin and nalidixic acid by the same method which was mentioned before. Selective agar 
supplemented with 25 µg /ml novobiocin and 20 µg /ml nalidixic acid was used as the plating 
medium to select the resistant mutants.E. coli Nissle 1917 with and without plasmid were obtained 
from Institute of Molecular Infection Biology, University of Würzburg and they were resistant to 
rifampicin. Selective agar supplemented with 30 µg /ml rifampicin used for reisolation.        
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Bdellovibrio bacteriovorus was isolated from broiler chickens and obtained from Institute of 
Bacteriology and Mycology, Faculty of Veterinary Medicine, University of Leipzig.  
 
3.5 Experimental protocol  
3.5.1 Experiment I 
Chickens were divided into five groups of 20 animals (table 2)  
 
Group A, received E. coli Nissle 1917-NON (5 x 107 viable cells) and B. bacteriovorus (5 x 109 
viable cells) per bird at first day directly into the crop by gavage, while chickens were challenged 
orally in second day with S. Enteritidis-NON (2.5 x 106 viable cells) per bird. Chickens were 
additionly received E. coli Nissle 1917-NON (9 x 108 viable cells) and B. bacteriovorus (1 x 107 
viable cells) per ml every day from 14 to 20 day old directly into the crop by gavage. From 21 to 
27, the birds were received E. coli Nissle 1917-NON (2 x 108 viable cells) and B. bacteriovorus (5 x 
108 viable cells) per ml in drinking water.    
 
Group B, received E. coli Nissle 1917-NON (5 x 107 viable cells) and B. bacteriovorus (5 x 109 
viable cells) per bird at second day directly into the crop by gavage, while chickens were challenged 
orally at first day with S. Enteritidis-NON (2.5 x 106 viable cells) orally per bird. Chickens received 
E. coli Nissle 1917-NON (9 x 108 viable cells) and B. bacteriovorus (1 x 107 viable cells) per ml 
every day from 14 to 20 day old directly into the crop by gavage. The birds were received E. coli 
Nissle 1917-NON (2 x 108 viable cells) and B. bacteriovorus (5 x 108 viable cells) per ml every day 
from 21 to 27 day old in drinking water.     
 
Group C, received E. coli Nissle 1917 not marked with novobiocin and nalidixic acid (1 x 106 
viable cells) and B. bacteriovorus (1 x 109 viable cells) per bird at first day directly into the crop by 
gavage, while chickens were challenged orally at second day with S. Enteritidis not marked with 
novobiocin and nalidixic acid (1.7 x 106  viable cells) per bird. Chickens received E. coli Nissle 
1917 (3 x 108 viable cells) and B. bacteriovorus (1 x 108 viable cells) per ml every day from 14 to 
20 day old directly into the crop by gavage. Chickens were received E. coli Nissle 1917 (1.1 x 108 
viable cells) and B. bacteriovorus (7 x 108 viable cells) per ml every day from 21 to 27 day old in 
drinking water.    
 
Group D, acts as positive control, chickens were challenged orally with S. Enteritidis-NON (2.5 x 
106 viable cells) per ml at first day of the experiment directly into the crop by gavage.  
 
Group E, acts as negative control, chickens were received neither E. coli Nissle 1917, B. 





Table (2) Experimental design (first experiment) 
 








1st day* 5x107 5x109 - 
2nd day* - - 2,5x106 
14th-20th 
days* 




2x108 5x108 - 
1st day* -  2,5x106 
2nd day* 5x107 5x109 - 
14th-20th 
days* 




2x108 5x108 - 
1st day* 1x106 1x109 - 
2nd day* -  1,7x106 
14th-20th 
days* 




1.1x108 7x108 - 
D 20 1st day* - - 2,50x106 
E 20 - - - - 
 
* orally into the crop 
** in drinking water  
• E. coli marked NON 
•• E. coli not marked 
 
 
3.5.2 Experiment II 
Chickens were divided into five groups of 20 animals (table 3)  
Group A, act as positive control for E. coli Nissle 1917-RIF with plasmid, chicken received E. coli 
Nissle 1917-RIF (5 x 108 viable cells ) per bird at the first day directly into the crop by gavage. 
After that the birds received E. coli Nissle 1917-RIF (5 x 108 to 7.5 x 109 viable cells) per ml from 
the second day to the last day of the experiment every day in drinking water.  
 
Group B, received E. coli Nissle 1917-RIF with plasmid (5 x 108 viable cells) per bird at the first 
day directly into the crop by gavage, while chickens were challenged orally at the second day with 
S. Enteritidis-NON (2.5 x 105 viable cells) per bird. After that the birds received E. coli Nissle 1917-
RIF (5 x 108 to 7.5 x 109 viable cells) per ml from the second day to the last day of the experiment 
every day in drinking water.  
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Group C, received E. coli Nissle 1917-RIF-plasmid free (5 x 108 viable cells) per bird at the first 
day directly into the crop by gavage, while chickens were challenged orally at the second day with 
S. Enteritidis-NON (2.5 x 105 viable cells) per bird. After that chickens received E. coli Nissle 1917-
RIF-without plasmid (5 x 108 to 7.5 x 109 viable cells) per ml from second day to the last day of the 
experiment every day in drinking water.  
 
Group D, acts as positive control, birds were challenged orally with S. Enteritidis-NON (2.5 x 105 
viable cells) per bird at the second day of the experiment directly into the crop by gavage.  
 





Table (3) Experimental design (second experiment) 
 




E. coli S. Enteritidis 
PT4 
1st day* 5x108 - A 20• 
From 2 nd to 
27th days** 
5x108 – 7,5x109 - 
1st day* 5x108  B 20• 
From 2 nd to 
27th days** 
5x108 – 7,5x109 at 2,5x105 
1st day* 5x108  C 20•• 
From 2 nd to 
27th days** 
5x108 – 7,5x109 at 2,5x105 
D 20 2nd day* - at 2,5x105 
E 20 - - - 
 
* orally into the crop 
** in drinking water  
• with plasmid 
•• plasmid free 
 
3.6 Bacteriological examination 
3.6.1 Collection of the samples 
At 7 days, 14 days, 21 days and 28 days of age, five chickens from each group were killed by 
decapitation. The caeca, caecal contents, crop, proventricuolus, duodenum, lung, liver, heart blood, 
and spleen were collected aseptically and examined bacteriologically. Blood serum was collected 
and evaluated for serum IgY against S. Enteritidis and E. coli Nissle 1917, serum avidin level.  
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3.6.2 Determination of aerobic and anaerobica bacteria, S. Enteritidis and E. coli Nissle 1917 
per gram of caecal content 
A 0.1 to 0.5-g amounts of caecal contents from each chickens was weighted and placed in a 
sterilized glass tube. The initial dilution was made by adding 9 volumes of sterile HM-buffer. 
Further serial 10 fold dilutions using sterile HM-buffer solution were made. Following dilution, 
0.01-ml amounts of the suspension from the dilutions, including the intial dilution, were taken and 
spread on Nutrient agar for determination of aerobic total bacterial counts,  MacConkey,s agar for 
determination of Gram negative bacterial counts, Gassner agar (Oxoid) were prepared with 
Novobiocin 25 µg and Nalidixic acid 20 µg/ml for isolation of S. Enteritidis-NON and E. coli 
Nissle 1917-NON, Gassner agar (Oxoid) were prepared with Rifampicin 30 µg/ml for isolation of 
E. coli Nissle 1917-RIF to inhibit the growth of other bacteria. The plates were aerobically 
incubated for 24 hr at 37 °C, and the number of cfu per gram of caecal contents was determined. On 
other hand, C. perfringens was isolated on sheep blood agar which supplemented with Neomycin 
200 µg/ml and Polymixin B 100 µg/ml and incubated anaerobically by 37 °C for 48 hours (figure 2) 
and identified by gram preparation (figure 3) and egg-yolk lactose agar. Mann Rogosa Sharpe 
(MRS) agar from (Oxoid) for isolation of Lactobacillus and Bifidobacterium. The plates were 
anaerobically incubated for 48 hr at 37 °C, and the number of cfu per gram of caecal contents was 







Figure 2. C. perfringens on blood agar plate, typical circular haemolysis, 48 hours, 37 °C 






3.6.3 Organ colonization by S. Enteritidis 
The organ cultures were conducted according to the method described by HAFEZ et al. (1986). One 
gram of crop, proventricuolus, duodenum, caecum, liver, lung, heart blood, and spleen was 
collected aseptically and pre-enriched separately in 9 ml of buffered pepton water and incubated at 
37 °C for 24 hrs. 0.1 ml of this pre-enriched broth was transferred to 10 ml Rappaport Vassilliadis 
enrichment broth and incubated at 42 °C for 48 hrs. The samples were then streaked on Gassner 




Figure 3. C. perfringens, Gram stain, Gram-positive to gram-variable, plump, briquette-
shaped rodes, x 1250 
 
 
3.6.4 Isolation and identification of Bdellovibrios 
3.6.4.1 Isolation of Bdellovibrio spp. from caecal contents 
A 0.1 to 0.5-g amounts of caecal contents from each chickens was weighted and placed in a 
sterilized glass tube. The initial dilution was made by adding 9 volumes of sterile HM-buffer. 500 
µl from diluted caecal contents 1:10 were mixed thoroughly with 1ml prey cells (E. coli Nissle 
1917) which was prepared in concentration of 109 cfu/ml in top layer semisolid agar. After that the 
whole solution was poured on the bottom agar and allowed to cool until solid (pouring method). 
Dropping method in which the prey cells were mixed with the semisolid top agar and poured on the 
bottom agar. The plates were allowed to cool until solid. 10 µl from diluted caecal contents was 
dropped on the two layers agar. The plates were incubated at 37 °C for 4-7 days. After that the 
plates could be examined for suspected plaques of Bdellovibrio spp., figure 4. To verify suspected 




















Figure 5. A phase contrast microscope, looking for Bdellovibrio (left arrow) and prey cells E. 
coli strain Nissle 1917 (right arrow) x 1250 
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3.6.4.2 Preparation of HM buffer  
The HM buffer was composed by addition of 1mM CaCl2 x 2 H2O and 0.1 mM MgCl2 x 7 H2O to 
Hepes-buffer (N-2 hydroxyethyl piperazine-N-2 ethanesulfonic acid) of the company Sigma as 
10mM solution, pH was adjusted to 7.6 and autoclaved at 121 °C for 15 minute(TUDOR and 
CONTI 1977a) 
 
3.6.4.3 Preparation and composition of prey cells medium 
The prey cells medium consisted of 20 g of inulin, 10 g yeast extract, 20 g of CaCO3 15 g (Difco) 
Bacto-agar and suspended in 1000 ml distilled water. pH adjusted at 7.6 and autoclaved at 121 °C 
for 15 minutes. 
 
3.6.4.4 Double-layer method 
The double layer agar consists of bottom and top layer agar. The tris YP medium was added to 
promote the activity of the bdellovibrio (STOLP and PETZOLD 1962). Composition of the Tris-YP 
medium was yeast extract (Difco) 3.0 g, peptone (Difco) 0.6 g and Tris-buffer (50 mM, pH 7.5) in 
1000 ml of distilled water. 
 
3.6.4.4.1 Preparation of bottom agar media   
12 g Bacto-agar (Difco) was added to 1000 ml distilled water which contains 2mM CaCl2 x 2 H2O 
and 3mM MgCl2 x 6 H2O. The medium was autoclaved at 121 °C for 15 minute. After cooling to 60 
°C, 100 ml from sterile Tris-YP medium was added to the agar. The plates were kept under sterile 
conditions 2-3 days at room temperature before used (SEIDLER and STARR 1969) 
 
3.6.4.4.2 Preparation of top agar media  
6 g Bacto-agar (Difco) was added to 1000 ml distilled water which contains 2mM CaCl2 x 2 H2O 
and 3mM MgCl2 x 6 H2O. The medium was autoclaved at 121 °C for 15 minute. After cooling to 60 
°C, 100 ml from sterile Tris-YP medium was added to the agar and dispersed in 5 ml sterile glass 
tubes. 
 
3.7 Immunological examination 
The avidin and immunoglobulins: IgY-anti-E. coli strain Nissle 1917, IgY-anti-S. Enteritidis were 
determined in the serum samples with enzyme immunoassay (EIA). 
All EIA were done with ELISA-plates (microlon, 96 well, high binding, Greiner, Frickenhausen, 
Germany). All plates were incubated for 1 h at room temperature and a volume of 100 µl serum in 
the well. The coating buffer was 0.1 M NaHCO3 and the wash buffer was phosphate-buffered saline 
as described by Dulbecco without Ca and Mg (PBS, pH 7.35), with 0.1% (v/v) Tween 20, PBST 
(Sigma-Aldrich, Taufkirchen, Germany). The plates were then washed three times with the wash 
buffer (PBST) by using the Nunc-Immuno-Washer 12 (NUNC, Wiesbaden, Germany). The 
horseradish peroxidase was determined with the substrae H2O2  and 3, 3, 5, 5-tetramethylbenzidine 
 35 
(TMB). The substrate reaction was stopped with 1 M H2SO4 (50 µl/well). The optical density was 
measured with microplate-ELISA-reader at 450nm. 
 
3.7.1 EIA for avidin 
The ELISA-plate was coated with biotin-conjugated bovine serum albumin (5µg/ml). The standard 
was avidin (hen egg white, Pierce – Perbio, Bonn, Germany) ranging from 1 to 40 ng/ml. The 
samples were diluted 1:50. The assay buffer for dilution of the standard and plasma samples was 50 
mM Tris/HCl (pH 7.5), 0.15 M NaCl, 0.2% (w/v) bovine casein, 0.1% (w/v) bovine serum albumin 
and 0.1% tween 20 (v/v). The avidin detection antibody was IgG conjugated with horseradish 
peroxidase (Dianova, Hamburg, Germany) diluted 1:10000 in assay buffer. 
 
3.7.2 EIA for IgY-anti-E. coli strain Nissle 1917 and IgY-anti-S. Enteritidis 
The ELISA-plate was coated with 100 µl/well of 5 µg/ml of the bacterial protein antigen from E. 
coli strain Nissle 1917 or from S. Enteritidis. The bacterial antigens were isolated from the 
cultivated and washed bacterial cells after disruption with glass beads with a diamter of 0.1mm. 
After 1 h of incubation the plates were washed twice with PBST and then 100 µl/well of 1:100 
diluted samples and the diluted pooled avian serum (internal standard for serum antibodies with 100 
relative units per ml) was added. The dilution buffer was 50 mM Tris/HCl (pH 8.0), 0.15 M NaCl, 
0.5% (w/v) bovine casein, 10 mM EDTA and 0.1% Tween 20 (v/v). The detection antibody was 
IgG (rabbit) anti-avian IgY conjugated with horseradish peroxidase (Dianova, Hamburg, Germany) 
diluted 1:5000 in dilution buffer. 
 
 
3.8 Experiment III 
3.8.1 Effect of E. coli strain Nissle 1917 (not marked) on the growth rate of the S. Enteritidis 
PT4 in vitro 
Peptone broth were inoculated with S. Enteritidis PT4 (2.5 x 104, 3.5 x 104 and 6 x 104 ) cfu/ml and 
E. coli Nissle 1917 (not marked) 6 x 107, 2.5 x 107 and 1 x 108 cfu/ml in the first, second and third 
experiments respectively. The second broth inoculated with S. Enteritidis PT4 (3 x 104, 2.5 x 104 
and 6.5 x 104) cfu/ml in the first, second and third experiments respectively which was a control. 
Both brothes incubated at 37 °C for about 48 hours. The S. Enteritidis was counted after 6, 24 and 
48 hours. 
 
3.8.2 Effect of E. coli strain Nissle 1917 (RIF-with plasmid) on the growth rate of the S. 
Enteritidis PT4 in vitro 
The first broth was inoculated with S. Enteritidis PT4 (2 x 104, 2.5 x 104 and 8.5 x 104) cfu/ml and 
E. coli Nissle 1917 (RIF) 5 x 106, 1.5 x 106 and 1 x 108 cfu/ml in the first, second and third 
experiments respectively. The second broth inoculated with S. Enteritidis (3 x 104, 2.5 x 104 and 6.5 
x 104) cfu/ml in the first, second and third experiments respectively acts as a control. Both brothes 
incubated at 37 °C for about 48 hours. The S. Enteritidis was counted after 6, 24 and 48 hours. 
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3.8.3 Effect of E. coli strain Nissle 1917 (RIF-plasmid free) on the growth rate of the S. 
Enteritidis PT4 in vitro 
The first broth was inoculated with S. Enteritidis PT4 (1 x 104, 2 x 104 and 6.5 x 104) cfu/ml and 
with E. coli Nissle 1917 (RIF-plasmid free) 1 x 107, 2 x 106 and 2 x 108  cfu/ml in the first, second 
and third experiments respectively. The second broth inoculated with S. Enteritidis PT4 (3.5 x 104, 
3 x 104 and 6.5 x 104) cfu/ml in the first, second and third experiments respectively acts as a control. 
Both brothes incubated at 37 °C for about 48 hours. The S. Enteritidis was counted after 6, 24 and 
48 hours. 
 
 3.9 Statistical analysis 
Biostatistical analysis: - the available results were statistically processed with the statistical program 
SPSS 11. The values of total aerobic bacterial count, Gram negative bacterial counts, Bdellovibrio 
bacterial counts, C. perfringens bacterial counts and Lactobacillus-Bifidobacterium counts were 
logarithmed in order to receive a normal distribution of the values. The examination on normal 
distribution of the values was accomplished with the Shapiro wilk test. From the logarithm’s values 
of E. coli strain Nissle 1917, S. Enteritidis, the total aerobic bacterial counts, Gram-negative 
bacterial counts, Bdellovibrio bacterial counts, C. perfringens bacterial counts, Lactobacillus-
Bifidobacterium counts, serum avidin levels, IgY against E. coli strain Nissle 1917 and IgY against 
S. Enteritidis were calculated. The significance examinations with the ANOVA (variance analysis) 






















4.          Results 
 
4.1 Results of  experiment I 
 
4.1.1 Effect of oral application of E. coli strain Nissle 1917 with Bdellovibrio bacteriovorus on 
colonization intensity  of E. coli strain Nissle 1917 in the caecum of SPF chickens 
The colonization of E. coli strain Nissle 1917 was increase in the trial group A in comparison to the 
trial group B at 7 days old. E. coli Nissle 1917 was not found at 14 days old from all trial groups. 
The colonization of E. coli was increase in both trial groups A and B at age of 21 and 28 days. 
There was a significant increase in the E. coli strain Nissle 1917 colonization in the trial group A at 
7 and 28 days old in comparison to 14 and 21 days old in the same group (P<0.05) but in group B 
E. coli was significantly increased at 21 and 28 days old in comparison to 14 and 7 days old (figure 
6 and table 4 A,B,C and D ). 
 
 
Figure 6. The colonization intensity of E. coli  Nissle 1917 after oral 































4.1.2 Effect of oral application of E. coli strain Nissle 1917 with B. bacteriovorus on 
colonization of S. Enteritidis in the caecum of SPF chickens experimentally infected with S. 
Enteritidis 
A significant reduction in S. Enteritidis PT4 colonization was observed in the trial group B at 28 
days old in comparison to the positive one (P<0.05). The colonization of S. Enteritidis PT4 was 
significantly decreased in the trial group C at 14 days old (P<0.05) in comparison to the positive 
one (figure 7 and table 4 A,B,C and D ). 
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Figure 7. Effect of E. coli  strain Nissle 1917 with B. bacteriovorus on 





























4.1.3 Relationship between the colonization of E. coli strain Nissle 1917 and S. Enteritidis in 
the caecum of SPF chickens experimentally infected with S. Enteritidis  
A negative correlation was observed between the colonization of E. coli strain Nissle 1917 and S. 




Figure 8. Relationship between the colonization of E. coli  strain 
















































4.1.4 Effect of oral application of E. coli strain Nissle 1917 with B. bacteriovorus on total 
aerobic bacterial counts in caecum of SPF chickens experimentally infected with S. Enteritidis 
A significant reduction in the total aerobic bacterial counts were observed in the negative control 
group E in comparison to the trial and positive control (A-D) from age of 7 to 21 days (P<0.05). At 
28 days the total aerobic bacterial counts were significantly decreased in the trial groups (A-C) and 
negative control E (P<0.05) in comparison to the positive control (figure 9 and table 4 A,B,C and 





Figure 9. Effect of E. coli  strain Nissle 1917 with B. bacteriovorus 




































4.1.5 Effect of oral application of E. coli strain Nissle 1917 with B. bacteriovorus on Gram 
negative bacterial counts in caecum of SPF chickens experimentally infected with S. 
Enteritidis 
A significant reduction in the Gram negative bacterial counts were observed in the negative control 
group in comparison to the trial and positive control groups from 7 till 21 days but at 28 days a 
significant reduction in the Gram negative bacterial counts were observed in the negative control 




Figure 10. Effect of E. coli  strain Nissle 1917 with B. 


































4.1.6 Effect of oral application of E. coli strain Nissle 1917 with B. bacteriovorus on 
Bdellovibrio bacterial counts in caecum of SPF chickens experimentally infected with S. 
Enteritidis 
There was a significant increase in the bdellovibrio bacterial counts in the trial groups in 
comparison to the control groups (P<0.05) from 7 till 28 days. No significant difference were 
observed in the bdellovibrio bacterial counts between the trial groups (figure 11 and table 4 A,B,C 
and D).  
 
 
Figure 11. Effect of E. coli strain Nissle 1917 with B. bacteriovorus  on 































4.1.7 Effect of oral application of E. coli strain Nissle 1917 with B. bacteriovorus on reisolation 
of S. Enteritidis from different parts of intestinal tract and organs of SPF chickens 
experimentally infected with S. Enteritidis 
A reduction in the salmonella reisolation rate from crop and proventriculus was observed in the trial 
groups at 7, 14 and 28 days in comparison to the positive control (figure 12, 13 and table 5 A,B,C 
and D). A reduction in the salmonella reisolation rate was observed from duodenum in the trial 
groups from 7 to 28 days in comparison to the positive control (figure 14 and table 5 A,B,C and D). 
No reduction in salmonella reisolation rate was observed from the caecum in trials groups in 
comparison to the positive control (figure 15 and table 5 A,B,C and D) 
 
 
Figure 12. Effect of E. coli  strain Nissle 1917 with B. 


























Figure 13. Effect of E. coli  strain Nissle 1917 with B. 


























Figure 14. Effect of E. coli  strain Nissle 1917 with B. 


























Figure 15. Effect of E. coli  strain Nissle 1917 with B. 



























A reduction in the salmonella reisolation rate from the heart blood was observed in trial groups at 
14 and 21 days in comparison to the positive control (figure 16 and table 5 A,B,C and D). A 
reduction in the salmonella reisolation rate from the lung was seen in trial groups from 7 to 28 days 
in comparison to the positive control (figure 17 and table 5 A,B,C and D). A reduction in the 
salmonella reisolation rate from the liver was observed in trial groups at 7 and 14 days in 
comparison to the positive control (figure 18 and table 5 A,B,C and D). A reduction in the 
salmonella reisolation rate from spleen was observed in trial groups at 7, 14 and 21 days in 




Figure 16. Effect of E. coli  strain Nissle 1917 with B. bacteriovorus 

























Figure 17. Effect of E. coli  strain Nissle 1917 with B. 

























Figure 18. Effect of E. coli  Strain Nissle 1917 with B. bacteriovorus 


























Figure 19. Effect of E. coli  strain Nissle 1917 with B. 




























4.1.8 Effect of oral application of E. coli strain Nissle 1917 with B. bacteriovorus on the 
mortality rate in SPF chickens experimentally infected with S. Enteritidis PT4 
A high mortality rate in the positive control group (10 %) was observed in comparison to the trial 
groups. One of the three trial groups had also (5 %) mortalities (figure 20 and table 6). 
 
    
 
Figure 20. Effect of E. coli  strain Nissle 1917 with B. bacteriovorus 



























4.1.9 Effect of oral application of E. coli strain Nissle 1917 with B. bacteriovorus on body 
weight of SPF chickens experimentally infected with S. Enteritidis 
No significant difference on the body weight gain was observed of the trial groups in comparison to 
the control groups from 7 to 28 days (figure 21 and table 7 A,B,C and D). 
 
 
Figure 21. Effect of E. coli  strain Nissle 1917 with B. 




























4.1.10 Effect of oral application of E. coli strain Nissle 1917 with B. bacteriovorus on the serum 
avidin level of SPF chickens experimentally infected with S. Enteritidis 
A significant reduction in the serum level of avidin was shown in the trial groups A and C in 
comparison to the positive control (P<0.05) at 7 day old (figure 22 and table 8 A, B, C and D). 
 
 
Figure 22. Effect of E. col i strain Nissle with B. bacteriovorus  on 






















4.1.11 Effect of oral application of E. coli strain Nissle 1917 with B. bacteriovorus on the 
serum IgY-anti-S. Enteritidis level of SPF chickens experimentally infected with S. Enteritidis 
A significant high level in the serum antibody against S. Enteritidis was seen in the trial group B in 
comparison to the positive control (P<0.05) at 7 day old. A significant increase in the level of 
antibodies against S. Enteritidis in the positive control at 21 and 28 days and trial group B at 28 
days (P<0.05) in comparison to other groups (figure 23 and table 8 A, B, C and D) 
 
Figure 23. Effect of E. coli  strain Nissle 1917 with B. 































4.1.12 Effect of oral application of E. coli strain Nissle 1917 with B. bacteriovorus  on the 
serum IgY-anti-E. coli strain Nissle 1917 level of SPF chickens experimentally infected with S. 
Enteritidis 
A significant higher antibody level against E. coli in the trial group B and negative control were 
observed at day 7 (P<0.05) in comparison to positive control. No significant difference in the 
antibody level was shown from 14 till 28 days (figure 24 and table 8 A, B, C and D). 
 
Figure 24. Effect of E. coli  strain Nissle 1917 with B. bacteriovorus 































4.2 Results of  experiment II 
 
4.2.1 Oral application of E. coli strain Nissle 1917 with and without plasmid and colonization 
of E. coli strain Nissle 1917 in the caecum of SPF chickens experimentally infected with S. 
Enteritidis 
No significant difference was seen in the E. coli strain Nissle 1917 colonization in all trial groups at 
7 and 28 days old. The colonization of E. coli strain Nissle 1917 was significantly increase in the 
trial group C received E. coli Nissle 1917 without plasmid at 14 annd 21 days old (P<0.05) in 
comparison to the other trial groups (figure 25 and table 9 A, B, C and D) 
 
 
Figure 25. Results of colonization of E. coli  strain Nissle with and 
































4.2.2 Effect of oral application of E. coli strain Nissle 1917 with and without plasmid on the 
colonization of S. Enteritidis in the caecum of SPF chickens experimentally infected with S. 
Enteritidis 
A significant reduction of the S. Enteritidis colonization in the caecum of trial groups B and C in 
comparison to the positive control group (P<0.05) at 7 days old. No significant in the S. Enteritidis 
colonization was observed between trial and positive control group at 14 days old. A sharp 
significant reduction in the S. Enteritidis colonization was observed in the trial group B in 
comparison to the trial group C and positive control group (P<0.05) at 21 days old. At 28 days old, 
there was more significant reduction in the S. Enteritidis colonization in the trial group B and C in 
comparison to positive control group, also a significant reduction in S. Enteritidis colonization was 
seen in trial group B (P<0.05) in comparison to trial group C (figure 26 and table 9 A, B, C and D)   
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Figure 26. Effect of E. coli  strain Nissle 1917 with and without 


























4.2.3 Relationship between the colonization of E. coli strain Nisle 1917 with and without 
plasmid and S. Enteritidis in the caecum of experimentally infected chickens 
A negative correlation was observed between the colonization of E. coli strain Nissle 1917 and S. 
Enteritidis PT4 in trial group B at 21 and 28 days but in group C only at 28 days (figure 27) 
 
 
Figure 27. Relationship between E. coli strain Nissle 1917 with and 
















































4.2.4 Effect of oral application of E. coli strain Nissle 1917 with and without plasmid on total 
aerobic bacterial counts in the caecum of SPF chickens experimentally infected with S. 
Enteritidis 
No significant in the total aerobic bacterial counts were seen in the trial groups in comparison to the 
control group at 7, 14 and 28 days old. A significant reduction in the total aerobic bacterial counts 
were observed in the trial group A in comparison to the other trial and control groups (P<0.05) at 21 




Figure 28. Effect of E. coli  strain Nissle 1917 with and without 


































4.2.5 Effect of oral application of E. coli strain Nissle 1917 with and without plasmid on Gram 
negative bacterial counts in the caecum of SPF chickens experimentally infected with S. 
Enteritidis 
There were a significant reduction in the Gram negative bacterial counts in the negative control 
group in comparison to the other trial and positive control groups (P<0.05) at 7, 14 and 21 days old. 
A significant reduction of Gram negative bacterial counts were seen in the trial group A and 
negative control group in comparison to other trial and positive control group (P<0.05) at 28 days 





Figure 29. Effect of E. coli  strain Nissle 1917 with and without 

































4.2.6 Effect of oral application of E. coli strain Nissle 1917 with and without plasmid on 
Bdellovibrio bacterial counts in the caecum of SPF chickens experimentally infected with S. 
Enteritidis 
No significant was seen in the isolation of bdellovibrios from trial groups in comparison to the 
control groups from 7 to 28 days old (figure 30 and table 9 A, B, C and D) 
 
 
Figure 30. Effect of E. coli  strain Nissle 1917 with and without 


































4.2.7 Effect of oral application of E. coli strain Nissle 1917 with and without plasmid on 
Lactobacillus-Bifidobacterium bacterial counts in the caecum of SPF chickens experimentally 
infected with S. Enteritidis 
A significant decrease in the Lactobacillus-Bifidobacterium bacterial counts were seen in the 
positive control group at 7, 14 and 21 days old, in trial group B at 7 days old and in trial group B 
and A 21 days old (P<0.05). No significant were observed at 28 days of age (figure 31 and table 9 
A, B, C and D) 
Figure 31. Effect of E. coli  strain Nissle 1917 with and without 



























4.2.8 Effect of oral application of E. coli strain Nissle 1917 with and without plasmid on C. 
perfringens bacterial counts in the caecum of SPF chickens experimentally infected with S. 
Enteritidis 
A significant increase in the C. perfringens bacterial counts was observed in positive control 
(P<0.05) at 7 days of age in comparison with the all trial groups (A-C) and negative control group 
E, but at 14 days the C. perfringens was increase in positive control and trial group C in comparison 
to the other trial groups A, B and negative control (figure 32 and table 9 A,B,C and D) 
Figure 32. Effect of E. coli  strain Nissle 1917 with and without 


























4.2.9 Effect of oral application of E. coli strain Nissle 1917 with and without plasmid on 
reisolation rate of S. Enteritidis from different parts of intestinal tract and organs of SPF 
chickens experimentally infected with S. Enteritidis 
A reduction in the salmonella reisolation rate from crop was observed in the trial groups at 14 and 
28 days in comparison to the positive control (figure 33 and table 8 A, B, C and D). A reduction in 
the salmonella reisolation rate from proventriculus was observed in the trial groups B and C at day 
14 but only in trial group B at 21 days in comparison to the positive control (figure 34 and table 8 
A,B,C and D). A reduction in the salmonella reisolation rate from duodenum was observed in the 
trial groups day 14 in comparison to the positive control (figure 35 and table 8 A,B,C and D). A 
reduction in the salmonella reisolation rate from caecum was observed in the trial groups at 28 days 
in comparison to the positive control (figure 36 and table 8 A, B, C and D).  
 
Figure 33. Effect of E. coli  strain Nissle 1917 with and without 

























Figure 34. Effect of E. coli  strain 1917 with and without plasmid on 

























Figure 35. Effect of E. coli  strain Nissle 1917 with and without 

























Figure 36. Effect of E. coli  strain Nissle 1917 with and without 



























A reduction in the salmonella reisolation rate from the heart blood was observed in the trial groups 
at 7, 14 and 21 days in comparison to the positive control (figure 37 and table 8 A, B, C and D). No 
reduction in the salmonella reisolation rate was observed from the lung in the trial groups from 7 to 
28 days in comparison to the positive control (figure 38 and table 8 A, B, C and D). A reduction in 
the salmonella reisolation rate from the liver was observed in the trial group B at 7 days in 
comparison to the positive control (figure 38 and table 8 A, B, C and D). A reduction in the 
salmonella reisolation rate from the spleen was observed in the trial group B at 7 and 14 days in 
comparison to the positive control (figure 39 and table 8 A, B, C and D)   
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Figure 37. Effect of E. coli  strain Nissle 1917 with and without 
























Figure 38. Effect of E. coli  strain Nissle 1917 with and without 
























Figure 39. Effect of E. coli  strain Nissle 1917 with and without plasmid 

























Figure 40. Effect of E. coli  strain Nissle 1917 with and without 



























4.2.10 Effect of oral application of E. coli strain Nissle 1917 with and without plasmid on the 
mortality rate of SPF chickens experimentally infected with S. Enteritidis PT4 
A mortality rate was observed in the positive control (15 %) in comparison to the trial groups. The 




Figure 41. Effect of E. coli  strain Nissle 1917 with and without 




























4.2.11 Effect of oral application of E. coli strain Nissle 1917 with and without plasmid on body 
weight of SPF chickens experimentally infected with S. Enteritidis 
No significant difference observed in the body weight of the trial groups in comparison to the 
control groups from 7 till 28 days old (figure 42 and table 12 A, B, C and D). 
 
Figure 42. Effect of E. coli  strain Nissle with and without plasmid on 


























4.2.13 Effect of oral application of E. coli Nissle 1917 with and without plasmid on the serum 
avidin level of SPF chickens experimentally infected with S. Enteritidis 
The serum level of avidin was higher in both trial groups B and C in comparison to positive control  
and trial group A(P<0.05) at 7 and 14 days (figure 43 and table 13 A, B, C and D) 
 
Figure 43. Effect of E. col i strain Nissle 1917 with and without 























4.2.14 Effect of oral application of E. coli Nissle 1917 with and without plasmid on the serum 
IgY-anti-S. Enteritidis level of SPF chickens experimentally infected with S. Enteritidis 
No significant in the serum level of antibodies against S. Enteritidis were seen between the trial and 
control groups at 7 and 14 days old. A significant increase in the serum antibody level was observed 
in the trial group C am 21 and 28 but trial group B only at 28th day (P<0.05) in comparison to the 
positive control (figure 44 and table 13 A, B, C and D). 
Figure 44. Effect of E. coli  strain Nissle 1917 with and without 

































4.2.15 Effect of oral application of E. coli Nissle 1917 with and without plasmid on the serum 
IgY-anti-E. coli level of SPF chickens experimentally infected with S. Enteritidis 
A significant higher level of antibody against E. coli Nissle 1917 was observed in trial groups A, C 
and negative control at  at day 7 and only in trial group C at day 14 (P<0.05) in comparison to the 
positive control. At day 28 was significant higher level of antibody in both trial groups A and C 
(P<0.05) in comparison to other groups   (figure 45 and table 13 A, B, C and D) 
Figure 45. Effect of E. coli  strain Nissle 1917 with and without 

































4.3 Results of Experiment III 
 
4.3.1 Effect of E. coli strain Nissle 1917 (not marked) on the growth rate of the S. Enteritidis 
PT4 in vitro 
The results reveal a reduction of growth rate of S. Enteritidis PT4 inoculated with E. coli strain 
Nissle 1917 (not marked) after 6, 24 and 48 hours in comparison to the control broth contained S. 
Enteritidis PT4. On the other hand the S. Enteritidis PT4 rapidly increased till the peak of growth 





Figure 46. Effect of E. coli strain Nissle 1917 (not marked) on the 




























4.3.2 Effect of E. coli strain Nissle 1917 (RIF-with plasmid) on the growth rate of S. Enteritidis 
PT4 in vitro 
The results reveal a reduction of growth rate of S. Enteritidis PT4 inoculated with E. coli strain 
Nissle 1917 (RIF-with plasmid) after 6, 24 and 48 hours in comparison to the control broth 
contained S. Enteritidis PT4. On the other hand the S. Enteritidis PT4 rapidly increased till the peak 






Figure 47. Effect of E. coli  strain 1917 (RIF-with plasmid) on the 

























4.3.3 Effect of E. coli strain Nissle 1917 (RIF-without plasmid) on the growth rate of the S. 
Enteritidis PT4 in vitro 
The results reveal a reduction of growth rate of S. Enteritidis PT4 inoculated with E. coli strain 
Nissle 1917 (RIF-without plasmid) after 6, 24 and 48 hours in comparison to the control broth 
contained S. Enteritidis PT4. On the other hand the S. Enteritidis PT4 rapidly increased till the peak 
of growth after 24 and 48 hours (figure 48 and table 16)  
 
Figure 48. Effect of E. coli  strain Nissle 1917 (RIF-without plasmid) 



























5.1 Critical discussion of used methods 
Salmonella infections has a great medical and economical impact in Germany due to its remarkable 
increase in the last decennium. Antimicrobial treatment does not improve the symptom and multi 
drug resistance develops in a germ-free pig (TREBICHAVSKY et al. 1998). In the first experiment, 
we have observed the probiotic effects of E. coli strain Nissle 1917 and B. bacteriovorus on the S. 
Enteritidis PT4 colonization in intestinal tract of SPF chickens. So we used the combination of E. 
coli strain Nissle 1917 and B. bacteriovorus because of bdellovibrios act as a biological control 
agent against Gram negative bateria, Pseudomonas, Aeromonas spp., E. coli, S. Poona and Shigella 
spp. (JACKSON and WHITING 1992). Bdellovibrio has lytic properties, which  plays an important 
role in maintenance of homestasis in the ecological system (EDAO et al. 1998, EDAO. 2001). The 
used B. bacteriovorus was already adapted on E. coli strain Nissle 1917 in our laboratories. We 
used this combination because E. coli strain Nissle 1917 can protect B. bacteriovorus (bdelloplasts) 
from higher acidity of proventriculus. On the other hand, we investigated the effects of E. coli strain 
Nissle 1917 against S. Enteritidis PT4.    
After 7 days of application of E. coli strain Nissle 1917 with B. bacteriovorus, both bacteria were 
successfully isolated at day 7, but not day 14. This means that B. bacteriovorus was not able to 
maintaine in other Gram negative bacteria of the gastrointestinal tract. Chickens of trial groups 
administered orally the combination of bacteria using gavage from 14 to 21 days and subsequently 
7 days through drinking water. After this treatment, the E. coli strain Nissle 1917 was isolated in 
high concentrations and we have observed a significant reduction in S. Enteritidis PT4 colonization. 
Many authors observed that the patients with intestinal disorders need long term treatments with E. 
coli strain Nissle 1917, sometimes treat least 8-12 weeks and four times daily (MÜLLER-
LISSNER. 2000, GOERG. 2000).    
The combination between E. coli strain Nissle 1917 and B. bacteriovorus had not achieved the 
desirable effects which observed by many authors in vitro. This desirable effects were not observed 
because of bdellovibrio was in limited numbers and B. bacteriovorus was adapted on E. coli strain 
Nissle 1917. We assume no lytic effects on S. Enteritidis or under this conditions the concentration 
of B. bacteriovorus in the caecum of infected chickens was not high enough to eliminate S. 
Enteritidis.      
   
In the second experiment, chickens have administered two strains of E. coli Nissle 1917. The first 
one was like the natural strain (two cryptic plasmids) and the second one was plasmid free. We have 
used these two strains to observe the probiotic effects on the salmonella colonization in the caecum, 
stability of the intestinal microflora, body weight and immune system of the birds. The used strains 
of E. coli were rifampicin resistant to reisolate these strains more easy from chickens.  
Intially oral administration of probiotic strains of E. coli for one time and subsequent every day 
until end of experiment through drinking water was conducted to maintain similarly high level of 
probiotic effect. We have observed the probiotic effects of natural strain of E. coli in the chickens 
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without salmonella infection by E. coli in control group. The control group allowed to investigate 
the dynamic changes in the caecum of chickens and the immunological picture without salmonella 
after oral application of probiotic strain. The two experiments were not comparable because of 
different strategies of treatment with E. coli with and without bdellovibrios and as well as different 
applications of the probiotic bacteria.   
 
5.2 Discussion of the results  
5.2.1 Discussion of the results of experiment 1 
5.2.1.1 Effect of oral appliction of E. coli strain Nissle 1917 and B. bacteriovorus on the 
colonization of E. coli strain Nissle 1917 in the caecum of SPF chickens experimentally 
infected with S. Enteritidis 
Our results show that E. coli strain Nissle 1917 has been successfully colonized in the caecum of 
day old SPF chicks at the age of 7, 21 and 28 days in comparison to 14 days old. The colonization 
of E. coli strain Nissle 1917 occurred shortly after oral application in the first or the second day of 
the experiment. Colonization was significantly increased in trial groups A and C received E. coli at 
first day before S. Enteritidis PT4 in comparison to the trial group B which received S. Enteritidis 
PT4 at first day. The colonization of E. coli in the intestinal tract of animals and humans were 
investigated in several studies (LODINOVA-ZADNIKOVA et al. (1992, 1998) they reported that 
oral administration of the live vaccine COLINFANT (E. coli O83:K24:H31) and probiotic Mutaflor 
(E. coli O6:K5:H1) to newborn children prepared from non-enteropathogenic E. coli strains, both 
strains colonized effectively the intestine and remained for several weeks after only one application. 
 
The colonization of E. coli strain Nissle 1917 was gradually decreased at 14 days old in all trial 
groups because of chickens have received only one dose of E. coli strain Nissle 1917 until 14 days 
old, or may be due to the lytic effects of bdellovibrio. The colonization was high from 21 to 28 days 
old because of daily doses from E. coli strain Nissle 1917 directly into the crop by gavage from 14 
to 21 days old and in drinking water from 21 to 28 days old. Many studies revealed that the 
application of E. coli for the patients with intestinal disorders must be two to four times daily for at 
least two to four months ((MÜLLER-LISSNER. 2000, GOERG. 2000). The situation of one day 
old SPF chickens are not comparable to uncolonized newborn children or germ free rats. The SPF 
chickens were very early colonized by physiological bacteria.   
 
5.2.1.2 Effect of oral appliction of E. coli strain Nissle 1917 and B. bacteriovorus on the 
colonization of S. Enteritidis in the caecum and mortality rate in SPF chickens experimentally 
infected with S. Enteritidis 
E. coli are capable to produce biological antimicrobial substances such as colicin, microcin and 
short-chain fatty acids. The contribution of normal E. coli flora to the microbial barrier of the 
gastrointestinal tract is based on their antagonism to pathogenic germs. Our results show that the 
colonization of S. Enteritidis in the caecum of day old SPF chicks was significantly reduced in trial 
group B in comparison to the positive control group especially at 21 and 28 days old and in trial 
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group C at 14 days old. The reduction in the S. Enteritidis colonization resulted from the 
antagonistic effects of E. coli and this reduction of salmonella colonization was only occurred at 21 
and 28 days old because of continuous doses of E. coli. Our results were in agree with observation 
thos reported by many authors indicate that the E. coli Nissle 1917 produce antagonistic substances 
(SONNENBORN and GREINWALD 1991, HEESEMANN and SCHUBERT 2000) The growth 
and metabolic activity of E. coli may lower the pH  and chemical composition of the colonic lumen 
that was unfavourable to pathogenic bacteria or was blocking receptors in the intestinal mucosa and 
thus preventing adhesion of pathogenic bacteria which established (REMBACKEN et al. 1999). E. 
coli strain Nissle 1917 exhibits strong antagonistic activity against pathogenic enterobacteria in vivo 
using gnotobiotic animals. E. coli Nissle 1917 had a favourable effect on reduction of the number of 
infections, deaths in conjunction with infection, a reduced presence of pathogenic microflora in the 
alimentary tract and elsewhere in childern. In carriers the strain replaced successfully pathogenic 
strains and assisted the restitution of the impaired intestinal microflora  (LODINOVA-
ZADNIKOVA et al. 1992, 1998). Early presence of non-enteropathogenic E. coli strains in the 
intestine decreased significantly the colonization of the intestine with pathogenic bacteria 
(MALCHOW. 1997, LODINOVA-ZADNIKOVA and SONNENBORN 1997).  
 
Our results show that a high mortality rate (10%) in the positive control group post inoculation with 
S. Enteritidis at 5th day of age in comparison to the trial groups B and C but the motality rate in the 
trial group A was 5%. Our results are in agree with the results reported by WATKINS and MILLER 
(1983) prophylactic treatments with L. acidophilus significantly reduced mortality rate in the 
chickens infected with S. Typhimurium and Staphylococcus aureus. Another study revealed that 
prophylactic treatments with L. acidophilus significantly decreased the mortality rate in gnotobiotic 
chickens infected with pathogenic E. coli (WATKINS et al. 1982).      
 
5.2.1.3 Effect of oral appliction of E. coli strain Nissle 1917 and B. bacteriovorus on reisolation 
of S. Enteritidis from different parts of intestinal tract and organs of SPF chickens 
experimentally infected with S. Enteritidis 
Our results show a reduction in the reisolation rate of S. Enteritidis from crop, proventriculus and 
duodenum in the trial groups in comparison to the positive control group at 7, 14 and 28 days old, 
but there was no difference in the S. Enteritidis reisolation rate observed from the caecum in trial 
groups in comparison to the positive control group from 7 to 28 days old. There was a reduction in 
the S. Enteritidis reisolation rate in the heart blood, lungs, livers and spleens of trial groups in 
comparison to the control group from 7 till 28 days old. Our results indicated that the used probiotic 
E. coli strain Nissle 1917 had successfully reduced the invasive rate of S. Enteritidis to the different 
organs of SPF chickens. (TELLEZ et al. (2001) who observed a significant difference in the 
isolation rate of S. Enteritidis from the internal organs (liver and spleen) after probiotic 
supplementation. In our results, there were no reduction in S. Enteritidis reisolation rate from 
caecum of trial groups in comparison to the positive control group. These results agree with 
FUKATA et al. (1999) no significant difference on S. Enteritidis reisolation was observed in the 
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caecal contents of three treated groups with probiotics compared to the positive control. SAVAGE 
(1977) who observed that the lumen can be colonized by microbes in any area of the tract but may 
be colonized normally only in areas of relative stasis, such as the caecum.  
 
 
5.2.1.4 Effect of oral appliction of E. coli strain Nissle 1917 and B. bacteriovorus on the 
Bdellovibrio concentration in the caecum of SPF chickens experimentally infected with S. 
Enteritidis 
Our results show that bdellovibrios were successfully isolated from the caecum of all trial groups in 
comparison to the negative and positive control group. The prey cells (E. coli strain Nissle) had 
protected the bdellovibrio in the intestinal tract specially from the acidity of the proventriculus. 
Bdellovibrio was already adapted on E. coli strain Nissle 1917 and unfortunately it had lytic effects 
especially on E. coli strain Nissle 1917 but not the used S. Enteritidis PT4 strain. The bdellovibrio 
was isolated in low concentration and also after daily application. This may be due to anaerobic 
conditions of the caecum of chickens which prevent the bdellovibrios to degrade the pathogens, 
high temperature of the chickens or high acidity of the proventriculus which destroy the most 
vegetative form of bdellovibrio. In vitro, bdellovibrios were widly used as decontamination method 
for Gram negative bacteria (LAMBINA et al. 1987, IBRAGIMOV. 1980, EDAO. 2000 ). In vivo, 
bdellovibrios were isolated from cows, horses, pigs and ducks (IBRAGIMOV. 1980) and from 
caecum of broiler and layer chickens (ELSAYED. 2002). In our experiment, we have been used a 
suspension contained Bdellovibrio bacteriovorus and E. coli strain Nissle 1917. The probiotic strain 
E. coli Nissle 1917 was acting as transporter (prey cells) for bdellovibrio. This used suspension may 
allow to have a high concentration of bdelloplasts (TUDOR and CONTI 1977a, b).  
 
 
5.2.1.5 Effect of oral appliction of E. coli strain Nissle 1917 and Bdellovibrio bacteriovorus on 
the intestinal microflora in the caecum and body weight of SPF chickens experimentally 
infected with S. Enteritidis 
Our results show a significant reduction in the total aerobic bacterial counts in the trial groups A, B, 
C and negative control groups at 28 days in comparison to the positive control group but the Gram 
negative bacterial counts were significantly decrease in the trial group C and negative control group 
at 28 days. Our results indicated that the oral application of E. coli strain Nissle 1917 with 
bdellovibrio had significantly decreased both total and Gram negative bacterial counts in the 
caecum of chickens. Oral application of non pathogenic E. coli significantly reduced the presence of 
pathogenic bacteria in digestive tract (LODINOVA-ZADNIKOVA et al. (1992). Many studies also 
established that oral intake of probiotics beneficially affects the host animal by improving its 
intestinal microbial balance, suppression of harmful microorganisms or exert an influence on 
commensal microorganisms (FULLER. 1989, FULLER and GIBSON 1997, KAILASAPATHY 




In our results, there was no significant difference observed in the body weight among the trial 
groups in comparison to the control groups. Our results were closely similar with the results 
reported by ADLER and DAMASSA (1980), DAMRON et al. (1981), PROMSOPONE et al. 
(1998) no significancy in the weight gain of chicks received feed supplemented with probiotics. 
Other authors reported about improvement of the body weight after probiotic supplementation 
(TORTUERO. 1973, KRÜGER et al. 1977). 
 
5.2.1.6 Effect of oral appliction of E. coli strain Nissle 1917 and Bdellovibrio bacteriovorus on 
the immunological parameters of SPF chickens experimentally infected with S. Enteritidis 
The serum avidin was significantly higher in the positive control group and trial group B in 
comparison to the trial groups A and C at 7 days old. A high level of avidin is usually accompanied 
by severe inflammations. This high level of avidin in the positive control group and in the trial 
group B was due to severe inflammation results from S. Enteritidis infection. The other trial groups 
A and C had low level of avidin although both groups were infected with S. Enteritidis because of 
the chickens of both groups have been received E. coli strain Nissle 1917 at the first day of the 
experiment which slight protected the chicken from high invasion of S. Enteritidis. This means that 
application of the probiotic E. coli strain Nissle 1917 must be before infection with S. Enteritidis. 
Our results are in agree with the results reported by TUOHIMAA et al. (1989) avidin is a host acute 
defense protein induced by inflammation caused by injurious factors such as microbes. 
 
Our results reveal that a significant increase in the antibodies level against S. Enteritidis in trial 
group B only in comparison to the positive control group at 7 days old. This high level of antibody 
in trial group B is possibly a result of the oral intake of the probiotic strain of E. coli Nissle 1917 
which has been improved the immune system of the chickens after infection at first day of the 
experiment with S. Enteritidis. This high level of antibody may be due to the chickens of the trial 
group B had received firstly S. Enteritidis which stimulated the immune system or the application of 
probiotic strain of E. coli Nissle 1917 had successfully the immune system of the birds of trial 
group. These results closely agree with many studies which revealed that oral intake of E. coli 
Nissle 1917 stimulates the mucosal and systemic humoral immunity.  (CUKROWSKA et al. 2001, 
2002). Another studies revealed that probiotics can enhance both specific and non specific immune 
response (PESTKA. 1993, DE SIMONE. 1992, PERDIGON et al. 1995, SCHIFFRIN et al. 1995, 
TANNOCK. 1999, FERENCIK et al. 1999, MATSUZAKI and CHIN 2000). The antibodies 
production against S. Enteritidis was increased in the positive control group after 14th day of age 
and still high till the end of experiment in comparison to the trial groups. These results which 
observed in the positive control group after infection with S. Enteritidis agree with the results 
reported by other authors. S. Enteritidis specific antibodies of infected hens reached a peak at day 
14 post-inoculation and remained elevated (WITHANAGE et al. 1999). A high level of antibody 
against S. Enteritidis was shown in the trial group B at day 28 which accampanied by a significant 
reduction in the salmonella colonization in caecum. 
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Our results show a significant increase in the antibody levels against E. coli Nissle 1917 in the 
negative control group and trial group B in comparison to the other trial and positive control groups 
at 7 days. The positive control group had very low antibodies against E. coli Nissle 1917 because of 
the salmonella infection had consumed high levels of antibodies. In the trial group B, the chickens 
were although infected with salmonella but had high maternal antibodies. Our results were similar 
to the results observed by HOCKERTZ. (1991) who revealed that E. coli strain Nissle 1917 is an 
efficient immunomodulator of the unspecific immune system.     
 
 
5.2.2 Discussion of the results of experiment 2 
5.2.2.1 Effect of oral appliction of E. coli strain Nissle 1917 with and without plasmid on the 
colonization of E. coli strain Nissle 1917 in the caecum of SPF chickens experimentally 
infected with S. Enteritidis 
Our results show that E. coli strain Nissle 1917 has successfully colonized the caecum of SPF 
chickens at 7, 14, 21 and 28 day of age old in all trial groups. A significant increase in the 
colonization of E. coli strain Nissle 1917 was observed in the trial group C at days 14 and 21 which 
had received the plasmid free strain. Our results indicated that the two different strains of E. coli 
Nissle 1917  can successfully colonize the caecum of SPF chickens. These results were similar to 
many studies which investigated the establishment of the important non-pathogenic E.coli strain 
Nissle 1917 in the gastrointestinal tract (GI-tract) of germfree and monoassociated rats. E. coli 
strain Nissle 1917 colonizes the GI-tract of rats with a high proliferation rate (LORENZ and 
SCHULZE 1996). 
   
 
5.2.2.2 Effect of oral appliction of E. coli strain Nissle 1917 with and without plasmid on the 
colonization of S. Enteritidis in the caecum of SPF chickens experimentally infected with S. 
Enteritidis 
Our results show a significant reduction of S. Enteritidis colonization in the caecum of SPF 
chickens after oral application of the two strains of E. coli Nissle 1917 at 7th and 28th day of age in 
both trial groups B and C in comparison to positive control group. A significant reduction was seen 
in the trial group B at day 21 which received the natural strain in comparison to the positive control 
group. These results indicated that the reduction of S. Enteritidis colonization was more observed in 
the trial group received the natural strain in comparison to trial group C which received the plasmid 
free strain. This means that the two plasmids may have a function in antagonistic effects against 
pathogens. Further investigations have to clear this effect. Our results revealed that the probiotic 
strains E. coli Nissle 1917 can successfully reduce the colonization of S. Enteritidis in the caecum 




Our results show a high mortality rate in the positive control group post inoculation with S. 
Enteritidis. The mortality rate reached 15 % at 5th day of age in comparison to the trial groups 
which were infected with S. Enteritidis at the same time. The motality rate in the trial group A was 
10 % although the chickens of this group had only the probiotic strain E. coli Nissle 1917. The both 
animals (10 %) were weak after hatching. These results agree with the results observed by 
LODINOVA-ZADNIKOVA et al. (1998) E. coli strain Nissle 1917 influenced significantly the 
number and incidence of infections, the mortality rate, invasion of pathogens and supressed those 
present already. 
 
5.2.2.3 Effect of oral appliction of E. coli strain Nissle 1917 with and without plasmid on 
reisolation of S. Enteritidis from different parts of intestinal tract and organs of SPF chickens 
experimentally infected with S. Enteritidis 
Our results showed no reduction in the S. Enteritidis reisolation in the crop, proventriculus and 
duodenum of trial groups in comparison to the positive control group at 7 days old. A reduction of 
the S. Enteritidis reisolation was found in the trial groups from 14th to 28th day of age, the S. 
Enteritidis reisolation from the caecum was decreased only at day 28 in comparison to the positive 
control group. This result is different from the first experiment which could not show any reduction 
of salmonell counts in the caecum of trial groups. We have observed a reduction in the S. Enteritidis 
reisolation rate from heart blood and spleens at days 7 and 14 but in the livers only at day 7 and no 
reduction was occurred in the lungs of trial groups in comparison to the positive control group. Our 
results indicated that the used probiotic E. coli strain Nissle 1917 had successfully reduced the 
invasive rate of S. Enteritidis to the different organs and different parts of intestinal tract of SPF 
chickens. These observed results agree with the results reported by LORENZ and SCHULZE 
(1996) who found that oral application of E. coli strain Nissle 1917 in experimentally with Candida 
albicans infected gnotobiotic rats protected the infected rats from overgrowth of C. albicans in 
different parts of intestinal tract.    
 
5.2.2.4. Effect of oral appliction of E. coli strain Nissle 1917 with and without plasmid on the 
intestinal microflora in the caecum and on body weight of SPF chickens experimentally 
infected with S. Enteritidis 
A significant reduction in the total aerobic bacterial counts were found in the trial group A at 21st 
day of age in comparison to the other trial and positive control groups. On the other hand, our 
results observed a significant reduction in Gram negative bacterial counts in the trial group A at day 
28 and negative control group from days 7 till 28 old in comparison to other groups. These results  
are similar to those obtained from the first experiment indicate too that the E. coli Nissle 1917 can 
reduce the pathogenic bacteria or replace the pathogenic bacteria with non pathogenic one in the 
caecum of SPF animals received our probiotic strain. These results were similar with many studies 
revealed that E. coli strain Nissle 1917 can significantly reduce or inhibit the bacterial pathogens 
(MALCHOW. 1997, LODINOVA-ZADNIKOVA and SONNENBORN 1997).  
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Our results also show a significant increase of the lactobacillus-bifidobacterium counts in the trial 
and negative control groups in comparison to the positive control group from 7th to 21st days of 
age. These results indicated that high colonization of the caecum with S. Enteritidis accampanied by 
low lactobacillus-bifidobacterium counts. No inverse relationship was observed between the 
probiotic strains of E. coli Nissle 1917 colonization and the lactobacillus-bifidobacterium counts. 
These obtained results were in agree with several studies revealed that Lactobacilli and Coliforms 
have the ability to control the salmonella in chickens (BARNES et al. 1980, BABA et al. 1991, 
FUKATA et al. 1991a). 
 
Our results show a significant decrease in the C. perfringens bacterial counts in the caecum of trial 
groups A and B and negative control group in comparison to the positive control group at days 7 
and 14 of age. Our results are agree with those revealed a negative correlations exists between the 
colonization of C. perfringens in the caecum of chickens and probiotics intake (HUDAULT et al. 
1982, FUKATA et al. 1991b, ELWINGER et al. 1992, SCHNEITZ et al. 1998). 
 
This  also show that no significant difference in the bdellovibrio bacterial counts was seen in trial 
groups in comparison to the control groups. Our results indicate that the intake of the probiotic not 
increased the bdellovibrio bacterial counts. Bdellovibrio can effectively reduce the numbers of 
Aeromonas spp., E. coli, Pseudomonas spp., S. Poona and Shigella spp. (JACKSON and WHITING 
1992). This results confirm our own one from the first experiment and those of other investigators 
that the probiotic E. coli Nissle 1917 has no significant effects on the mean body weight 
(ESTRADA et al. 2001, TELLEZ et al. 2001).  
 
 
5.2.2.5 Effect of oral appliction of E. coli strain Nissle 1917 with and without plasmid on the 
immunological parameters of SPF chickens experimentally infected with S. Enteritidis 
The results show a significant high level of serum avidin in the trial groups B, C and the positive 
control group at 7th and 14th days of age in comparison to the negative control group and trial 
group A. These results indicated that the salmonella infection had significantly increased the serum 
level of avidin. Our results show that oral application of probiotic strains was not able to reduce the 
concentration of avidin after salmonella infection. This means that the salmonella infection has 
induced the inflammation cascade of the animals. Avidin is a high-affinity biotin-binding egg-white 
protein, is not restricted to the avian, amphibian and reptilian oviducts. In the acute phase of 
inflammation, avidin is synthesized and secreted by various injured tissues in the domestic fowl. 
Acute inflammation caused by mechanical or thermal tissue injury, septic bacterial infection and 





Our results show a significant increase in the level of antibodies against S. Enteritidis in the trial 
groups B and C at 21st and 28th days of age in comparison to the positive control group. These high 
levels of antibodies in the trial groups were accompanied by a sharp reduction in the salmonella 
colonization in comparison to the positive control group. Our results means that oral application of 
probiotic strain of E. coli Nissle 1917 stimulate successfully the immune system of the birds which 
reflected by high production of antibodies against salmonella. The Nissle strain was increased 
serum IgG more than ten times, serum IgM more than twenty times and the amounts of IgM, IgG 
and IgA increased also in the intestinal content (TREBICHAVSKY et al., 1998). These results 
confirm the immunological results observed in the first experiment.     
 
Our results also show a significant increase in the antibodies level against E. coli Nissle 1917 in the 
trial groups C and A in comparison to the positive control group. After salmonella infection, the 
antibodies were consumed very quickly in the positive control group in comparison to the trial 
groups C and A. These results also means that oral application of probiotic strains of E. coli Nissle 
every day in the drinking water had been improved the immune system of the birds. Our results 
were similar with several studies revealed that dietary consumption of probiotic significantly 
enhance levels of interferon-alpha. In vitro upon stimulation of their peripheral blood mononuclear 
cells. There were also significant increases in the phagocytic capacity (ARUNACHALAM et al. 
2000). 
      
5.2.3 Discussion the results of the first and second experimental infection 
The Probiotic strian E. coli Nissle 1917 has successfully colonized the caecum of SPF chickens in 
both experiment. Oral application of probiotic E. coli Nissle 1917 has significantly reduced the 
salmonella colonization in the trial groups in comparison to the positive control group. E. coli strain 
Nissle 1917 decreased the reisolation rate of S. Enteritidis from different parts of intestinal tract and 
organs in the second experiment but no reduction of salmonella reisolation rate from the caecum in 
the first experiment was observed. This may be due to the higher infection dose of salmonella in the 
first experiment in comparison to the second one. The mortality rate among the trial groups was 
higher in the first experiment in comparison to the second experiment. A significant reduction in the 
total and Gram negative bacterial counts at day 21st and 28th respectively was seen in the trial 
groups in comparison to the positive control the first experiment but in the second experiment, a 
significant reduction in the total and Gram negative bacterial counts at day 28th. Bdellovibrios were 
significantly increased in the trial groups of the first experiment in comparison to the second one, 
this was due to the trial groups in the first experiment have received bdellovibrio with E. coli Nissle 
1917. 
 
Oral application of E. coli Nissle 1917 has significantly decreased the serum level of avidin in the 
trial group A and C in comparison to the positive control group in the first experiment but in the 
second one no reduction in the level of avidin in trial group B had the probiotic strain and 
salmonella was obsereved. This effect may be due to using of two different concentrations of 
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salmonella in both experiments. The level of antibody against S. Enteritidis was significantly 
increased in the trial groups in comparison to the positive control in both experiments, this means 
that E. coli Nissle 1917 has improved the immune system of SPF chickens. The level of antibody 
against E. coli Nissle 1917 was significantly increased in the trial groups in comparison to the 
positive control group in both experiment. This indicate that immune response to oral application of 
E. coli Nissle 1917.  
 
5.2.4 Discussion the results of experiment 3 
5.2.4 Effect of E. coli Nissle 1917 with and without plasmid on the growth rate of the S. 
Enteritidis PT4 in vitro 
Our results show a reduction in the growth rate of S. Enteritidis which was inoculated with E. coli 
Nissle 1917 with and without plasmid after 6 hours, 24 hours and 48 hours in comparison to the 
control one. These results means that E. coli Nissle 1917 can produce antagonistic substances which 
inhibit the growth of pathogens. Our results agree with the results observed by several studies in 
vitro that E. coli strain Nissle 1917 show antagonistic effects against Salmonella, Shigella spp., 
some enteropathogenic E. coli, Proteus spp., Candida spp. (SONNENBORN and GREINWALD 
1991). E. coli strain Nissle 1917 acts against enteropathogenic E. coli and S. Typhimurium 
(SCHULZE et al. 1992). E. coli strain Nissle 1917 exhibits strong antagonistic action in vitro 
against a variety of pathogenic and nonpathogenic microorganisms, probably due to the production 
of microcins (LODINOVA-ZADNIKOVA et al. 1998). An avirulent, wild-type avian E. coli was 
electrotransformed with a plasmid coding for the production of microcin. The transformant E. coli 
inhibited the growth of seven serotypes of Salmonella commonly associated with colonization and 
contamination of poultry products and seven strains of E. coli O157:H7 (WOOLEY et al. 1999). E. 
coli strain Nissle 1917 had antagonistic effects against enterotoxic E. coli, enterohaemorrhagic E. 
coli, S. Enteritidis, S. Typhimurium and yeast (HEESEMANN and SCHUBERT 2000). E. coli 
strain Nissle 1917 decreased the invasion rate of pathogenic E. coli and S. Typhimurium to 
intestinal tract (Olschlager et al. 2001, Boudeau et al. 2001). E. coli strain Nissle 1917 had a 
competitive character against many microorganisms in vitro and vivo. It has reduced the growth of 
different bacteria and yeast such as Proteus vulgaris, S. Enteritidis, Shigella dysenteriae, Yersinia 
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1- The effect of oral application of E. coli strain Nissle 1917 with Bdellovibrio bacteriovorus on the 
colonization of S. Enteritidis PT4, reduction of the mortality rate, total aerobic bacterial counts, 
Gram negative bacterial counts, bdellovibrio bacterial counts and body weight of Specific Pathogen 
Free chickens were investigated. A significant reduction in the colonization of S. Enteritidis PT4 in 
the caecum of trial groups at 14, 21 and 28 days old in comparison to the positive control group was 
observed. A reduction in mortality rate in the trial groups was seen in comparison to the positive 
control group which had 10 %. The total aerobic and Gram negative bacterial counts were 
significantly decreased in the trial groups at 28 days old in comparison to the positive control group. 
Bdellovibrio bacterial counts were significantly increased in the trial groups in comparison to the 
control groups. No significant difference was seen in the mean body weight of the trial groups in 
comparison to control groups.  
 
2- The effect of oral application of E. coli strain Nissle 1917 with Bdellovibrio bacteriovorus on 
reisolation rate of S. Enteritidis from different parts of the intestinal tract and organs of SPF 
chickens was investigated. A reduction in the S. Enteritidis reisolation rate was seen from crop, 
proventriculus, duodenum, heart blood, lungs, livers and spleens of the trial groups in comparison 
to the positive control group but not from the caecum. 
 
3- The effect of oral application of E. coli strain Nissle 1917 and Bdellovibrio bacteriovorus on the 
serum avidin levels, IgY against S. Enteritidis and IgY against E. coli strain Nissle 1917 levels of 
SPF chickens experimentally infected with S. Enteritidis was investigated. A significant reduction 
in the serum avidin levels was observed in the trial groups at 7 days old in comparison to the 
positive control group. The antibody levels against S. Enteritidis was significantly increased in the 
trial group at 7 days old in comparison to the positive control group. A significant increase at day 7 
in the antibody levels against E. coli strain Nissle 1917 was seen in the trial group in comparison to 
the positive control group.  
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4- The effect of oral application E. coli Nissle 1917 with and without plasmid on reduction on the 
colonization of S. Enteritidis PT4, reduction of the mortality rate, total aerobic bacterial counts, 
Gram negative bacterial counts, bdellovibrio bacterial counts, Lactobacillus-Bifidobacterium 
counts, C. perfringens bacterial counts and body weight of SPF chickens were investigated. A 
significant reduction in the colonization of S. Enteritidis PT4 in the caecum of trial groups at 7, 21 
and 28 days old in comparison to the positive control group was observed. No mortalities were seen 
in the both trial groups in comparison to the positive control group which had 15 % mortalities. The 
total aerobic and Gram negative bacterial counts were significantly decreased in the trial groups at 
21 and 28 days respectively old in comparison to the positive control group. No significant 
difference was observed in bdellovibrio isolation from the trial groups in comparison to the control 
group. Lactobacillus-Bifidobacterium bacterial counts were significantly increased in the trial 
groups at 7, 14 and 21 days old in comparison to the positive control group. A significant reduction 
in C. perfringens bacterial counts were seen in the trial groups at 7 and 14 days old in comparison to 
positive control group. No significant difference was observed in the mean body weight of the trial 
groups in comparison to control groups.  
  
5- The effect of oral application E. coli Nissle 1917 with and without plasmid on the reisolation of 
S. Enteritidis from different parts of intestinal tract and organs of SPF chickens was investigated. A 
reduction in the S. Enteritidis reisolation rate was seen from crop, proventriculus, duodenum, 
caecum, heart blood, lungs, livers and spleens of the trial groups in comparison to the positive 
control group. 
 
6- The effect of oral application E. coli Nissle 1917 with and without plasmid on the serum avidin 
levels, IgY against S. Enteritidis and IgY against E. coli strain Nissle 1917 levels of SPF chickens 
experimentally infected with S. Enteritidis were investigated. No significant reduction in the serum 
avidin levels were seen in the trial groups in comparison to the positive control group. The antibody 
levels against S. Enteritidis were significantly increased in the trial groups at 21 and 28 days old in 
comparison to the positive control group. A significant increase in the antibody levels against E. 
coli strain Nissle 1917 were seen in the trial groups in comparison to the positive control group. 
 
7- From the results observed in the first and second experiments we concluded that probiotic strain 
E. coli Nissle 1917 can successfully colonize the caecum of SPF chickens from 7 to 28 days old. 
Oral appliction of probiotic strain E. coli Nissle 1917 has significantly reduced the S. Enteritidis 
colonization, total and Gram negative bacterial counts, mortality rate, reisolation rate of S. 
Enteritidis in organs and the intestinal tract except the caecum in first experiment in the trial groups 
in comparison to positive control. The combination between E. coli strain Nissle 1917 and B. 
bacteriovorus had not achieved the desirable effects in the first experiment which observed by 
many authors in vitro. Bdellovibrio was significantly increased in the trial groups of the first 
experiment in comparison to the second experiment. This may be a possible effect of Bdellovibrio 
which is yet to be confirmed. No significant difference was observed in the mean body weight in 
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both experiment. A significant reduction of serum avidin levels were observed in the trial groups of 
the first experiment but not in the second experiment. We have observed a significant improvement 
in the immune system of the birds as a results of oral application of E. coli strain Nissle 1917.     
 
8- Antagonistic effect of E. coli Nissle 1917 with and without plasmid on the growth rate of the S. 
Enteritidis PT4 in vitro was investigated. We concluded that E. coli Nissle 1917 with and without 
plasmid successfully reduced the growth rate of S. Enteritidis in comparison to the control one.   
 
   
   
    
   





























7.     Zusammenfassung 
 
Untersuchungen zur Beeinflussung von experimentellen Salmonella Enteritidis PT4 
Infektionen bei Küken durch den probiotischen Stamm Escherichia coli Nissle 1917 
Imad Azmi Awadein Mohamed 
 
Institut für Bakteriologie und Mykologie, Veterinärmedizinische Fakultät, Universität Leipzig und 
Institut für Geflügelkrankheiten, Veterinärmedizinische Fakultät, Freie Universität Berlin    
 
Eingereicht im Januar, 2004 
Schlüsselworte: (E. coli Stamm Nissle 1917, Küken, S. Enteritidis, Probiotika, Bdellovibrionen) 
(94 Seiten, 48 Abbildungen, 16 Tabellen und 150 Referenzen) 
 
1- Untersucht wurden die Auswirkungen der oralen Applikation von E. coli Stamm Nissle 1917 und 
Bdellovibrio bacteriovorus auf die Reduktion der Ansiedlung von S. Enteritidis PT4, auf die 
Reduktion der Mortalitätsrate, auf die Gesamtzahl aerober  und Gram-negativer Bakterien, auf die 
Anzahl von Bdellovibrionen und auf das Körpergewicht von SPF-Hühnern. Im Vergleich zur 
positiven Kontrollgruppe konnten bei der Ansiedlung von S. Enteritidis PT4 im Caecum der 
Testgruppen an den Tagen 14, 21 und 28 signifikante Unterschiede festgestellt werden. Im 
Vergleich zur positiven Kontrollgruppe, die eine Mortalitätsrate von 10% aufweist, war die 
Mortalitätsrate der Testgruppen deutlich reduziert. Ebenso waren in den Testgruppen die aerobe 
und Gram-negative Gesamtkeimzahl am Tag 28 im Vergleich zur positiven Kontrollgruppe deutlich 
verringert. Signifikanten Anstieg der Bdellovibrionen Anzahl zeigten die Testgruppen sowohl im 
Vergleich zur positiven als auch negativen Kontrollgruppe. Beim Vergleich zwischen dem 
Gesamtkörpergewicht der Testgruppen zu dem der negativen und den überlebenden Tieren der 
positiven Kontrollgruppe gab es keine signifikanten Unterschiede. 
 
2- Untersucht wurden die Auswirkungen der oralen Applikation von E. coli Stamm Nissle 1917 und 
Bdellovibrio bacteriovorus auf die Reisolation von S. Enteritidis PT4 aus verschiedenen Teilen des 
Intestinaltrakts und diverser Organe von SPF-Hühnern. In Kropf, Proventrikel, Herzblut, Lunge, 
Leber und Milz der Testgruppen konnte im Vergleich zur positiven Kontrollgruppe eine Reduktion 
ermittelt werden, die Reisolation von S. Enteritidis aus dem Caecum der Testgruppen zeigte keinen 
Unterschied im Vergleich zur positiven Kontrollgruppe. 
 
3- Untersucht wurden die Auswirkungen der oralen Applikation von E. coli Stamm Nissle 1917 und 
Bdellovibrio bacteriovorus an Konzentrationen von Serum-Avidin, IgY gegen S. Enteritidis und 
IgY gegen E. coli Nissle 1917 bei experimentell mit S. Enteritidis-infizierten SPF-Hühnern. Die 
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Untersuchungen ergaben eine signifikante Senkung der Serum-Avidin-Konzentration im Vergleich 
zur positiven Kontrollgruppe, vor allem sieben Tage post infectionem mit S. Enteritidis. Ein 
signifikanter Anstieg der Konzentration von IgY gegen S. Enteritidis konnte bei den Testgruppen 
im Vergleich zur positiven Kontrollgruppe vor allem an den Tagen sieben verzeichnet werden. Ein 
signifikanter Anstieg der Konzentration von IgY gegen E. coli Nissle 1917 konnte in allen 
Testgruppen im Vergleich zur positiven Kontrollgruppe festgestellt werden. 
 
4- Untersucht wurden die Auswirkungen der oralen Applikation von E. coli Nissle 1917 mit und 
ohne Plasmid auf die Reduktion der Ansiedelung von S. Enteritidis PT4, auf die Reduktion der 
Mortalitätsrate, die aerobe und Gram-negative Gesamtkeimzahl, die Bdellovibrionen-
Gesamtkeimzahl, Keimzahlen von Lactobacillus, Bifidobacterium und C. perfringens und das 
Körpergewicht von SPF-Hühnern. Im Vergleich zur positiven Kontrollgruppe konnte im Caecum 
der Testgruppen ein signifikanter Rückgang der Ansiedelung von S. Enteritidis an den Tagen 7, 21 
und 28 verzeichnet werden, außerdem konnte bei den Testgruppen kein Todesfall festgestellt 
werden, wohingegen die Sterblichkeitsrate der positiven Kontrollgruppe bei 15% lag. Ein 
signifikantes Absinken in der totalen Gesamtkeimzahl und der Gram-negativen Gesamtkeimzahl 
konnte für die Testgruppen im Vergleich zur positiven Kontrollgruppe an den Tagen 21 
beziehungsweise 28 verzeichnet werden. Die Isolation von Bdellovibrionen aus den Testgruppen 
ergab keinen Unterschied zu den Kontrollgruppen. Die Lactobacillus-Bifidobacterium-Keimzahl 
war in den Testgruppen im Vergleich zur positiven Kontrollgruppe signifikant erhöht, vor allem am 
Tag sieben. Die C. perfringens-Keimzahl war in der positiven Kontrollgruppe gegenüber den 
Testgruppen am Tag 7 und 14 signifikant erhöht. Die Vergleiche des Körpergewichts der 
Testgruppen, negativer und überlebender Tiere der positiven Kontrollgruppe zeigten keinen 
signifikanten Unterschied. 
 
5- Untersucht wurden die Auswirkungen der oralen Applikation von E. coli Stamm Nissle 1917 mit 
und ohne Plasmid auf die Reisolation von S. Enteritidis aus unterschiedlichen Teilen des 
Intestinaltraktes und aus Organen von SPF-Hühnern. Im Kropf, Proventrikel, Duodenum, Herzblut, 
Lunge, Leber und Milz konnte bei den Testgruppen im Vergleich zur positiven Kontrollgruppe eine 
Senkung der Reisolationsrate festgestellt werden, wohingegen sich keine Unterschied beim 
Vergleich der Caeca von positiver Kontrollgruppe und von den Testgruppen zeigte. 
 
6- Untersucht wurden die Auswirkungen der oralen Applikation von E. coli Stamm Nissle 1917 mit 
und ohne Plasmid auf die Konzentrationen von Serum-Avidin, IgY gegen S. Enteritidis und IgY 
gegen E. coli Nissle 1917 bei experimentell mit S. Enteritidis-infizierten SPF-Hühnern. Bei der 
Serum-Avidin-Konzentration konnte kein Unterschied zwischen Testgruppen und positiver 
Kontrollgruppe festgestellt werden. Die Testgruppen zeigten ihrerseits im Vergleich zur positiven 
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Kontrollgruppe eine signifikante Erhöhung der Konzentration von IgY gegen S. Enteritidis, vor 
allem an den Tagen 21 und 28. Ein signifikanter Anstieg der Konzentration von IgY gegen E. coli 
Nissle 1917 konnte in allen Testgruppen im Vergleich zur positiven Kontrollgruppe, vor allem an 
den Tagen sieben und vierzehn festgestellt werden. 
 
7- Aus den Resultaten des ersten und des zweiten Versuchs schließen wir, dass der probiotische 
Stamm E. coli Nissle 1917 das Caecum von 7 bis 28 Tage alten Hühnern erfolgreich kolonialisieren 
kann. Orale Applikation des Stammes kann die Ansiedlung von S. Enteritidis, aerobe und Gram-
negative Gesamtkeimzahl, Mortalitätsrate, Reisolationsrate von S. Enteritidis in Organen und im 
Intestinaltrakt (mit Ausnahme des Caecums im ersten Versuch) deutlich reduzieren. Die 
Kombination von E. coli Nissle 1917 und Bdellovibrio bacteriovorus hatte nicht den gewünschten 
Effekt, der auch von mehreren Autoren in-vitro beobachtet wurde. Bdellovibrionen waren in den 
Testgruppen des ersten Versuchs im Vergleich zu denen im zweiten deutlich erhöht. Beim 
durchschnittlichen Körpergewicht konnte kein signifikanter Unterschied zwischen beiden 
Versuchen festgestellt werden. Der Serum-Avidin-Spiegel war im ersten Versuch in der Testgruppe 
deutlich reduziert, im zweiten dagegen nicht. Dies ist möglicherweise auf den Effekt von 
Bdellovibrionen zurückzuführen, bedarf allerdings noch der weiteren Bestätigung. Im Allgemeinen 
konnten wir eine signifikante Verbesserung des Immunsystems der Vögel als Resultat der oralen 
Applikation von E. coli Nissle 1917 feststellen. 
 
8- Untersucht wurden die antagonistischen Effekte von E. coli Stamm Nissle 1917 mit und ohne 
Plasmid auf die in-vitro-Wachstumsrate von S. Enteritidis PT4. Wir konnten feststellen, dass E. coli 
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                 9. Appendix 
 
Table 4(A) Effect of oral application of E. coli strain Nissle 1917 with B.  bacteriovorus on 
colonization of S. Enteritidis and the intestinal microflora of 7 days old SPF 





PT 4 (NON) 
log10/g 






A 1 8.00 7.95 9.17 8.95 2.30 
A 2 0.00 8.04 9.17 9.00 2.30 
A 3 8.47 8.30 10.14 9.95 2.00 
A 4 0.00 7.87 9.39 9.00 2.69 
A 5 8.77 7.69 9.60 9.00 2.47 
  A 6* 8.92 0.00 9.30 9.00 0.00 
M 5.70 6.64 9.47 9.15 1.96 
SE 1.81 1.33 0.15 0.16 0.40 
B1 0.00 8.54 9.54 9.00 0.00 
B2 0.00 9.30 9.81 9.69 2.00 
B3 0.00 8.17 8.65 8.60 2.00 
B4 0.00 8.00 9.17 8.74 2.47 
B5 8.30 8.30 9.47 9.00 2.69 
M 1.66 8.46 9.33 9.01 1.84 
SE 1.66 0.23 0.20 0.19 0.48 
C1 0.00 9:30 9.39 9.39 2.47 
C2 0.00 0.00 9.17 9.00 2.30 
C3 0.00 9:00 9.81 9.00 2.69 
C4 0.00 8:47 10.00 8.77 2.60 
C5 0.00 8:69 9.30 9.30 2.47 
M 0.00 7.10 9.54 9.10 2.51 
SE 0.00 1.78 0.16 0.11 0.07 
D1 0.00 7.39 9.81 9.30 0.00 
D2 0.00 7.47 9.54 9.17 0.00 
D3 0.00 8.95 10.04 9.92 0.00 
D4 0.00 7.04 9.30 9.00 0.00 
D5 0.00 8.84 9.84 9.74 0.00 
  D6* 0.00 8.74 9.54 9.00 0.00 
  D7* 0.00 9.69 10.54 10.14 0.00 
M 0.00 8.31 9.80 9.47 0.00 
SE 0.00 0.38 0.15 0.18 0.00 
E1 0.00 0.00 8.30 8.00 0.00 
E2 0.00 0.00 8.39 8.39 0.00 
E3 0.00 0.00 8.00 7.60 0.00 
E4 0.00 0.00 9.00 8.74 0.00 
E5 0.00 0.00 8.39 8.17 0.00 
M 0.00 0.00 8.42 8.18 0.00 
SE 0.00 0.00 0.16 0.19 0.00 
*Chicks died on the fifth day     A, B, C, D, and E: Group number  
M: Mean        SE: Standard Error 
 
Table 4(B) Effect of oral application of E. coli strain Nissle 1917 with B.  bacteriovorus on 
colonization of S. Enteritidis and the intestinal microflora of 14 days old SPF chickens 





PT 4 (NON) 
log10/g 






A 7 0.00 8.04 9.69 9.17 2.00 
A 8 0.00 7.47 8.95 8.30 2.69 
A 9 0.00 7.00 9.30 8.47 2.47 
 A 10 0.00 6.17 10.00 9.84 2.30 
 A 11 0.00 7.00 8.87 8.30 2.69 
M 0.00 7.14 9.37 8.82 2.43 
SE 0.00 0.31 0.22 0.30 0.13 
B6 0.00 3.60 8.60 6.54 2.47 
B7 0.00 5.69 9.47 8.84 2.60 
B8 0.00 7.65 9.39 9.00 2.69 
B9 0.00 7.47 9.39 9.00 2.47 
 B10 0.00 7.30 9.69 8.30 2.00 
M 0.00 6.46 9.31 8.34 2.45 
SE 0.00 0.77 0.19 0.47 0.12 
C6 0.00 0.00 9.81 9.30 2.69 
C7 0.00 0.00 8.90 8.77 2.30 
C8 0.00 8.17 9.47 9.00 2.47 
C9 0.00 0.00 9.14 8.39 2.00 
  C10 0.00 0.00 9.30 9.23 2.30 
M 0.00 1.64 9.33 8.94 2.36 
SE 0.00 1.64 0.15 0.16 0.12 
D8 0.00 7.04 9.39 8.65 0.00 
D9 0.00 6.65 8.54 8.30 0.00 
  D10 0.00 7.65 9.30 9.30 0.00 
  D11 0.00 6.17 8.84 8.39 0.00 
  D12 0.00 7.69 8.95 8.30 0.00 
M 0.00 7.04 9.01 8.59 0.00 
SE 0.00 0.29 0.16 0.19 0.00 
E6 0.00 0.00 9.00 8.77 0.00 
E7 0.00 0.00 8.60 8.60 0.00 
E8 0.00 0.00 8.14 7.69 0.00 
E9 0.00 0.00 7.39 7.30 0.00 
 E10 0.00 0.00 8.00 7.69 0.00 
M 0.00 0.00 8.23 8.02 0.00 




Table 4(C) Effect of oral application of E. coli strain Nissle 1917 with B.  bacteriovorus on 
colonization of S. Enteritidis and the intestinal microflora of 21 days old  SPF chickens 





PT 4 (NON) 
log10/g 






A 12 4.00 3.84 9.47 9.39 2.47 
A 13 0.00 6.95 9.17 8.54 2.00 
A 14 0.00 6.60 8.47 8.47 2.69 
       A 15 0.00 6.17 9.00 8.84 2.47 
A 16 6.60 5.69 8.54 8.17 2.77 
M 2.12 5.85 8.93 8.69 2.49 
SE 1.36 0.54 0.19 0.21 0.14 
B11 6.69 6.69 9.17 8.65 2.47 
B12 5.69 5.69 8.39 8.39 2.47 
B13 3.39 3.39 8.00 8.00 2.69 
B14 0.00 7.17 9.69 9.47 2.00 
B15 6.17 0.00 8.00 8.00 2.47 
M 4.39 4.59 8.65 8.51 2.43 
SE 1.23 1.32 0.34 0.27 0.11 
C11 0.00 0.00 9.30 8.65 2.69 
C12 0.00 0.00 9.00 8.17 2.60 
C13 0.00 0.00 9.00 8.60 2.47 
C14 0.00 0.00 8.69 8.54 2.47 
C15 0.00 0.00 8.87 8.14 2.00 
M 0.00 0.00 8.98 8.42 2.45 
SE 0.00 0.00 0.10 0.11 0.12 
D13 0.00 7.17 8.17 8.17 0.00 
D14 0.00 6.60 8.47 8.00 0.00 
D15 0.00 0.00 8.39 8.39 0.00 
D16 0.00 7.17 9.30 8.47 0.00 
D17 0.00 6.17 8.39 8.39 0.00 
M 0.00 5.43 8.55 8.29 0.00 
SE 0.00 1.37 0.19 0.09 0.00 
E11 0.00 0.00 8.00 8.00 0.00 
E12 0.00 0.00 7.87 7.65 0.00 
E13 0.00 0.00 8.69 8.30 0.00 
E14 0.00 0.00 7.60 7.60 0.00 
E15 0.00 0.00 8.00 8.00 0.00 
M 0.00 0.00 7.85 7.79 0.00 




Table 4(D) Effect of oral application of E. coli strain Nissle 1917 with B.  bacteriovorus on 
colonization of S. Enteritidis and the intestinal microflora of 28 days old SPF chickens 





PT 4 (NON) 
log10/g 






A 17 6.30 6.30 8.39 8.39 2.47 
A 18 6.00 6.00 8.54 8.39 2.30 
A 19 6.39 6.39 8.39 8.30 2.47 
       A 20 6.00 5.69 8.39 8.39 2.60 
M 6.17 6.10 8.43 8.37 2.46 
SE 0.10 0.16 0.04 0.02 0.06 
B16 6.17 0.00 8.17 8.17 2.60 
B17 6.17 0.00 8.77 8.30 2.00 
B18 6.00 6.00 8.54 8.54 2.47 
B19 6.30 0.00 8.39 8.39 2.60 
B20 7.00 0.00 8.00 8.00 2.00 
M 6.33 1.20 8.38 8.28 2.34 
SE 0.17 1.20 0.14 0.09 0.14 
C16 0.00 0.00 7.77 7.60 2.47 
C17 0.00 0.00 7.84 7.47 2.69 
C18 0.00 0.00 7.17 7.04 2.30 
C19 0.00 0.00 7.95 7.84 2.30 
C20 0.00 0.00 8.23 7.95 2.00 
M 0.00 0.00 7.80 7.58 2.36 
SE 0.00 0.00 0.17 0.16 0.12 
D18 0.00 6.30 10.00 8.90 0.00 
D19 0.00 5.17 8.17 8.00 0.00 
D20 0.00 3.17 8.00 8.00 0.00 
M 0.00 4.88 8.80 8.30 0.00 
SE 0.00 0.91 0.15 0.30 0.00 
E16 0.00 0.00 7.69 7.60 0.00 
E17 0.00 0.00 7.74 7.65 0.00 
E18 0.00 0.00 8.47 8.39 0.00 
E19 0.00 0.00 7.69 7.69 0.00 
E20 0.00 0.00 7.00 7.00 0.00 
M 0.00 0.00 7.72 7.67 0.00 
SE 0.00 0.00 0.23 0.22 0.00 
 
 
Table 5(A) Effect of oral application of E. coli strain Nissle 1917 with B.  bacteriovorus on 
reisolation of S. Enteritidis from different organs of 7 days old SPF chickens experimentally 
infected with S. Enteritidis 
Sample 
Nr. Crop Provent. Duod. Caecum HB Lung Liver Spleen 
A 1 + + + + - + + + 
A 2 + + + + + + + - 
A 3 + + + + + - + - 
A 4 + + + + - + - - 
A 5 - + + + + - + + 
  A 6* + + + + + + + + 
   M %   83.67     100     100     100    66.64   66.64   83.33   49.98 
B1 - - - + + - - - 
B2 + + + + + - + + 
B3 + + + + + + + + 
B4 + - + + + + + + 
B5 + + + + + + + + 
    M %      80      60      80     100     100      60      80      80 
C1 + + + + + + + + 
C2 + + + + + + + + 
C3 + + - + - + + + 
C4 + + + + - + + + 
C5 + - - + + + - + 
    M %     100      80      60     100      60    100      80     100 
D1 + + + + + + + + 
D2 + + + + - + + + 
D3 + + + + + + + + 
D4 + + + + - + + + 
D5 + + + + + - + + 
  D6* + + + + + + + + 
  D7* + + + + + + + + 
    M %    100     100    100     100   71.40   85.68     100     100 
E1 - - - - - - - - 
E2 - - - - - - - - 
E3 - - - - - - - - 
E4 - - - - - - - - 
E5 - - - - - - - - 
    M %    0.00    0.00    0.00    0.00    0.00    0.00    0.00    0.00 
 
*Chicks died on the fifth day     A, B, C, D, and E: Group number  
M: Mean        Provent.: Proventriculus  
Duod.: Duodenum      HB: Heart blood 
Table 5(B) Effect of oral application of E. coli strain Nissle 1917 with B.  bacteriovorus on 
reisolation of S. Enteritidis from different organs of 14 days old SPF chickens experimentally 
infected with S. Enteritidis 
Sample 
Nr. Crop Provent. Duod. Caecum HB Lung Liver Spleen 
A 7 - - - + - - + + 
A 8 - - + + - - + - 
A 9 - - - + - - + + 
 A 10 - - - + - + - - 
 A 11 - - - + - - - + 
   M %    0.00    0.00      20     100    0.00      20      60      60 
B6 - - + + - - + + 
B7 - - - + - - - + 
B8 - - - + - + + - 
B9 + - - + - + - + 
 B10 + - + + - - + - 
    M %     40    0.00     40     100    0.00      40      60      60 
C1 + + + + + - + + 
C2 - + + + + + + + 
C3 + - + + - + + + 
C4 + - + + - + + + 
C5 + + + + - + - + 
    M %      80      60     100     100      40      80      80     100 
D8 + + - + - - + + 
D9 + + + + + + + + 
  D10 - - - + - - - + 
  D11 - - - + + + + + 
  D12 - - + + + - + + 
    M %     40     40     40     100      60      40      80    100 
E6 - - - - - - - - 
E7 - - - - - - - - 
E8 - - - - - - - - 
E9 - - - - - - - - 
 E10 - - - - - - - - 




Table 5(C) Effect of oral application of E. coli strain Nissle 1917 with B.  bacteriovorus on 
reisolation of S. Enteritidis from different organs of 21 days old SPF chickens experimentally 
infected with S. Enteritidis 
Sample 
Nr. Crop Provent. Duod. Caecum HB Lung Liver Spleen 
A 12 + - - + - + - + 
A 13 - - - + - - - - 
A 14 - - - + - - - - 
A 15 - - - + - - - - 
A 16 - - - + - - - - 
   M %      20     0.00     0.00     100     0.00      20     0.00     20 
B11 - - - + - - - + 
B12 - - - + + - - + 
B13 - - - + - - - - 
B14 - - - + - - + - 
B15 - - - + - + - + 
    M %    0.00    0.00    0.00    100     20     20     20     60 
C11 - - - + - - + + 
C12 + - + + - - + - 
C13 - - - + - + + - 
C14 - - - + - - - - 
C15 - - - + - - - - 
    M %     20    0.00     20     100    0.00      20      60     20 
D13 - - + + - - - + 
D14 - - - + - + - + 
D15 - - - - + - - - 
D16 - - + + - - - + 
D17 - - - + + + - + 
    M %    0.00    0.00      40      80     40      40     0.00      80 
E11 - - - - - - - - 
E12 - - - - - - - - 
E13 - - - - - - - - 
E14 - - - - - - - - 
E15 - - - - - - - - 










Table 5(D) Effect of oral application of E. coli strain Nissle 1917 with B.  bacteriovorus on 
reisolation of S. Enteritidis from different organs of 28 days old SPF chickens experimentally 
infected with S. Enteritidis 
Sample 
Nr. Crop Provent. Duod. Caecum HB Lung Liver Spleen 
A 17 - - - + - - - - 
A 18 - - - + - + - - 
A 19 - - + + + - - - 
   A 20 + - - + - - - - 
   M %     25     0.00      25     100      25      25     0.00     0.00 
B16 - - - + - - - - 
B17 - - - + - - - - 
B18 - - - + - - - - 
B19 - - - + - - - - 
B20 - - - + - + + - 
    M %     0.00     0.00     0.00     100     0.00      20     20    0.00 
C16 + - - + - + - + 
C17 - - - + - - - - 
C18 - - - + - - - - 
C19 + - - + - - - - 
C20 + - - + - - - - 
    M %      60    0.00    0.00     100    0.00      20    0.00      20 
D18 + - - + - + - - 
D19 - + - + - + - - 
D20 + - + + - - - - 
    M %   66.67   33.33   33.33     100    0.00   66.67    0.00    0.00 
E16 - - - - - - - - 
E17 - - - - - - - - 
E18 - - - - - - - - 
E19 - - - - - - - - 
E20 - - - - - - - - 




Table 6. Effect of oral application of E. coli strain Nissle 1917 with B.  bacteriovorus on the 
mortality rate in SPF chickens experimentally infected with S. Enteritidis PT4 
Group Nr. Mortality rate 
A 5 %* 
B 0 % 
C 0 % 
D 10 %* 
E 0 % 
*Chicks died on the fifth day 
 
Table 7(A) Effect of oral application of E. coli strain Nissle 1917 with B.  bacteriovorus on the 
body weight of 7 days SPF old chickens experimentally infected with S. Enteritidis PT4 








































*Chicks died on the fifth day     A, B, C, D, and E: Group number  




Table 7(B) Effect of oral application of E. coli strain Nissle 1917 with B.  bacteriovorus on the 
body weight of 14 days SPF old chickens experimentally infected with S. Enteritidis PT4 




 A10 90.10 



















  D10 77.00 
  D11 105.90 














Table 7(C) Effect of oral application of E. coli strain Nissle 1917 with B.  bacteriovorus on the 
body weight of 21 days old SPF chickens experimentally infected with S. Enteritidis PT4 









































Table 7(D) Effect of oral application of E. coli strain Nissle 1917 with B.  bacteriovorus on the 
body weight of 28 days old SPF chickens experimentally infected with S. Enteritidis PT4 








































Table 8(A) Effect of oral application of E. coli strain Nissle 1917 with B.  bacteriovorus on the 
immunological parameters of 7 days old SPF chickens experimentally infected with 
S. Enteritidis 
Samples Nr. Avidin (ng/ml) IgY-anti-S.E (rU/ml) IgY-anti-E.c. (rU/ml) 
A1 104.1 102.1 25.1 
A2 895.8 68.2 497.7 
A3 82.6 164.9 409.6 
A4 192.0 1.5 22.2 
A5 2.9 24.7 367.1 
M 255.48 72.28 264.34 
SE 162.89 28.95 100.49 
B1 895.80 16.01 39.37 
B2 895.80 34.38 1399.24 
B3 203.17 2377.03 4000.00 
B4 3.93 66.29 588.14 
B5 382.27 7.31 578.71 
M 476.19 500.21 1321.09 
SE 181.46 469.32 704.05 
C1 139.92 92.39 95.16 
C2 79.39 20.85 21.29 
C3 444.36 89.49 494.08 
C4 168.37 25.68 34.14 
C5 627.12 9.25 19.55 
M 291.83 47.53 132.84 
SE 104.67 17.93 91.36 
D1 99.6 8.3 19.8 
D2 114.8 98.2 315.6 
D3 895.8 18.9 21.7 
D4 338.8 16.0 13.8 
D5 895.8 8.3 10.8 
M 468.96 29.94 76.34 
SE 179.33 17.19 59.85 
E1 1.3 11.2 36.1 
E2 0.1 17.0 134.2 
E3 0.5 47.0 3113.3 
E4 0.5 524.2 643.5 
E5 0.3 101.5 1211.6 
M 0.54 140.18 1027.74 
SE 0.20 97.33 561.82 
 
 
A, B, C, D, and E: Group number  
M: Mean        
SE: Standard Error 
 
Table 8(B) Effect of oral application of E. coli strain Nissle 1917 with B.  bacteriovorus on the 
immunological parameters of 14 days old SPF chickens experimentally infected with  
S. Enteritidis 
Samples Nr. Avidin (ng/ml) IgY-anti-S.E (rU/ml) IgY-anti-E.c. (rU/ml) 
A6 0.3 14.1 175.8 
A7 0.0 16.0 45.4 
A8 0.5 34.4 100.6 
A9 16.1 1.5 1.0 
 A10 0.0 15.0 19.3 
M 3.38 16.20 68.42 
SE 3.18 5.26 31.67 
B6 1.91 3.44 64.43 
B7 0.00 9.25 19.13 
B8 0.89 11.18 451.38 
B9 32.42 10.21 1167.47 
  B10 0.00 7.31 56.41 
M 7.04 8.28 351.76 
SE 6.35 1.37 218.60 
C6 895.80 13.11 18.72 
C7 37.05 25.68 6.28 
C8 0.89 29.55 95.16 
C9 0.28 16.98 76.37 
  C10 895.80 15.05 58.14 
M 365.96 20.07 50.93 
SE 216.41 3.20 16.86 
D6 24.8 12.1 14.7 
D7 0.3 10.2 20.8 
D8 36.1 34.4 26.3 
D9 6.0 1.5 35.1 
  D10 43.7 6.3 192.3 
M 22.18 12.90 57.84 
SE 8.38 5.67 33.78 
E6 0.0 133.9 20.0 
E7 0.3 140.3 434.4 
E8 0.5 59.4 624.5 
E9 0.3 137.9 19.5 
  E10 0.0 121.1 194.8 
M 0.20 118.52 258.64 
SE 0.02 15.15 118.94 
 
Table 8(C) Effect of oral application of E. coli strain Nissle 1917 with  B.  bacteriovorus on the 
immunological parameters of 21 days old SPF chickens experimentally infected with S. 
Enteritidis 
Samples Nr. Avidin (ng/ml) IgY-anti-S.E (rU/ml) IgY-anti-E.c. (rU/ml) 
A11 143.8 15.0 10.4 
A12 8.6 9.2 43.3 
A13 5.2 5.4 70.1 
A14 0.5 1.0 12.4 
A15 0.5 4.4 29.3 
M 31.72 7.00 33.10 
SE 28.06 2.39 11.03 
B11 644.25 3.44 16.72 
B12 78.98 16.01 153.82 
B13 6.16 146.54 380.59 
B14 1.30 11.18 51.57 
B15 0.49 2.48 18.51 
M 146.24 35.93 124.24 
SE 125.38 27.77 68.78 
C11 3.12 211.31 146.70 
C12 0.00 3.44 36.84 
C13 4.74 134.93 36.84 
C14 0.00 18.91 10.91 
C15 12.83 1.00 35.13 
M 4.14 73.92 53.28 
SE 2.36 42.37 23.87 
D11 25.2 50.8 168.4 
D12 6.2 316.7 132.9 
D13 123.4 62.4 21.7 
D14 22.7 146.5 7.9 
D15 334.2 967.4 26.6 
M 102.34 308.76 71.50 
SE 61.54 171.38 32.94 
E11 0.0 44.4 24.9 
E12 0.0 42.6 18.0 
E13 0.0 51.5 22.0 
E14 0.0 94.9 9.7 
E15 0.0 64.6 627.9 
M 0.00 59.60 140.50 






Table 8(D) Effect of oral application of E. coli strain Nissle 1917 with B.  bacteriovorus on the 
immunological parameters of 28 days old SPF chickens experimentally infected with  
S. Enteritidis 
Samples Nr. Avidin (ng/ml) IgY-anti-S.E (rU/ml) IgY-anti-E.c. (rU/ml) 
A16 0.0 484.9 28.7 
A17 0.0 87.6 460.2 
A18 0.3 284.8 335.4 
A19 0.5 157.2 82.4 
M 0.20 253.63 226.68 
SE 0.12 87.24 102.62 
B16 7.78 673.46 70.08 
B17 0.00 703.43 13.59 
B18 0.49 1430.50 152.39 
B19 0.00 325.40 89.04 
B20 0.08 133.00 20.19 
M 1.67 653.16 69.06 
SE 1.53 221.94 25.31 
C16 12.63 21.81 36.49 
C17 0.00 22.78 229.27 
C18 0.00 109.80 257.59 
C19 0.00 162.01 667.30 
C20 18.49 383.41 39.74 
M 6.22 139.96 246.08 
SE 3.92 66.47 114.97 
D16 4.3 365.0 135.6 
D17 0.5 1157.8 257.6 
D18 0.9 66.3 89.0 
M 1.90 529.70 160.73 
SE 1.21 325.67 50.27 
E16 0.1 77.4 123.6 
E17 0.0 20.4 10.9 
E18 0.0 23.3 30.1 
E19 0.0 28.0 41.9 
E20 0.0 94.9 30.4 
M 0.02 48.80 47.38 











Table 9(A) Effect of oral application of E. coli strain Nissle 1917 with and without plasmid on 
colonization of S. Enteritidis and the intestinal microflora of 7 days old SPF chickens 























A1 7.00 0.00 8.54 8.18 0.00 7.11 0.00 
A2 7.74 0.00 9.00 8.85 0.00 7.00 0.00 
A3 7.54 0.00 9.18 8.54 0.00 7.70 0.00 
A4 7.18 0.00 9.18 8.48 0.00 7.48 0.00 
A5 7.40 0.00 9.00 8.40 0.00 7.08 0.00 
 A6* 8.78 0.00 9.18 9.00 0.00 5.00 0.00 
 A7* 9.78 0.00 10.00 10.00 0.00 5.48 0.00 
M 7.92 0.00 9.15 8.78 0.00 6.70 0.00 
SE 1.00 0.00 0.44 0.60 0.00 1.03 0.00 
B1 9.00 8.00 9.48 9.00 0.00 4.18 0.00 
B2 6.81 7.40 8.30 7.40 0.00 4.70 0.00 
B3 7.30 8.40 8.81 8.40 2.00 4.30 0.00 
B4 8.30 7.18 9.00 8.30 2.90 4.18 0.00 
B5 8.00 7.88 8.74 8.40 2.00 4.18 0.00 
M 7.88 7.77 8.87 8.30 1.38 4.31 0.00 
SE 0.86 0.49 0.43 0.57 1.31 0.23 0.00 
C1 8.88 8.00 9.40 9.18 0.00 7.00 0.00 
C2 8.00 7.70 8.88 8.65 2.30 7.30 0.00 
C3 9.00 6.18 9.54 9.18 0.00 7.40 0.00 
C4 8.00 7.93 9.00 8.00 0.00 7.18 0.00 
C5 9.00 7.70 9.78 9.54 0.00 7.48 0.00 
M 8.58 7.50 9.32 8.91 0.46 7.27 0.00 
SE 0.53 0.75 0.37 0.60 1.03 0.19 0.00 
D1 0.00 7.70 9.18 8.65 2.30 3.00 0.00 
D2 0.00 8.48 8.60 8.48 0.00 3.18 0.00 
D3 0.00 8.00 9.40 8.65 0.00 3.00 0.00 
D4 0.00 8.18 8.60 8.54 0.00 3.00 0.00 
D5 0.00 8.30 9.00 8.40 0.00 3.00 3.00 
  D6* 0.00 8.60 9.60 9.00 0.00 3.18 5.30 
  D7* 0.00 8.78 9.70 9.15 0.00 3.54 5.18 
  D8* 0.00 8.60 10.60 10.20 0.00 3.30 5.48 
M 0.00 8.33 9.34 8.88 0.29 3.15 2.37 
SE 0.00 0.36 0.66 0.59 0.81 0.20 2.65 
E1 0.00 0.00 8.90 8.48 0.00 7.00 0.00 
E2 0.00 0.00 9.40 8.00 0.00 7.18 0.00 
E3 0.00 0.00 8.48 8.00 0.00 7.30 0.00 
E4 0.00 0.00 8.78 7.70 0.00 7.18 0.00 
E5 0.00 0.00 9.78 8.23 0.00 7.18 0.00 
M 0.00 0.00 9.07 8.08 0.00 7.17 0.00 
SE 0.00 0.00 0.52 0.29 0.00 0.11 0.00 
 
*Chicks died on the fifth day  
 
Table 9(B) Effect of oral application of E. coli strain Nissle 1917 with and without plasmid on 
colonization of S. Enteritidis and the intestinal microflora of 14 days old SPF chickens 























A 8 6.60 0.00 9.18 8.00 0.00 7.70 0.00 
A 9 7.48 0.00 9.30 8.00 0.00 7.00 0.00 
 A 10 6.78 0.00 9.08 8.81 0.00 7.30 0.00 
 A 11 7.00 0.00 8.78 8.18 0.00 8.30 0.00 
 A 12 7.81 0.00 8.74 8.00 0.00 8.00 0.00 
M 7.13 0.00 9.02 8.20 0.00 7.66 0.00 
SE 0.50 0.00 0.54 0.35 0.00 0.52 0.00 
B6 7.00 6.74 8.81 7.65 0.00 8.00 0.00 
B7 8.00 7.54 9.00 8.78 0.00 8.30 0.00 
B8 7.18 7.00 9.00 8.00 0.00 8.00 0.00 
B9 7.40 7.48 9.00 8.48 0.00 8.30 0.00 
  B10 8.18 7.65 9.48 8.81 0.00 6.00 0.00 
M 7.55 7.28 9.06 8.34 0.00 7.72 0.00 
SE 0.52 0.39 0.44 0.51 0.00 0.97 0.00 
C6 8.00 7.74 9.48 8.30 0.00 8.00 0.00 
C7 7.74 7.54 9.00 8.65 0.00 6.90 0.00 
C8 8.30 6.00 9..60 8.74 0.00 7.70 4.30 
C9 8.78 7.30 9.18 8.81 0.00 6.60 4.00 
  C10 8.40 7.18 8.85 8.65 0.00 6.70 0.00 
M 8.24 7.15 9.22 8.63 0.00 7.18 1.66 
SE 0.40 0.68 0.43 0.20 0.00 0.63 2.28 
D9 0.00 7.54 9.88 8.40 0.00 6.00 4.48 
  D10 0.00 7.23 8.48 8.18 0.00 8.00 0.00 
  D11 0.00 7.40 9.18 8.18 0.00 8.00 0.00 
  D12 0.00 8.00 9.90 8.74 0.00 8.00 0.00 
   D13 0.00 7.70 8.90 8.18 0.00 6.00 0.00 
M 0.00 7.57 9.27 8.34 0.00 7.20 0.90 
SE 0.00 0.29 0.28 0.25 0.00 1.10 2.00 
E6 0.00 0.00 9.00 7.00 0.00 7.70 0.00 
E7 0.00 0.00 9.48 8.00 0.00 8.70 0.00 
E8 0.00 0.00 8.78 7.54 0.00 8.48 0.00 
E9 0.00 0.00 9.54 7.18 0.00 8.95 0.00 
  E10 0.00 0.00 9.93 7.40 0.00 8.90 0.00 
M 0.00 0.00 9.35 7.42 0.00 8.55 0.00 






Table 9(C) Effect of oral application of E. coli strain Nissle 1917 with and without plasmid on 
colonization of S. Enteritidis and the intestinal microflora of 21 days old SPF chickens 























 A13 6.18 0.00 8.00 7.48 0.00 6.00 0.00 
 A14 6.00 0.00 9.00 7.60 0.00 5.00 0.00 
     A15 6.00 0.00 9.18 7.40 0.00 6.78 0.00 
 A16 6.00 0.00 8.48 8.00 0.00 5.00 0.00 
 A17 6.00 0.00 9.30 8.00 0.00 7.00 0.00 
M 6.04 0.00 8.79 7.70 0.00 5.96 0.00 
SE 0.08 0.00 0.54 0.29 0.00 0.95 0.00 
B11 6.48 0.00 8.30 6.48 0.00 5.00 0.00 
B12 6.00 3.70 9.30 7.30 0.00 5.00 0.00 
B13 6.18 0.00 9.18 7.30 2.30 5.00 0.00 
B14 6.30 4.60 9.00 8.54 0.00 5.00 0.00 
B15 6.18 3..48 9.40 7.30 0.00 5.00 0.00 
M 6.23 2.36 9.04 7.38 0.46 5.00 0.00 
SE 0.18 2.19 0.44 0.74 1.03 0.00 0.00 
C11 6.30 6.60 9.30 8.30 0.00 6.70 0.00 
C12 6.74 6.00 8.70 7.48 0.00 7.00 0.00 
C13 7.00 4.90 9.65 8.48 0.00 8.00 0.00 
C14 6.00 3.00 9.00 7.18 2.48 8.00 0.00 
C15 6.48 6.08 8.60 7.00 0.00 6.90 0.00 
M 6.50 5.31 9.05 7.69 0.50 7.32 0.00 
SE 0.39 1.44 0.43 0.67 1.11 0.63 0.00 
D14 0.00 6.00 8.70 7.00 0.00 6.00 0.00 
D15 0.00 6.23 9.00 7.65 0.00 6.00 0.00 
D16 0.00 6.08 9.48 7.81 0.00 7.00 0.00 
D17 0.00 5.30 9.00 7.70 0.00 6.70 0.00 
D18 0.00 5.70 9.00 7.48 0.00 5.00 0.00 
M 0.00 5.86 9.04 7.53 0.00 6.14 0.00 
SE 0.00 0.37 0.28 0.32 0.00 0.77 0.00 
E11 0.00 0.00 9.30 7.00 0.00 7.00 0.00 
E12 0.00 0.00 9.18 6.00 0.00 8.00 0.00 
E13 0.00 0.00 9.40 7.00 0.00 8.00 0.00 
E14 0.00 0.00 9.48 7.48 0.00 8.30 0.00 
E15 0.00 0.00 9.54 7.00 0.00 8.00 0.00 
M 0.00 0.00 9.38 6.90 0.00 7.86 0.00 




Table 9(D) Effect of oral application of E. coli strain Nissle 1917 with and without plasmid on 
colonization of S. Enteritidis and the intestinal microflora of 28 days old SPF chickens 























A18 7.00 0.00 9.00 7.18 0.00 8.30 0.00 
A19 7.70 0.00 8.65 8.00 0.00 7.00 0.00 
    A20 7.54 0.00 9.00 8.40 0.00 7.00 0.00 
M 7.41 0.00 8.88 7.86 0.00 7.43 0.00 
SE 0.37 0.00 0.20 0.62 0.00 0.75 0.00 
B16 7.81 3.00 9.30 8.30 0.00 6.00 0.00 
B17 8.48 0.00 9.00 8.65 0.00 8.00 0.00 
B18 8.95 0.00 9.40 9.00 0.00 8.00 0.00 
B19 6.00 3.70 9.00 8.81 0.00 8.70 0.00 
B20 8.60 2.70 9.30 9.00 0.00 8.00 0.00 
M 7.97 1.88 9.20 8.75 0.00 7.74 0.00 
SE 1.18 1.75 0.19 0.29 0.00 1.02 0.00 
C16 9.00 3.65 9.81 9.30 0.00 8.30 0.00 
C17 7.18 4.00 8.00 8.00 2.00 8.00 0.00 
C18 7.18 4.00 9.30 8.18 0.00 8.60 0.00 
C19 7.00 4.00 9.00 7.65 2.70 7.00 0.00 
C20 7.00 0.00 9.00 8.00 0.00 7.00 0.00 
M 7.48 3.13 9.02 8.23 0.94 7.78 0.00 
SE 0.86 1.76 0.66 0.63 1.31 0.74 0.00 
D19 0.00 5.70 9.48 8.00 0.00    8.30 0.00 
D20 0.00 6.00 9.00 8.70 2.30    7.00 0.00 
M 0.00 5.85 9.24 8.35 1.15 7.65 0.00 
SE 0.00 0.21 0.34 0.49 1.62 0.92 0.00 
E16 0.00 0.00 9.48 6.65 0.00 8.48 0.00 
E17 0.00 0.00 9.40 6.00 0.00 8.60 0.00 
E18 0.00 0.00 9.00 6.00 2.48 8.70 0.00 
E19 0.00 0.00 9.30 6.95 0.00 8.60 0.00 
E20 0.00 0.00 9.30 7.00 0.00 8.70 0.00 
M 0.00 0.00 9.30 6.52 0.50 8.62 0.00 





Table 10(A) Effect of oral application of E. coli strain Nissle 1917 with and without plasmid on 
reisolation of S. Enteritidis from different organs of 7 days old SPF chickens experimentally 
infected with S. Enteritidis 
Sample 
Nr. Crop Provent. Duod. Caecum HB Lung Liver Spleen 
A 1 - - - - - - - - 
A 2 - - - - - - - - 
A 3 - - - - - - - - 
A 4  - - - - - - - 
A 5 - - - - - - - - 
  A 6* - - - - - - - - 
  A 7* - - - - - - - - 
   M % 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
B1 + + + + - + - - 
B2 + + + + + + + + 
B3 + + + + - + + - 
B4 + + + + + + + + 
B5 + + + + - + + + 
    M % 100 100 100 100 40 100 80 60 
C1 + + + + + + + + 
C2 + + + + + + + + 
C3 + + + + + + + + 
C4 + + + + + + + + 
C5 + + + + + + + + 
    M % 100 100 100 100 100 100 100 100 
D1 + + + + + + + + 
D2 + + + + + + + + 
D3 + + + + + + + + 
D4 + + + + + + + + 
D5 + + + + + + + + 
  D6* + + + + + + + + 
  D7* + + + + + + + + 
  D8* + + + + + + + + 
    M % 100 100 100 100 100 100 100 100 
E1 - - - - - - - - 
E2 - - - - - - - - 
E3 - - - - - - - - 
E4 - - - - - - - - 
E5 - - - - - - - - 
    M %    0.00    0.00    0.00    0.00    0.00    0.00    0.00    0.00 
 
* Chicks died on the fifth day 
 
Table 10(B) Effect of oral application of E. coli strain Nissle 1917 with and without plasmid on 
reisolation of S. Enteritidis from different organs of 14 days old SPF chickens experimentally 
infected with S. Enteritidis 
Sample 
Nr. Crop Provent. Duod. Caecum HB Lung Liver Spleen 
A 8 - - - - - - - - 
A 9 - - - - - - - - 
  A 10 - - - - - - - - 
  A 11 - - - - - - - - 
  A 12 - - - - - - - - 
   M %    0.00    0.00    0.00    0.00    0.00    0.00    0.00    0.00 
B6 - + + + + + + + 
B7 + + + + + + + + 
B8 + - - + + + + - 
B9 + + + + + + + + 
  B10 + + + + + + + + 
   M % 80 80 80 100 100 100 100 80 
C1 + + + + + + + + 
C2 + + + + + + + + 
C3 + - + + - + + + 
C4 + + + + - + + + 
C5 - - - + + + + + 
    M % 80 60 80 100 60 100 100 100 
D9 + + + + + + + + 
  D10 + + + + + + + + 
  D11 + + + + + + + + 
  D12 + + + + + + + + 
  D13 + + + + + + + + 
    M % 100 100 100 100 100 100 100 100 
E6 - - - - - - - - 
E7 - - - - - - - - 
E8 - - - - - - - - 
E9 - - - - - - - - 
  E10 - - - - - - - - 





Table 10(C) Effect of oral application of E. coli strain Nissle 1917 with and without plasmid on 
reisolation of S. Enteritidis from different organs of 21 days old SPF chickens experimentally 
infected with S. Enteritidis 
Sample 
Nr. Crop Provent. Duod. Caecum H B Lung Liver Spleen 
A 13 - - - - - - - - 
A 14 - - - - - - - - 
   A 15 - - - - - - - - 
A 16 - - - - - - - - 
A 17 - - - - - - - - 
   M %    0.00    0.00    0.00    0.00    0.00    0.00    0.00    0.00 
B11 - - - + - - - - 
B12 - - - + - - - - 
B13 + - - + - - - + 
B14 + + - + - - - - 
B15 + + - + - - - - 
    M % 60 40    0.00 100    0.00    0.00    0.00 20 
C11 + + + + - + - - 
C12 + + + + - - - - 
C13 + + + + - - - - 
C14 + - - + - - - - 
C15 + + + + - - - - 
    M % 100 80 80 100    0.00 20    0.00    0.00 
D14 + + + + - - - - 
D15 + + + + + - - - 
D16 - + + + - - - - 
D17 - - + + - - - - 
D18 - - - + - - - - 
    M % 40 60 80 100 20    0.00    0.00    0.00 
E11 - - - - - - - - 
E12 - - - - - - - - 
E13 - - - - - - - - 
E14 - - - - - - - - 
E15 - - - - - - - - 











Table 10(D) Effect of oral application of E. coli strain Nissle 1917 with and without plasmid on 
reisolation of S. Enteritidis from different organs of 28 days old SPF chickens experimentally 
infected with S. Enteritidis 
Sample 
Nr. Crop Provent. Duod. Caecum H B Lung Liver Spleen 
A 18 - - - - - - - - 
A 19 - - - - - - - - 
   A 20 - - - - - - - - 
   M %    0.00    0.00    0.00    0.00    0.00    0.00    0.00    0.00 
B16 - - - + - - - - 
B17 - - - - - - - - 
B18 - - - - - - - - 
B19 - - - + - - - - 
B20 - - - + - - - - 
    M %    0.00    0.00    0.00 60    0.00    0.00    0.00    0.00 
C16 - - - + - - - - 
C17 + - - + - - - - 
C18 + - - + - - - - 
C19 + - - + - - - - 
C20 - - - - - - - - 
    M % 60    0.00    0.00 80    0.00    0.00    0.00    0.00 
D19 + - - + - - - - 
D20 + - - + - - - - 
    M % 100    0.00    0.00 100    0.00    0.00    0.00    0.00 
E16 - - - - - - - - 
E17 - - - - - - - - 
E18 - - - - - - - - 
E19 - - - - - - - - 
E20 - - - - - - - - 





Table 11. Effect of oral application of E. coli strain Nissle 1917 with and without plasmid on 
the mortality rate in SPF chickens experimentally infected with S. Enteritidis PT4 
Group Nr. Mortality rate 
A 10 %* 
B 0 % 
C 0 % 
D 15 %* 
E 0 % 
 
* Chicks died on the fifth day 
 
 
Table 12(A) Effect of oral application of E. coli strain Nissle 1917 with and without plasmid on 
the body weight of 7 days old SPF chickens experimentally infected with S. Enteritidis PT4 






 A6* 40.30 






















 D6* 42.50 
 D7* 41.30 











*Chicks died on the fifth day 
 
Table 12(B) Effect of oral application of E. coli strain Nissle 1917 with and without plasmid on 
the body weight of 14 days old SPF chickens experimentally infected with S. Enteritidis PT4 
Sample Nr. Body weight in g 
A8 68.80 
A9 67.20 
 A10 74.40 
 A11 74.00 



















  D10 69.70 
  D11 73.50 
















Table 12(C) Effect of oral application of E. coli strain Nissle 1917 with and without plasmid on 
the body weight of 21 days old SPF chickens experimentally infected with S. Enteritidis PT4 











































Table 12(D) Effect of oral application of E. coli strain Nissle 1917 with and without plasmid on 
the body weight of 28 days old SPF chickens experimentally infected with S. Enteritidis PT4 












































Table 13(A) Effect of oral application of E. coli strain Nissle 1917 with and without plasmid on 
the immunological parameters of 7 days old SPF chickens experimentally infected with  
S. Enteritidis 
Samples Nr. Avidin (ng/ml) IgY-anti-S.E (rU/ml) IgY-anti-E.c. (rU/ml) 
A1 1.84 78.15 68.37 
A2 0.30 9.90 18.72 
A3 42.26 10.11 32.84 
A4 1.07 23.62 105.42 
A5 0.00 16.11 65.95 
M 9.09 27.58 58.26 
SE 8.30 12.89 15.16 
B1 625.15 14.25 116.26 
B2 211.50 13.35 145.29 
B3 31.31 4.01 13.69 
B4 219.88 17.06 142.38 
B5 1337.71 6.59 121.95 
M 485.11 11.05 107.91 
SE 234.27 2.46 24.22 
C1 1.84 15.87 177.52 
C2 454.95 10.74 35.59 
C3 59.55 6.96 320.00 
C4 101.70 7.90 140.65 
C5 674.19 4.99 98.44 
M 258.45 9.29 154.44 
SE 130.66 1.89 47.64 
D1 32.09 11.16 115.24 
D2 36.00 8.69 49.76 
D3 9.56 28.21 58.73 
D4 99.30 4.66 32.39 
D5 130.74 21.79 126.20 
M 61.54 14.90 76.46 
SE 22.84 4.37 18.64 
E1 0.00 42.64 95.74 
E2 2.61 11.37 32.84 
E3 0.00 3.69 102.58 
E4 0.00 33.60 115.75 
E5 4.93 16.35 28.70 
M 1.51 21.53 75.12 








Table 13(B) Effect of oral application of E. coli strain Nissle 1917 with and without plasmid on 
the immunological parameters of 14 days old SPF chickens experimentally infected with  
S. Enteritidis 
Samples Nr. Avidin (ng/ml) IgY-anti-S.E (rU/ml) IgY-anti-E.c. (rU/ml) 
A6 2.61 2.93 22.06 
A7 1.84 4.33 25.19 
A8 0.00 4.33 21.12 
A9 2.61 3.54 55.94 
  A10 10.34 18.03 24.99 
M 3.48 6.63 29.86 
SE 1.78 2.86 6.57 
B6 0.00 7.52 23.22 
B7 545.26 5.51 91.79 
B8 1.07 10.53 37.25 
B9 106.52 8.89 56.55 
  B10 61.13 6.77 127.82 
M 142.80 7.84 67.33 
SE 102.58 0.87 19.01 
C6 511.95 45.15 31.28 
C7 18.09 2.65 39.69 
C8 22.75 15.64 26.82 
C9 225.77 3.08 16.06 
  C10 4.93 5.34 29.76 
M 156.70 14.37 28.72 
SE 97.77 8.05 3.82 
D6 184.01 11.80 39.44 
D7 152.73 12.02 34.90 
D8 39.91 6.77 74.14 
D9 4.93 7.52 40.44 
  D10 8.02 7.33 92.65 
M 77.92 9.09 56.31 
SE 37.76 1.16 11.47 
E6 14.98 12.68 44.03 
E7 0.00 3.54 11.88 
E8 0.00 3.23 38.22 
E9 8.79 8.10 42.21 
  E10 0.30 8.10 32.84 
M 4.81 7.13 33.84 






Table 13(C) Effect of oral application of E. coli strain Nissle 1917 with and without plasmid on 
the immunological parameters of 21 days old SPF chickens experimentally infected with  
S. Enteritidis 
Samples Nr. Avidin (ng/ml) IgY-anti-S.E (rU/ml) IgY-anti-E.c. (rU/ml) 
A11 2.61 2.93 9.82 
A12 7.24 14.48 58.73 
A13 1.07 1.84 29.33 
A14 0.00 5.51 125.66 
A15 1.07 3.23 42.21 
M 2.40 5.60 53.15 
SE 1.28 2.30 19.82 
B11 4.15 27.11 64.59 
B12 0.30 9.29 8.89 
B13 0.00 2.23 23.03 
B14 288.88 181.98 25.19 
B15 0.00 3.38 13.19 
M 58.67 44.80 26.98 
SE 57.56 34.58 9.88 
C11 0.30 1018.25 19.08 
C12 1.84 2.23 21.68 
C13 0.00 94.86 21.87 
C14 0.00 27.93 28.70 
C15 0.00 7.14 17.64 
M 0.43 230.08 21.79 
SE 0.36 197.73 1.90 
D11 1.84 73.76 19.63 
D12 0.00 14.94 12.21 
D13 0.30 31.01 51.48 
D14 13.43 5.34 11.40 
D15 65.08 239.58 22.64 
M 16.13 72.93 23.47 
SE 12.49 43.28 7.32 
E11 1.07 15.64 19.45 
E12 1.07 8.10 6.64 
E13 1.07 4.82 39.94 
E14 0.00 3.85 24.99 
E15 1.84 1.97 10.13 
M 1.01 6.88 20.23 







Table 13(D) Effect of oral application of E. coli strain Nissle 1917 with and without plasmid on 
the immunological parameters of 28 days old SPF chickens experimentally infected with  
S. Enteritidis 
Samples Nr. Avidin (ng/ml) IgY-anti-S.E (rU/ml) IgY-anti-E.c. (rU/ml) 
A16 0.00 6.33 10.59 
A17 0.00 2.67 33.46 
A18 0.00 13.72 339.32 
M 0.00 7.57 127.79 
SE 0.00 3.25 105.97 
B16 2.03 32.99 80.51 
B17 0.00 251.47 86.81 
B18 0.00 118.01 27.11 
B19 1.34 328.25 13.98 
B20 0.00 177.80 230.35 
M 0.67 181.70 87.75 
SE 0.43 51.25 38.41 
C16 0.00 38.98 22.75 
C17 0.00 1000.00 80.87 
C18 0.00 108.86 25.30 
C19 0.00 27.07 92.27 
C20 0.00 37.17 112.54 
M 0.00 242.42 66.75 
SE 0.00 189.95 18.17 
D16 0.00 18.32 16.61 
D17 0.00 159.97 37.98 
M 0.00 89.15 27.30 
SE 0.00 100.16 15.11 
E16 0.00 9.16 22.75 
E17 0.00 16.88 57.33 
E18 0.00 11.43 49.35 
E19 0.00 18.03 36.60 
E20 0.00 22.09 9.77 
M 0.00 15.52 35.16 











Table 14 Effect of E. coli strain Nissle 1917 (not marked) on the growth rate of the S. 
Enteritidis PT4 in vitro 
 
Time of incubation S. Enteritidis with E. coli 
Nissle 1917 (log10/ml) 
S. Enteritidis control 
(log10/ml) 
0-hour 4.57 4.56 
6-hours 5.28 7.15 
24-hours 6.18 8.65 






Table 15 Effect of E. coli strain Nissle 1917 (RIF- with plasmid) on the growth rate of the S. 
Enteritidis PT4 in vitro 
 
Time of incubation S. Enteritidis with E. coli 
Nissle 1917 (log10/ml) 
S. Enteritidis control 
(log10/ml) 
0-hour 4.54 4.56 
6-hours 5.46 7.15 
24-hours 6.16 8.65 






Table 16 Effect of E. coli strain Nissle 1917 (RIF-without plasmid) on the growth rate of the S. 
Enteritidis PT4 in vitro 
 
Time of incubation S. Enteritidis with E. coli 
Nissle 1917 (log10/ml) 
S. Enteritidis control 
(log10/ml) 
0-hour 4.37 4.56 
6-hours 5.61 7.15 
24-hours 7.01 8.65 
48-hours 6.93 8.55 
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